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 The total syntheses of isomeric aglain natural products (±)-foveoglin A and (±)-
perviridisin B have been achieved via ESIPT (excited states intramolecular proton 
transfer)-mediated selective (3+2) photocycloaddition of 3-hydroxyflavone with 
trans,trans-1,4-diphenyl-1,3-butadiene (DPBD).  Using TADDOLs or Pirkle’s alcohol as 
chiral hydrogen-bonding additives, enantioselective ESIPT photocycloaddition was 
performed providing access to (+)-foveoglin A which also enabled confirmation of its 
absolute configuration. Photophysical studies have been conducted for ESIPT 
photocycloadditions revealing the possibility for exergonic electron transfer from the 
excited triplet state of 3-hydroxyflavones to dipolarophiles with appropriate redox 
potentials, which also provided a rationale for the observed selectivity.  
Further application of ESIPT photocycloaddition using 1-alkyl-2-aryl-3-
hydroxyquinolinones (3-HQ’s) to synthesize nitrogen-containing analogues of flavaglines, 
aza-rocaglates, will be described. Differential photoreactivity between 2-aryl-3-
hydroxyquinolinones (N-H-3-HQ’s) and 1-alkyl-2-aryl-3-hydroxyquinolinones (N-alkyl-
 
 ix 
3-HQ’s) was observed. A rationale for this observation was also provided based on 
photophysical measurements. A novel method to synthesize N-alkyl-3-
hydroxyquinolinones using sodium hydride as base was discovered to overcome limited 
access to photoreaction substrates. A recirculating photoflow reactor was applied to the 
ESIPT photocycloaddition to increase the efficiency of the reaction. Initial biological 
testing indicates that aza-rocaglates do not possess activity in comparison to related 
rocaglates which also provides further information on the SAR of the natural product 
scaffold. 
Computational studies were conducted in collaboration with Prof. David Coker’s group 
using Metadynamics simulation to study tetrakis-9-phenanthrenyl TADDOL-mediated 
asymmetric ESIPT photocycloadditions. With a choice of collective variables based on 
hydrogen-bonding interactions between TADDOL and 3-hydroxyflavone, the free energy 
surfaces associated with formation of the hydrogen-bonding complexes between TADDOL 
and the 3-hydroxyflavone/methyl cinnamate or 3-hydroxyflavone/stilebene pairs were 
obtained. The representative three-component model from the obtained free energy 
minimum indicate that in addition to hydrogen-bonding interactions, π-π stacking between 
the phenanthren-9-yl groups of TADDOL and the 3-hydroxyflavone substrate also 
facilitate the asymmetric photocycloaddition which has provided information for future 
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CHAPTER ONE  
Flavagline Natural Products, Previous Synthetic Studies, and ESIPT 
Reactions 
 
1.1 Isolation of Flavagline Natural Products and their Biological Activities 
Aglaia is the largest genus of the family Meliaceae, containing more than 120 
species, and is distributed throughout the tropical rainforest areas of southeast Asia and the 
Pacific region.1 More than thirty of these plant species are found to be a rich source of the 
cyclopenta[b]benzofuran or “flavagline” class of compounds, many of which have been 
shown to possess insecticidal and anticancer activities (Figure 1.1). Since the isolation of 
rocaglamide (1), the first member of the flavaglines, by King and coworkers in 1982 from 
A. elliptifolia,2 over 100 naturally occurring derivatives of rocaglamide have been isolated 
and characterized,1 including (–)-methyl rocaglate (2),3,4 (–)-rocagloic acid (3),5 (–)-
rocaglaol (4),4 (+)-aglaiastatin (5),6  and the complex rocaglate, (–)-silvestrol (6).7  The 
cyclopenta[b]benzofuran natural products have been tested to show potential anticancer 
activity; in particular, rocaglamide (1) and silvestrol (2) have been found to exhibit 
antiproliferative activity against various human cancer cell lines at nanomolar 
concentrations. The absolute configuration for silvestrol (2) was determined by X-ray 
crystallography and the absolute stereochemical assignment of (–)-rocaglamide (1) was 
determined via total synthesis by Trost and coworkers.8 The absolute configurations of (–




asymmetric synthesis by Porco and coworkers.9 The absolute stereochemistry of (+)-
aglaiastatin (5) was confirmed via total synthesis by the Porco laboratory.10 
Figure 1.1 Rocaglates, Aglains, and Forbaglins from Genus Aglaia. 
 
The other two classes of flavaglines, cyclopenta[bc]benzopyrans (aglains) and 
benzo[b]oxepines (forbaglins), are also presented in Figure 1.1. The absolute 
configuration of the hemiaminal-containing (–)-ponapensin (7)11 and the aminal-




which suggests that the biosynthetic precursor of aglain and rocaglate natural products 
possess the opposite absolute configuration. Additionally, the C13 position of (–)-
elliptifoline (8) was reassigned to have the opposite configuration than that was reported 
in the isolation report. (–)-foveoglin A (9)13 and (+)-perviridisin B (10)14 are isomers of (–
)-ponapensin (7) with the respect of phenyl and amide substituents at C3 and C4 position. 
(–)-foveoglin A (9) was found to have NF-κB inhibitory activity (IC50 = 0.37 µM) and 
cytotoxicity towards three different cancer cell lines (ED50 = 1.4 to 1.8 µM).
13 (+)-
Perviridisin B (10) also showed NF-κB inhibitory activity (ED50 = 2.4 µM) and cytotoxicity 
towards HT-29 cancer cell lines (ED50 = 0.46 µM).
14 
(+)-Forbaglins A (11) and B (12)15 have opposite stereochemistry at C13 in 
comparison to (–)-ponapensin (7) and (–)-elliptifoline (8) and their relative configurations 
were assigned through nOe experiments and X-ray crystallographic analysis. Thus far, no 
synthetic efforts towards determining the absolute configuration and biological activity of 
the forbaglins have been reported. 
1.2 Proposed Biosynthesis of Aglains, Rocaglamides and Forbaglins 
As previously mentioned, rocaglates, aglains, and forbaglins have all been isolated 
from genus Aglaia, and have the collective name “flavaglines” as these natural products 
are all proposed to share the same biosynthetic precursors, 3-hydroxyflavone (3-HF) 13 
and cinnamic amides 14. Proksch and coworkers16 have proposed that a formal (3+2) 
cycloaddition between 13 and 14 via a Michael addition/aldol reaction sequence should 
afford a common precursor, aglain ketone 15, for all the flavagline biosyntheses (Figure 




reduction of aglain ketone 15 provides access to aglains (17) which may be followed by 
oxidative cleavage of the C5-C10 bond to provide forbaglins (18). 
Figure 1.2 Proksch’s Biosynthetic Proposal of Flavaglines. 
 
 
An alternative biosynthetic proposal has been suggested by Staunton and 
coworkers. In their proposal, photochemical [2+2] cycloaddition between 5,7,4’-
trimethylapigenin (19) and dimethyl cinnamic amide 20 leads to 21. Further rearrangement 
to intermediate 22 followed by hydration would afford rocaglamide (1) (Figure 1.3).17 





1.3 Previous Synthetic Approaches to Rocaglates 
Due to their unique chemical structures (i.e. multiple functionalities and highly 
substituted skeletons) and fascinating biological activities, the total syntheses of rocaglates 
have been pursued by multiple synthetic organic groups. Additionally, the chemical 
synthesis of rocaglate analogues from a medicinal chemistry point of view has also been 
well documented in the past decades. This section will summarize the major advancements 
achieved in these areas in chronological order, including different approaches towards the 
rocaglate scaffold, development of asymmetric photochemistry, and biomimetic kinetic 
resolution. 
1.3.1 The First Total Synthesis of Rocaglamide and Absolute Configuration Assignment 
Scheme 1.1 Trost’s Total Synthesis of (–)-Rocaglamide. 
 
While several synthetic attempts have been reported,18,19 the first total synthesis of 
a natural flavagline (rocaglate) was accomplished by Trost and coworkers (Scheme 1.1).8 
Asymmetric conjunctive allylic annulation of compound 23 with chiral, enantiopure 
oxazepinedione 24 afforded cyclopentene 25 which established the absolute configuration 




shown), Friedel-Crafts alkylation of dimethylphloroglucinol 27 with compound 26 
followed by dehydration afforded cyclopentene 28. Selective transesterification with 
benzyl alcohol was then performed to facilitate subsequent decarboxylation. Oxidative 
cyclization with DDQ produced dihydrobenzofuran 29. Several reactions were next 
performed to progress 29 to target structure 1 including dihydroxylation, decarboxylation, 
and stereochemical inversion at C3. The total synthesis was completed in 16 steps and fully 
established the absolute configuration of (–)-rocaglamide. 
1.3.2 The Biomimetic Approach towards Rocaglate Natural Products 







Figure 1.4 Excited State Intramolecular Proton Transfer of 3-Hydroxyflavone 30. 
 
 
Based on Proksch and coworkers’ proposal, accessing the aglain ketone 
intermediates derived from 3-hydroxyflavones (3-HFs) and cinnamic derivatives should 
offer access to rocaglates through bridgehead ketone reduction or skeletal rearrangement 
(cf. Figure 1.2).16 In 2004, Porco and coworkers reported a unified biomimetic approach 
to rocaglamide, aglain, and forbaglin cores employing a biomimetic (3+2) 
photocycloaddition of 3-hydroxyflavones with methyl cinnamate (Scheme 1.2a).20 Upon 
photo-irradiation of 3-HF 30 ( 350 nm) excited state intramolecular proton transfer 
(ESIPT)21 may occur to generate an oxidopyrylium intermediate  (T1 excited state) (Figure 
1.4) which could be trapped with a dipolarophile (e.g. trans-methyl cinnamate 31) to afford 
the key aglain scaffold 32. Forbaglin core 33 was then synthesized by treatment of 32 with 
Pb(OAc)4 leading to oxidative fragmentation. Rocaglate core 35 may be obtained through 





The total synthesis of (±)-methyl rocaglate (2) was then achieved using this 
methodology (Scheme 1.2b). Upon photo-irradiation of 3-hydroxyflavone 13 in presence 
of methyl cinnamate 31, aglain 36 and benzo[b]cyclobutapyran-8-one 37 were obtained. 
Conversion of both 36 and 37 to α-ketol rearrangement product 38 using sodium methoxide 
followed by hydroxyl-directed reduction efficiently yielded (±)-methyl rocaglate (2). This 
approach proved a significant advance towards the synthesis of flavagline natural products, 
as rocaglamide, aglain, and forbaglin natural products could all be accessed through this 
method. 
Subsequently, Porco and coworkers developed an enantioselective variant of the 
(3+2) photocycloaddition and applied this methodology to the syntheses of (–)-methyl 
rocaglate (2), (–)-rocaglamide (1), (–)-rocagloic acid (3), and (–)-rocaglaol (4) (Scheme 
1.3). Using tetrakis-1-pyrenyl TADDOL 3922 as a chiral hydrogen-bonding template, 
enantioselective ESIPT photocycloaddition was achieved in 86% ee (measured from 
rocaglate 2). After recrystallization, the enantiomeric excess was enhanced to 94% with 











Scheme 1.3 Enantioselective Syntheses of (–)-Rocaglamide and Congeners 
 
Krapcho decarboxylation of β-ketoester ent-38 using lithium chloride, followed by 
hydroxyl-directed reduction, produced (–)-rocaglaol (4) in 96% ee after recrystallization. 
(–)-Rocaglamide (1) was obtained from (–)-methyl rocaglate (2) through saponification to 
(–)-rocagloic acid (3), and subsequent amide coupling with dimethylamine. Using this 
method, the absolute configurations of (–)-methyl rocaglate (2), (–)-rocagloic acid (3), and 
(–)-rocaglaol (4) were confirmed. Furthermore, this methodology by Porco and coworkers 
has been recognized as a major advancement in the field of enantioselective 
photochemistry.23 Porco and coworkers subsequently applied this methodology to the total 
synthesis of the complex rocaglate natural product (–)-silvestrol (6).24 Rizzacasa and 






Scheme 1.4 Porco’s Enantioselective Total Syntheses of (+)-Ponapensin (7) and (+)-Elliptifoline (8), 
Enantiomers of the Natural Metabolites 
 
With this biomimetic asymmetric approach towards rocaglates in hand, Porco and 
coworkers also studied the enantioselective total syntheses of two aglain natural products, 
(+)-ponapensin (7) and (+)-elliptifoline (8) (Scheme 1.4).12 Enantioselective ESIPT 
photocycloaddition of 3-hydroxyflavone 13 and methyl cinnamate 31 was performed in the 
presence of a stoichiometric amount of TADDOL 40 as a chiral hydrogen-bonding additive 
to yield aglain ketone in 69% yield and 3:1 dr. After recrystallization in acetonitrile, ketone 
hydrate (+)-36 was obtained as a single compound. Reduction of hydrate (+)-36 with 
sodium triacetoxyborohydride afforded aglain (+)-41 in 10:1 dr. The enantiomeric excess 
of (+)-41 was then enhanced to 98% via two recrystallizations and absolute 
stereochemistries were confirmed by X-ray analysis. Subsequent ester-amide exchange 
using trimethylaluminum afforded amide-acetal (+)-43, which was subjected to a CSA-




tiglic amide 44 as nucleophile instead of methanol, (+)-elliptifoline (8) was obtained, which 
resulted in stereochemical reassignment of the C13 position. More interestingly, after 
optical rotation measurement, Porco and coworkers concluded that the synthetic aglain 
natural products were the enantiomers of the natural samples. Since ketone hydrate (+)-36 
was confirmed to be the synthetic precursor toward (–)-methyl rocaglate (2), they proposed 
that in nature an enzymatic, kinetic resolution may occur on the racemic aglain ketone core 
structure. In this resolution, (+)-aglains selectively undergo ketol rearrangement/reduction, 
and (–)-aglains are reduced leading to enantiopure (–)-rocaglates and (–)-aglain scaffolds, 
respectively. 
Scheme 1.5 Porco’s Asymmetric Total Synthesis of (+)-Aglaiastatin and (–)-Aglaroxin C 
 
This biosynthetic proposal also led to the development of a biomimetic kinetic 
resolution using chiral, racemic aglain ketone hydrate (±)-36 to produce enantiopure 
rocaglates by Porco and coworkers (Scheme 1.5).10 A highly enantio- and 
diastereoselective transfer hydrogenation of racemic aglain ketones was developed using 




catalyst. Using this protocol, (–)-41 was obtained in 45% yield and in 96% ee with recovery 
of enantiopure starting material in 42% yield. Ketol rearrangement of (+)-36, followed by 
ester-amide exchange and subsequent hemiaminal formation, led to the formation of 46. 
Heating 46 with ammonium acetate produced (+)-aglaiastatin (5) which was then 
transformed to (–)-aglaroxin C (47) by DDQ-mediated dehydrogenation. 
1.3.3 Frontier’s and Tius’ Approaches to Rocaglamide via Nazarov Cyclization 
Scheme 1.6 Frontier’s Synthesis of (±)-Rocaglamide (1) 
 
Frontier and coworkers also reported a synthesis of (±)-rocaglamide (1) which 
utilized the Nazarov cyclization as a key step.27 Vinyl magnesium bromide addition to 




double bond cleavage, furnished aldehyde 49. Lithium phenylacetylide addition to 49, 
followed by protection of the derived propargyl alcohol, afforded propargyl ether 50, which 
was then transformed to stannyl alkoxyallene 51 by trapping the allenyl anion (generated 
by tert-butylithium deprotonation) with tri-n-butyltin chloride. Epoxidation of 51 using m-
CPBA afforded epoxide intermediate 52 which underwent rearrangement to pentadienyl 
cation 53 and subsequent Nazarov cyclization afforded the tricyclic core structure 54. 
Removal of the para-methoxybenzyl (PMB) protecting group by DDQ followed by 
triflation and palladium(0)-catalyzed carbonylation furnished the α,β-unsaturated ketone 
55. Diastereoselective hydrogenolysis of 55 provided a keto-rocaglate intermediate, which 
was subjected to hydroxyl-directed reduction with sodium triacetoxyborohydride, 
saponification, and amide coupling yielded (±)-rocaglamide (1). A similar Nazarov 
cyclization strategy was also utilized by Magnus and coworkers to synthesize intermediate 
55 in a shorter step-count to achieve a formal synthesis of (±)-methyl rocaglate (2).28 
More recently, Tius and coworkers reported an enantioselective synthesis of both 
enantiomers of rocaglamide (1) as shown in Scheme 1.7.29 Diketo-ester 56 was treated 
with palladium(0) and a TADDOL-derived phosphoramidite ligand 57 to afford 
cyclopentenone 58 in 89:11 e.r., which set the stereochemistry at the C3 (rocaglamide 
numbering) position that will control all the subsequently introduced stereocenters. 
Treatment of 58 with PIFA in presence of allyl alcohol installed an allyloxy group at the 
C3a position stereoselectively. Exposure of the product to Meerwein’s salt ([Me3O
+][BF4
-
]) followed by ester hydrolysis and amide coupling led to production of enol ether 59. With 




lithiated and transmetallated with LaCl3·2LiCl prior to exposure to 59, thereby producing 
tertiary alcohol 61 as a single isomer. After recrystallization of 61 leading to the recovery 
of highly optically enriched 61 (98.5:1.5 e.r.) in 75% yield from the mother liquor, 
selenium dioxide-mediated removal of the allyl protecting group followed by treatment 
with potassium tert-butoxide afforded dihydrobenzofuran intermediate 62. Methyl enol 
ether cleavage using magnesium iodide (MgI2) produced a keto-rocaglamide derivative 
which was afforded (–)-rocaglamide (1) after hydroxyl-directed reduction using sodium 
triacetoxyborohydride. 
Scheme 1.8 Tius’ Asymmetric Synthesis of (–)-Rocaglamide (1). 
 
1.4   Development of ESIPT Photoreaction Methodologies 
As shown in the previous section, ESIPT photocycloaddition has been proven to be 




important photochemical process, ESIPT-mediated photoreaction/photocycloaddition has 
drawn attention from other groups. In 1965, Weller and coworkers first reported ESIPT of 
salicylic ester substrate 63 and upon photoirradiation, the photoexcited tautomer T* was 
observed by fluorescence measurements (Figure 1.5).30 For aromatic organic compounds, 
ESIPT generally arises upon electronic excitation when both acidic and basic 
functionalities on the molecule experience simultaneous enhancement of acidity and 
basicity. Although this phenomenon has been widely utilized in some modern designs for 
photostabilizers,31 fluorescent chemosensors,32 scintillators,33 and solar collectors,34 use of 
ESIPT photoexcited tautomeric intermediates to synthesize novel molecular scaffolds have 
not been extensively reported until recently. This section will serve to summarize the major 
advancements in ESIPT photoreaction/cycloaddition methodology.  
Figure 1.5 First Reported Excited State Intramolecular Proton Transfer of Salicylic Ester 63. 
 
1.4.1 Yate’s and Wan’s ESIPT Reaction Discovery 
The first ESIPT reaction reported by Yates and coworkers was based on 
photohydration of (o-hydroxyphenyl)acetylene 64 (Scheme 1.9a).35 Upon photoexcitation, 
(o-hydroxyphenyl)acetylene 64 was transformed into a o-hydroxyacetophenone 66 under 
mild aqueous acidic conditions. More recently, Freccero and coworkers reported that (o-
hydroxyphenyl)acetylenes can react with propylamine to afford compound 67 via an 





generated vinylidene quinone methides 65b were characterized using transient 
spectroscopic measurements. Although ESIPT processes have been reported before, this 
report represented the first irreversible ESIPT photochemical process. Subsequently, Wan 
and coworkers reported the first example of ESIPT from phenol to a phenyl group.37 2-
Phenylphenol 68 was irradiated in a mixture of D2O/CH3CN and deuterium-incorporated 
products 70 and 72 were observed (Scheme 1.9b), indicating that upon photoexcitation, 
ESIPT may occur from the phenol moiety to the 2-phenyl group to afford quinone methide 
intermediates 69a or 69b which may undergo reverse proton transfer to yield 70. 
Alternatively, ESIPT through the protic solvent D2O would allow formation of quinone 
methide intermediate 71 which led to formation of 72 by reverse proton transfer. 
Since this deuterium incorporation experiments unambiguously demonstrated the 
formation of the ESIPT intermediate, Wan and coworkers subsequently reported an ESIPT 
cyclization utilizing o-hydroxybiaryl substrate 73 (Scheme 1.9c).38 Water-mediated ESIPT 
occurred from the phenol moiety to the 7-carbon atom of the accepting naphthyl ring to 
bring about a novel ring closure to form dihydrobenzoxanthene 74 in high yield. 
Compound 74 was readily oxidized to 1,9-benzoxanthene 75 by refluxing in toluene in the 
presence of catalytic amounts of Pd/C. A similar deuterium incorporation experiment was 
also performed to probe the mechanism of the reaction. Photoexcitation of substrate 73 in 
the presence of D2O/CH3CN led to formation of deuterium-incorporated product 77 via 
intermediate 76a or 76b. In addition, ESIPT to the 2ʹ-carbon atom of the naphthyl ring also 




Wan and coworkers also reported that by extending aromatic ring system of a o-
hydroxybiaryl compound from a naphthyl to an anthracenyl group, a different type of 
ESIPT occurred (Scheme 1.9d).38 Following deuterium-labelling experiments, compound 
80 was proposed to undergo a long range ESIPT process assisted by deuterium oxide to 
produce the quinone methide intermediate 82. Subsequently, addition of H2O (or D2O) may 
form compound 83 and enolization of 82 would generate deuterated product 84. 







1.4.2 Kutateladze’s ESIPT Photocycloaddition Methodology 
As demonstrated in the previous section, irreversible ESIPT processes will lead to 
the formation of new products through a unique mechanism. More recently, Kutateladze 
and coworkers have reported highly interesting ESIPT-mediated reactions to access novel 
scaffolds that traditional chemical reactions were not able to. Using an o-azaxylylene as a 
photoexcited intermediate, Kutateladze and coworkers reported a number of novel, 













Scheme 1.10 Kutateladze’s Photoassisted Access to Polyheterocycles 
  
For example, Kutateladze and coworkers discovered that photo irradiation of 2-
aminobenzaldehyde 85a or 2-aminoacetophenone 85b led to the formation of o-
azaxylylenes 86a/86b as ESIPT intermediates which may be trapped by the pendant furan 
in an intramolecular fashion to afford photocycloadducts (Scheme 1.10).39 Both [4+2] and 
[4+4] photocycloadducts were obtained in high diastereoselectivity. This reaction 
represented the first example of [4+2] and [4+4] cycloaddition reactions of photogenerated 
aza-xylylenes with unsaturated pendant groups. More interestingly, compound 89 with an 
anthraquinone moiety was also able to undergo ESIPT photocycloaddition to provide 
products 90 and 91. ESIPT photocycloaddition of enantiomerically pure precursors 
containing a cyclic amino acid such as 92a and 92b was also studied. Photocyclization of 




hydroxy epimer with a d.r. of 12.5:1 for the proline derivative and 4:1 for the thiaproline 
analogue. The polyheterocyclic core of 93 and 94 was formed stereospecifically, thus 
indicating full stereochemical control of the folding of the tether in the transition state by 
the (thia)proline moiety and 100% chirality transfer. 
Subsequently, Kutateladze and coworkers demonstrated that the aforementioned 
photo-excited aza-xylylene intermediates could also be generated from o-amido imines via 
ESIPT to undergo intramolecular cycloadditions.40 Quinoxalinones 95 and 99 bearing a 
carbonyl group conjugated to the imine were designed to not only help to generate a more 
electron-deficient photogenerated azaxylylene but also allow for utilization of an oxophilic 
Lewis acid, such as Ti(OiPr)4, to further polarize and activate the aza-xylylenes. Irradiation 
of 95 was carried out with Nichia 365 nm UV LEDs to give [4+4] cycloaddition product 
96 and [4+2] cycloaddition products 97 and 98 (Scheme 1.11a). The quinoxalinone core 
was also found to be photoreactive toward pyrrole-based unsaturated pendants, as observed 
with compound 99. Upon photo irradiation of 99, stereoselective [4+2] photocycloaddition 
occurred to produce hexacyclic compound 100. The enantiopure photocycloadduct 100 
was further modified by post-photochemical transformations into diazacanes containing a 









Scheme 1.11 Kutateladze’s Intramolecular ESIPT Photocycloaddition of o-Amido Imines and Development of 
an Asymmetric ESIPT Photocycloaddition Using Imine-Containing Chiral Auxiliaries. 
  
Since imine-containing compounds were found to be photoactive to produce ESIPT 
photocycloadducts, Kutateladze and coworkers also demonstrated that chiral oxazoline 
containing photoprecursors could also be utilized a chiral auxiliairies to undergo 
enantioselective intramolecular ESIPT photocycloadditions (Scheme 1.11b).41 
Photocycloaddition of achiral model compound 102 resulted in the clean formation of both 
[4+2] and [4+4] photoproducts 103 and 104. Hydrolysis of the hemiaminal moiety on the 




106 thus demonstrating the feasibility to utilize chiral oxazoline auxiliaries in 
diastereoselective ESIPT photocycloadditions. A number of photoprecursors bearing chiral 
oxazoline auxiliaries were subsequently synthesized and evaluated in the 
photocycloaddition. Two diastereomers, distinguishable by NMR, were formed during the 
photocycloaddition which enabled calculation of diastereomeric excess prior to the workup 
of the reaction. Compound 107 bearing a chiral t-butyl group on the oxazoline moiety 
proved to be the optimal auxiliary, providing ent-105 in 86% enantiomeric excess 
following hydrolysis of the [4+4] photocycloaddition product, and 60% ee for the [4+2] 
photocycloadduct ent-106. A preparative scale (100 mg) of this reaction was also 
conducted to yield ent-105 in 90% ee and 51% isolated yield. 
Scheme 1.12  Kutateladze’s Dearomatization of Arenes with Aza-o-xylylenes via Intramolecular ESIPT 
Photocycloaddition 
 
Kutateladze and coworkers also reported that photo-generated aza-o-xylylene 




ESIPT photocycloadditions (Scheme 1.12).42 Upon photo excitation of 108, an ESIPT 
intermediate  was generated which would further lead to excited triplet intermediate 109 
via intersystem crossing (ISC). The electrophilic N-centered radical on 109 could first 
initiate the dearomatization reaction,43 with the overall process resembling a formal 
inverse-electron-demand Diels–Alder cycloaddition to produce photocycloadduct 110 in 
47% yield. Compound 111 with a dimethoxyphenol moiety was also found to undergo 
cycloaddition, resulting in the formation of methoxycyclohexadiene product 112 which 
spontaneously hydrolyzed to cyclohexenone product 113. Aromatic amides, such as 
photoprecursor 114 also underwent photocycloaddition to provide two diastereomers. 
Upon treatment with p-TsOH, intramolecular acid-catalyzed nucleophilic capture of the 
benzylic hydroxy group of the anti-diastereomer produced a stable ketal product 115, while 
the syn-diastereomer hydrolyzed directly to enone compound 116. 
1.4.3 Porco’s ESIPT Photocycloaddition to Access Rocaglate Scaffolds 
Porco and coworkers, using optimized reaction conditions and sequences, 
demonstrated the broad substrate scope of their ESIPT photocycloaddition methodology in 
the syntheses of rocaglate analogs 117 to 131 (Scheme 1.13).44 In this study, the use of a 
CHCl3/TFE(trifluoroethanol)  (7:3) solvent mixture was found to be the optimal condition 
for the cycloadduct production as well as diastereoselectivity. Conversion of the resulting 
aglain photocycloadduct to cyclopenta[b]benzofurans was achieved using two methods. 
Methyl ester-containing aglain scaffolds could be converted to keto-rocaglates using 
sodium methoxide to induce -ketol shift. However, in some cases TMSOTf-mediated 




such as thioesters, to nucleophilic methoxide. Novel rocaglates were obtained using this 
methodology including thioester 117, Weinreb amide 118, amide 119, and nitrile 121. 
Variation of the aromatic ring of the cinnamate reaction partner also showed broad 
substrate scope, including electron withdrawing groups as found in 126, heterocycle 127, 
and diene 122. The favored endo diastereoselectivity of the ESIPT photocycloaddition is 
presumably due to a π-π stacking interactions between the aromatic group on cinnamate 
and the para-methoxyphenyl moiety on 3-hydroxyflavone 13. 
An in vitro protein translation inhibition assay of the synthetic rocaglates performed 
by Prof. Jerry Pelletier at McGill University showed that compounds 119 and 120 were the 
most potent derivatives, with IC50 values of 300-400 nM demonstrating excellent potency 
when compared with the positive control, (–)-silvestrol (6), which showed an IC50 of 100 
nM in the same assay. In vivo studies demonstrated that Weinreb amide 118 was identified 
to be a highly potent translation inhibitor, inhibiting 85% of protein synthesis over the 
course of an hour, similar to (-)-silvestrol (6). Subsequently, Weinreb amide 118 was also 
identified as a potent inhibitor of heat shock factor 1 (HSF1), a transcriptional regulator of 
tumorigenesis and other cellular processes.45 Tumor masses in mouse xenograft models 













In summary, this chapter described flavagline natural products, bioactive species 
biosynthetically generated from 3-hydroxyflavones and cinnamic derivatives. Many 
synthetic approaches towards rocaglamides have been achieved, including the first 
asymmetric synthesis by the Trost group, as well as the biomimetic approach by the Porco 




group using biomimetic, ESIPT-mediated (3+2) photocycloadditions. Although syntheses 
of rocaglates and aglain natural products have been achieved, no efforts towards isomeric 
aglain natural products, such as foveoglin A (9), have been reported. In addition to the   
ESIPT photocycloadditions reported by the Porco laboratory, other literature-reported 
ESIPT reactions and photocycloadditions were also discussed. Even though only limited 
synthetic methodologies involving ESIPT-generated intermediates can be found in the 
literature, this type of photoreaction demonstrated unique reactivity patterns, and that 
further methodology development will undoubtedly lead to new reactivity. 
In the following chapter, we will describe our efforts towards the isomeric aglain 
natural products (±)-foveoglin A (9) and (±)-perviridisin B (10), as well as the asymmetric 
synthesis of (+)-foveoglin A (9) and its absolute stereochemistry determination. These 
studies also involved a collaboration with Prof. Jayaraman Sivaguru and coworkers at 
North Dakota State University to conduct photophysical and mechanism experiments. We 
next will disclose studies involving ESIPT photocycloadditions of 3-hydroxyquinolinones 
with methyl cinnamate to access nitrogen-containing analogs, called aza-rocaglates. In 
collaboration with Professor David Coker and coworkers at Boston University, we 
additionally have studied the mechanism of the asymmetric ESIPT photocycloaddition of 
3-hydroxyflavone with cinnamates using TADDOL as a chiral additive using 
computational approaches. These studies have also served to guide our design of 






CHAPTER TWO  
Total Syntheses of Isomeric Aglain Natural Products Foveoglin A and 
Perviridisin B: The Mechanistic Studies of ESIPT Photocycloadditions 
 
2.1 ESIPT Photocycloaddition of 3-Hydroxyflavone with Diphenylbutadiene 
Although the asymmetric syntheses of (+)-ponapensin and (+)-elliptifoline were 
achieved using ESIPT photocycloaddition reactions (cf. Chapter 1.3.2),12 the isolation of 
isomeric aglain natural products such as foveoglin A13 provides new challenges for the 
application of ESIPT photocycloaddition reactions in total synthesis. Based on previous 
work carried out in the Porco laboratory demonstrating that ESIPT photocycloaddition of 
3-hydroxyflavone (3-HF, 1) with trans-stilbene 2 was able to provide photocycloadduct 3 
in 5:1 d.r. (Scheme 2.1a),44 we planned to perform an ESIPT photocycloaddition of 3-
hydroxyflavone 1 with trans,trans-1,4-diphenyl-1,3-butadiene (DPBD, 4).  In theory, if the 
photocycloaddition occurred, photocycloadducts 5-8 can potentially be generated. In 
particular, selective synthesis of diastereomers 7 and 8 could be utilized for the total 
synthesis of the congeners foveoglin A (9) and perviridisin B (10) (Scheme 2.1b). 
Retrosynthetically, we proposed that foveoglin A (9) and perviridisin B (10) could be 
formed through oxidative amidation of aldehydes 11 and 12 with the corresponding 
amines. Aldehydes 11 and 12 in turn could arise from oxidative cleavage of the styrenyl 
moiety on the aglain core structures resulting from diastereoselective reduction of 





Scheme 2.1 (3+2)-Photocycloaddition Involving 3-Hydroxyflavones with Dipolarophiles 2 and 4 and 
Retrosynthetic Analysis of the Isomeric Aglain Natural Products 
  
To begin our synthetic studies, ESIPT photocycloaddition of 3-hydroxyflavone 1 
with DPBD 4 was first conducted using standard reaction conditions (Scheme 2.2a). 
Gratifyingly, upon photoirradiation of 3-hydroxyflavone 1 and DPBD 4 in a CHCl3/TFE = 
7:3 solvent mixture at 0 °C for 12 h, substantial formation of diastereomers 7 and 8 was 
observed as an inseparable mixture in 49% yield and in 4:1 ratio of diastereomers. 
Although there was potential that extending the conjugation of the dipolarophile into a 
diene would erode selectivity of the ESIPT photocycloaddition, we observed good regio 




syntheses of 9 and 10. The inseparable mixture of diastereomers was treated with NaBH4 
in THF to afford the corresponding secondary alcohols in 5:1 d.r., which ultimately enabled 
isolation of the desired major diastereomer 13 in 32% yield. The relative stereochemistry 
of 13 was also unambiguously established by X-ray crystallographic analysis of the 
corresponding para-bromobenzoate derivative 14 (Scheme 2.2b). To further test the 
stability of 14 towards oxidative conditions, aglain derivative 13 was treated with the mild 
oxidant MnO2 which led to C-C bond oxidative fragmentation providing benzo[b]oxepine 
15, demonstrating the fragility of the C5-C10 bond. 
Scheme 2.2 ESIPT Photocycloaddition of 3-Hydroxyflavone with DPBD 4 
 
2.2 Design of a Recirculating Photoflow Reactor for the ESIPT Photocycloadditions  
We next considered conducting the ESIPT photocycloaddition of 3-HF 1 and 




previous photoreactions were all conducted in a Pyrex glass tube, several limitations were 
found during these studies: 1) limited amounts of starting material can be applied, thus 
limiting our reactions to milligram scale; 2) more than 10 hours irradiation was required 
for most of the substrates to afford useful yields and conversion; 3) low temperature (0 °C) 
was needed for the photoreaction to minimize photodegradation of 3-HF 1,46 which was 
complicated by the significant amount of heat release by the UV-lamp. The use of 
photoflow chemistry would not only alleviate these issues, but may additionally facilitate 
our reaction when compared to traditional photochemical setups/methods.47  
Figure 2.1 Design of the Rayonet Continuous Photoflow Reactor 
 
For our continuous photoflow reactor design, a Rayonet® recirculating photoflow 
reactor was constructed using PTFE Tubing (1/32"ID x 1/16"OD) (Cole-Parmer® 
Instrument Company) wrapped around a 500 mL Pyrex graduated cylinder (Figure 2.1). 
The reactor (tubing) volume was measured to be 56 mL. The reactor was placed into 
Rayonet RPR-100 photobox equipped with RPR-3500Å irradiation lamps (max = 350 nm). 




single channel pumphead, model: 120S, Waston Marlow Fluid Technology Group) using 
2 conical adapter assemblies (IDEX Health & Science, P-798). Two needle adapters (IDEX 
Health & Science, Flangeless Ferrule Tefzel®, P-300X; Flangeless Short Nut, P-335X; 
Luer Adapters, P-655) were also installed to connect the reaction flask to the peristaltic 
pump and reaction tubing. A Thermo Scientific™ Neslab CC65 Immersion Cooler was 
used as a cooling system for the photoflow reactor, which was found to maintain reaction 
temperatures below 0 °C for 8 h. 
Table 2.1  Diastereoselectivity of ESIPT Photocycloaddition.  
 
Entry Solvent Temp. Time Additive Outcome 
(7:8) [a,b] 
1 CH2Cl2 0 C, 6 h N.A. 48%, 2:1 d.r. 
2 CH2Cl2/MeOH (3:1) 0 C, 6 h N.A. 43%, 3:1 d.r. 
3 CH2Cl2 0 C, 6 h p-TsOH 37%, 3:1 d.r. 
4 CH2Cl2/i-PrOH (2:1) 0 C, 6 h N.A. 51%, 1:1 d.r. 
5 CH2Cl2 0 C, 6 h benzophenone 50%, 2:1 d.r. 
6 CH3CN/MeOH (1:1) 0 C, 6 h N.A. 47%, 2:1 d.r. 
7 THF 0 C, 6 h N.A. 47%, 3:1 d.r. 
8 CHCl3/TFE (7:3) 0C, 6 h N.A. 67%, 5:1 d.r. 






With the reciculating photoflow reactor in hand, we next studied the ESIPT 
photocycloaddition under recirculating flow conditions (Table 2.1). In comparison with 
batch photoreactions, higher yields were obtained in a shorter reaction time period and less 
photodegradation byproducts were observed. ESIPT photocycloadditions of 3-HF 1 with 
DPBD 4 using various solvents was also conducted using the Rayonet recirculating 
photoflow reactor to examine effects on diastereoselectivity. From these experiments, we 
found that although the mildly acidic alcohol trifluoroethanol (pKa = 12) was able to 
facilitate the photocycloaddition reaction and highest d.r. for production of endo-
diastereomer 7 (entry 8), use of the more acidic additive, para-toluenesulfonic acid (pKa 
= 8.5) resulted in higher photodecomposition and lowered isolated yields (entry 3). Triplet 
sensitizers such as benzophenone led to a slight increase in yield but no significant 
improvement was found (entry 5). Isopropanol in combination with dichloromethane 
provided the best solvent for production of the exo-diastereomer 8 which paved the way 
for the synthesis of perviridisin B (10).  
2.3 Total Syntheses of (±)-Foveoglin A and (±)-Perviridisin B 
With increased amounts of 7/8, and in turn aglain 13, in hand, the synthesis of (±)-
foveoglin A was next undertaken. Treatment of 13 with TBSOTf yielded the mono-
silylated compound 16; the silylation step was considered in order to prevent undesired 
oxidative fragmentation. However, 16 could not be desilylated under numerous acidic or 
fluoride-based deprotection conditions (Scheme 2.3a). Presumably, this lack of reactivity 
is due to further stabilization of the silyl group from the phloroglucinol moiety. 




protecting group and upon treatment of 13 with TMSOTf, double silylation was achieved 
to afford compound 17. The crude product was directly subjected to osmium tetroxide-
catalyzed dihydroxylation and lead (IV) acetate-mediated diol cleavage to produce 
aldehyde 18 in 71% yield. The aldehyde 18 was further reacted with amine 19 in-situ 
generate a corresponding imine intermediate which was subsequently oxidized under 
Pinnick-type oxidation conditions48 using sodium chlorite to access amidation product 20 
in 75% yield. Treatment of 20 with tetrabutylammonium fluoride then yielded (±)-
foveoglin A (9) in 6 steps and 22% over-all yield (Scheme 2.3b). 
Scheme 2.3 Total Synthesis of (±)-Foveoglin A 
 
In order to achieve the synthesis of the congener perviridisin B (10), practical 
access to the exo-diastereomer 8 was required. Therefore, the photocycloaddition of 1 with 
4 was conducted using 2:1 CH2Cl2 /iPrOH which provided the highest selectivity for 8 (cf. 




mixture using sodium triacetoxyborohydride followed by silylation with TMSOTf afforded 
10S-exo-aglain scaffold 22 (Scheme 2.4). Using the previously demonstrated double bond 
oxidative cleavage conditions with foveoglin A (9), 10S-exo-aldehyde compound 23 was 
obtained. To prepare amine 27, tiglic ester 24 was saponified and coupled with mono-Boc-
protected 1,4-diaminobutane to furnish amide 25. The allylic alcohol moiety was further 
protected with an acetate group to prevent undesired decomposition in the following 
deprotection step. Removal of the Boc protecting group using trifluoroacetic acid afforded 
amine 27 which was directly subjected to Pinnick-type oxidative amidation conditions with 
aldehyde 23 to obtain amide 28. After treatment of tetrabutylammonium fluoride for silyl 
deprotection and in situ hydrolysis of the allylic acetate with aqueous sodium bicarbonate, 
(±)-perviridisin B (10) was cleanly obtained.49 





2.4 Enantioselective Synthesis of (+)-Foveoglin A and Assignment of its Absolute 
Configuration  
Having established an efficient route towards isomeric aglain natural products 9 
and 10, asymmetric syntheses of these natural products via an enantioselective ESIPT 
photocycloaddition was studied. Although we have previously reported the 
enantioselective ESIPT photocycloaddition of 3-hydroxyflavone with methyl cinnamate 
using TADDOLs as chiral hydrogen bonding additives (cf. Section 1.3.2), the reported 
dipolarophile scope was limited to cinnamate derivatives. The use of a dipolarophile such 
as DPBD 4 which lacks the ester moiety as a potential hydrogen-bonding acceptor should 
provide further information on the previous mechanistic proposal that a host-guest 
complexation of 3-HF 1 by hydrogen-bonding additives controls enantioselectivity in 























1 12 h, -75 °C Rayonet 
(310 - 400 nm) 
PhMe/CH2Cl2 
(1:2) 
29 40%, 52% ee 
2 12 h, -75 °C Rayonet PhMe/CH2Cl2 
(1:2) 
30 39%, 45% ee 
3 12 h, -75 °C Rayonet CH2Cl2 29 41%, 69% ee 
4 12 h, -75 °C Rayonet CH2Cl2 31 30%, 49% ee 
5 5 h, -30 °C Rayonet 
Photoflow 
CH2Cl2 29 67%, 31% ee 
6 10 h, -78 °C UV-LED 
(365 - 370 nm) 
CH2Cl2 30 65%, 49% ee 
7 10 h, -78 °C UV-LED PhMe/CH2Cl2 
(1:2) 
29 31%, 71% ee 
8 10 h, -78 °C UV-LED CH2Cl2  29 67%, 83% ee 
9 10 h, -78 °C UV-LED CH2Cl2 31 41%, 71% ee 








Figure 2.2 Pirkle’s Alcohol 31 as an NMR Additive to Determine Enantiomeric Ratios of γ-Lactones. 
 
In the presence of a stoichiometric amount of a hydrogen-bonding additive, 3-HF 
1 and DPBD 4 were irradiated for 12 h at -75 °C using a Rayonet photobox and low 
temperature was maintained by a dry ice / isopropanol mixture (dry ice bath was refilled 
every hour).  Limited solubility of DPBD 4 at low temperatures was observed which 
prompted us to dilute the reaction mixture (0.005 M for 3-HF 1) to achieve homogeneity. 
The resulting crude mixture of diastereomers was directly reduced to afford aglain 13 for 
enantiomeric excess determination via chiral HPLC analysis. phenanthr-9-yl-TADDOL 29 
was found to provide the best enantioselectivity in dichloromethane (Table 2.2) while use 
of a toluene/dichloromethane solvent mixture or pyren-1-yl-TADDOL 30 did not result in 
improved enantioselectivity. Presumably, this may be due to the reduced solubility of 
DPBD 4 and pyren-1-yl-TADDOL 30 in toluene solvent. The previously mentioned 
recirculating photoflow reactor was also employed for this reaction; however, in this case 
only 31% ee was observed. More interestingly, we are able to demonstrate that a chiral 
trifluoroethanol derivative, Pirkle’s alcohol 31 can also mediate this reaction to provide 13 
in 49% ee. Pirkle’s alcohol 31 has been previously used as an additive in NMR analysis to 
determine enantiomeric ratios of γ-lactones through formation of diastereomeric 
complexes (Figure 2.2),50 and this result demonstrates the first example of using Pirkle’s 




In order to achieve more optimal temperature control for the enantioselective 
photocycloaddition and also simplify the operation of the photoreaction, a novel UV-LED 
low temperature setup was developed (Figure 2.3). A UV-LED (365 nm) light source 
provides narrow band UV emission which well covers the absorption wavelength of 3-
hydroxyflavone 1, but generates very little heat in comparison to the Rayonet photobox. 
Using a dry ice dewar with an optic window, the temperature of reaction mixture could be 
maintained at -78 °C for 10 h with only one addition of dry ice, thereby enhancing 
operational simplicity.  
Figure 2.3 Graphic Description of UV-LED Low Temperature Photoreaction Setup. 
 
Enantioselective ESIPT photocycloadditions using this new UV-LED photo 
reaction setup were then conducted. To our delight, a general improvement was observed. 
Using phenanthr-9-yl-TADDOL 29, an 83% ee was achieved after reduction of the 
inseparable mixture of diastereomers (d.r. = 6:1) by sodium borohydride to product (+)-13 
(entry 8), whereas use of pyren-1-yl-TADDOL 30 only delivered 49% ee of the product 




product. We subsequently attempted recrystallization of the product (+)-13 to obtain 
enantiopure material. However, crystals of centrosymmetric racemate (±)-13 were obtained 
with enantiomeric enrichment of the mother liquor to 93% ee. The corresponding p-
bromobenzoate (+)-14 was next prepared but also failed to provide an enantiopure crystal. 
The absolute configuration of (+)-13 was ultimately determined by comparison of a 
calculated VCD (vibrational circular dichroism) spectrum of (+)-14 with the experimental 
VCD spectrum of (+)-14.50 The latter studies were conducted in collaboration with Dr. 
Lauren Brown in the BU-CMD. 
Scheme 2.5 Asymmetric Synthesis of (+)-Foveoglin A  
 
With aglain scaffold (+)-13 in hand, we next turned our attention to synthesize (+)-
foveoglin A (9). Using the previously described synthetic sequence, (+)-13 was subjected 
to silylation, oxidative double cleavage, Pinnick-type oxidative amidation sequence to 
afford the core structure of the natural product (+)-20 in 95% ee followed by deprotection 
using TBAF to furnish (+)-foveoglin A (9) in 96% ee ([]D20 -30.0 natural (c 0.16, CHCl3), 
[]D
23 +25.3 synthetic (c 0.16, CHCl3)). As the absolute configuration of (+)-13 was 




foveoglin A (Figure 2.4) as levorotatory which showed good agreement with our previous 
observation for aglain natural products such as ponapensin (cf. Section 1.3.2).  
Figure 2.4 Absolute Configuration of Natural (–)-Ponapensin in Comparison with (–)-Foveoglin A. 
 
2.5 Mechanistic Studies of ESIPT Photocycloadditions 
Photophysical investigations were next conducted to elucidate a mechanistic 
rationale for the observed diastereoselectivity for photocycloadducts 7 and 8 as well as 
understand the comparative excited state reactivity of 3-HF 1 with various dipolarophiles 
such as methyl cinnamate 30 and trans-stilbene 2. Extensive photophysical measurements 
were first conducted to understand the ESIPT process of 3-HF 1. These studies were done 
in collaboration with Professor Jayaraman Sivaguru and Anthony Clay at North Dakota 
State University (NDSU) (now at Bowling Green State University). A dual fluorescence 
emission (fluorescence of the normal state N centered at 439 nm and the tautomer state T 
centered at 527 nm) was observed for 1 at both room temperature and 77 K (Figure 2.5 
A). The phosphorescence spectrum of 1 recorded in freezed TFE at – 78 °C (Figure 2.5 B) 
shows a max for phosphorescence emission (528 nm) indicating a triplet energy (ET) of 
54.2 kcal/mol. As the photocycloaddition occurs with various dipolarophiles, fluorescence 
quenching of 3-HF 1 in the presence of methyl cinnamate 32 and trans-stilbene 2 was 




cinnamate 32 or trans-stilbene 2, no noticeable quenching of the excited tautomer 
fluorescence signal of 3-HF 1 was observed (Figure 2.5 C-D) which indicated that the 
singlet excited state of 3-HF 1 did not play a role in the initiation of ESIPT 
photocycloadditions.  
Figure 2.5 Photophysical Studies to Probe Excited State Reactivity of 3-HF 1. 
 
A) Absorbance (blue) of 1 in TFE [1] =2.35 M. Fluorescence (red) of 1 in TFE with exc=360 nm. 
B) Phosphorescence of 1 recorded in TFE glass, exc=360 nm. C) Quenching of the fluorescence 
of 1 with varying concentrations (2.35 to 12 M) of 32 CHCl3:TFE (7:3 v/v). D) Quenching of the 
fluorescence of 1 with varying concentrations (2.35 to 12 M) of 2 in CHCl3:TFE (7:3 v/v). E) 
Absorbance of 4 (6.2 M) with addition of 1 at increasing equivalents (0 to 1.9 M) recorded in a 
mixture of CHCl3:EtOH (7:3) F) Fluorescence of 4 with addition of 1 at various equivalents (0 to 





From the quenching experiments, we were able to identify that no significant 
quenching of fluorescence signal was observed by addition of methyl cinnamate 32 or 
trans-stilbene 2. Therefore, a singlet energy transfer mechanism can likely be ruled out. 
This result is also consistent with the fact that the singlet energy of DPBD (80 kcal/mol) is 
higher than the singlet energy of 3-HF 1 (71 kcal/mol) in which singlet energy transfer is 
forbidden. Based on a previous literature report, the triplet energy of DPBD is 42 kcal/mol, 
which supports the possibility of a triplet energy transfer mechanism when considering that 
the triplet energy of 3-HF 1 is 55 kcal/mol based on the max = 520 nm observed in the 
phosphorescence spectrum of 1.  
To further study this process, our NDSU collaborators subsequently attempted to 
record the transient absorption of 3-hydroxyflavones both in the presence and absence of 
various dipolarophiles. Previous literature has already suggested that the transient 
absorption of the parent 3-hydroxyflavone 33 is complicated by overlapping absorptions 
from both the singlet and triplet excited states of the normal and the photo-tautomerized 
species.51 Unfortunately, attempts to record transient absorptions of both 1 and 33 met with 
similar complications as previously investigated 3-hydroxyflavones, namely the 
aforementioned overlapping absorptions of differential excited states, as well as low 
stability of the 3-hydroxflavones under laser irradiation. These complications ruled out the 
use of transient absorption studies to gain useful information regarding the quenching of 
the presumed triplet excited states of 1 and 33 with various dipolarophiles.  
Alternatively, as 3-hydroxyflavones are known to be antioxidants,52 a low oxidation 




photoinduced electron transfer (PET) mechanism. In order to elucidate and characterize 
excited state reactivity through a possible PET pathway, we determined the oxidation and 
reduction potentials of 3-HF 1 and various dipolarophiles using cyclic voltammetry and 
differential pulse voltammetry (Table 2.3). Based on the reduction and oxidation potentials 
as well as the excited state energy of 3-HF 1 (ET =54.6 kcal/mol), the feasibility of electron 
transfer was ascertained using the Rehm-Weller equation (Table 2.3). Inspection of Table 
2.3 reveals that exergonic electron transfer from the excited triplet state of 1 to trans,trans-
1,4-diphenyl-1,3-butadienes 1 as well as methyl cinnamate 32 is feasible. Due to lack of 
fluorescence quenching of 1 (Figure 2.5 D), electron transfer or energy transfer from the 
singlet excited state of 1 is likely not operative, so the phototautomer triplet state (3T) of 3-
HF 1 can feasibly initiate ESIPT photocycloaddition. 
Table 2.3 Photophysical and Electrochemical Parameters for Photocycloaddition of 3-HF with 
Dipolarophiles.a 
Entry Parameter 1 32 2 4 
1 ET 
(kcal/mol) 
54.2 49 55 42 
2 Ered (V) - -2.34 -1.08 -0.96 
3 G (eV) - 1.15 -0.11 -0.23 
4 G (kcal/mol) - 26.5 -2.54 -5.3 
aAll redox values were taken in MeCN as solvent. Glassy carbon was used as the working electrode for trans-
trans-1,4-diphenyl-1,3-butadiene 4 and 3-hydroxyflavone 1. A platinum (Pt) electrode was used for 1. The 
reference electrode employed was Ag/AgCl and Ag wire pseudo-electrode, respectively. 
Tertbutylammonium-hexafluorophosphate (TBAHFP) was used as the supporting electrolyte. In all cases, 
ferrocene was used as internal standard. The singlet (3.08 eV) and triplet (2.35 eV) state energies of energy 
of 1 were computed from the fluorescence and phosphorescence spectra, respectively. 
 
Based on the computed free energies from Rehm-Weller equation for 1 and 4 and 




deciphering the nature of the excited reactant initiating the (3+2) photocycloaddition 
became vital. To address this point, absorption and emission studies were performed with 
1 and 4 at varying concentrations (Figure 2.5 E-F). Examination of Figure 2.5 E shows 
that the absorption of 4 centered at 332 nm undergoes a hypochromic shift upon addition 
of 1 indicating that there is likely a distortion of diene geometry in the presence of 1. 
Similarly, the fluorescence intensity of 4 centered at 379 nm was lowered upon addition of 
1. This is likely due to the reduction in the absorptivity (hypochromic effect) of 4 by 
addition of 1. Additionally, the rise of an emission band centered at 530 nm was observed 
which matched the emission of the phototautomer of 1. These observations indicate that 
upon excitation of the reaction mixture at 320 nm, both DPBD 4 and the 3-hydroxyflavone 
1 are excited.  Due to the overlap of the absorption spectra for reaction partners 1 and 4, 
control experiments were conducted to achieve selective excitation of 1 (1 equiv.) vs. 4 (5 
equiv.) (cf. Figure 2.5A and 2.5E) for ESIPT photocycloaddition. Using a purple LED as 
light source (395 nm <  < 405 nm), photocycloadducts were produced indicating that 
selective photoexcitation of 3-HF 1 can mediate ESIPT photocycloaddition with reaction 
partners such as DPDB 4.  As a result, this adds credibility to the hypothesis that 3T of 3-









Scheme 2.6 Mechanism of ESIPT Photocycloaddition Involving Excited 3-HF 1 with Dipolarophiles 
 
According to our photochemical and photophysical studies, depending on the 
excitation wavelength of the photoreaction and type of reactants employed, 
photocycloadditions can occur through different pathways leading to (3+2) 
photocycloaddition (Scheme 5). Based on the triplet energy and redox potential of 1 and 
the nature of the dipolarophile (Table 2.3), we hypothesize that either triplet diradical or 
electron transfer pathways are available for (3+2) photocycloaddition. Irradiation of 1 
where the incident wavelength is greater than 390 nm (due to overlapping chromophores, 
competitive absorbance occurs with respect to DPBD 4 and 1 in the deep UV region 
spectrum when broad band irradiation is employed) results in the normal singlet excited 




phototautomer (1T) subsequently undergoes intersystem crossing (ISC) to the 
corresponding triplet excited state (3T). The phototautomer triplet (3T) undergoes coupling 
with a dipolarophile (e.g. stilbene 2) via a radical pathway (Scheme 2.6) resulting in 
production of the triplet diradical TDR-34 (initial bond formation at the C2 position is also 
possible). Finally, the triplet diradical TDR-34 may undergo intersystem crossing to the 
singlet diradical SDR-34 which may be followed by ring closure to the observed 
photocycloadduct 3. With dipolarophiles such as DPBD 4 and methyl cinnamate 32 which 
possess favorable redox potentials (cf. Table 2.3), an electron transfer pathway is also 
feasible resulting in the radical ion pair 35 (cf. 35a and 35b for cinnamate 32 and DPBD 
4, respectively) which undergoes subsequent addition resulting in the triplet diradical TDR-
36. The latter species undergo intersystem crossing to the singlet diradical SDR-36 which 
subsequently forms the observed photocycloadducts. We believe that the approach and the 
electronics of the donor-acceptor pair control the selectivity for the photocycloaddition. In 
addition, although an electron donor-acceptor (EDA) complex formation after 
photoinduced electron transfer was not observed from spectroscopic measurement, 
formation of an EDA complex between the excited triplet state of 1 and 4 then followed by 








2.6 ESIPT Photocycloadditions of 3-Hydroxyflavone with Unsymmetrical DPBDs 
Scheme 2.7 ESIPT Photocycloaddition of 3-HF 1 with Substituted Unsymmetrical Dipolarophiles 
 
 
Based on our mechanistic hypothesis, we also evaluated ESIPT 
photocycloadditions of 3-HF 1 with a number of DPBD and stilbene derivatives bearing 




transfer (PET) from the triplet excited state of 3-HF 1 to dipolarophile may occur. 
Therefore, installation of electron withdrawing groups on the dipolarophile may improve 
reactivity and result in enhanced yields. With this hypothesis as a guide, a number of 
diphenylbutadienes or stilbenes were then synthesized via Horner-Wadsworth-Emmons 
methodology which exclusively provided the E-olefin for the ESIPT photocycloaddition 
studies.  
For example, pentafluorophenyl DPBD 3753 was found to readily undergo ESIPT 
photocycloaddition with 3-HF 1 (Scheme 2.7a). In order to determine the regioselectivity 
for the photocycloaddition, the inseparable mixture of photocycloadducts was reduced 
using sodium borohydride followed by silylation and oxidative double cleavage to afford 
two isolable products (ratio = 4:1) in which the major product was found to be aldehyde 
40 and the minor product was a previously synthesized compound 18. This result indicated 
that upon photoirradiation, the electron-deficient pentafluorophenyl moiety of 37 may 
further stabilize negative charge after formation of a radical ion pair which appears to 
dominate the selectivity for the photocycloaddition. Additionally, a π-π stacking (donor-
acceptor) interaction (cf. 38, Scheme 2.7)53 between the phloroglucinol moiety of 1 and 
the pentafluorophenyl substituent on 37 also appears to effect the regioselectivity during 
the photocycloaddition. The free energy for ESIPT photocycloaddition of 3-HF 5 with 
pentafluorophenyl DPBD 37 was calculated to be G = -6.6 kcal/mol from Relm-Weller 
equation54, thus indicating an exergonic PET pathway.  Other dipolarophiles such as bis-
trifluoromethylphenyl DPBD 4155 underwent site-selective photocycloaddition. 




photocycloaddition with 3-HF 5 to yield 44 and 45 in 3:1 ratio after reduction. Installation 
of cyano substitution appears to attenuate photoreactivity and only decomposition of 3-HF 
1 was observed. In the case of dipolarophiles such as 46 and 47, the presence of push-pull 
substituents may lead to TICT (Twisted Intramolecular Charge Transfer)57 excited state of 
dipolarophiles which may attenuate photoreactivity via unproductive relaxations. 
Additionally, the generally low solubility of all the cyano-containing DPBDs examined 
may contribute to the lack of ESIPT photocycloaddition reactivity. 
2.7 Summary and Outlook 
In summary, selective ESIPT photocycloaddition of 3-HF 1 with trans,trans,-1,4-
diphenyl-1,3-butadiene 4 has been achieved, which has served as a key reaction step to 
accomplish syntheses of the isomeric aglain natural products (±)-foveoglin A (9) and (±)-
perviridisin B (10). Additionally, a Rayonet-based continuous photoflow reactor was 
designed for the ESIPT photocycloadditions to increase photoreaction efficiency and 
minimize byproduct formation. By choosing various solvent mixtures for these ESIPT 
photocycloadditions, the diastereomeric ratio of 7/8 could be controlled from 5:1 (by using 
CHCl3/TFE = 7:3) to 1:1 (by using CH2Cl2/isopropanol = 2:1). Diastereoselective 
reduction using borohydride reagents followed by silylation, oxidative double cleavage, 
and oxidative amidation afforded foveoglin A (9) and perviridisin B (10). An 
enantioselective variant of this ESIPT photocycloaddition was further developed by using 
a stoichiometric amount of chiral hydrogen bonding additives. Using a UV-LED as light 
source in combination with TADDOL 27 at -78 °C provided 83% enantiomeric excess of 




ee and as well as absolute configuration assignment.  Photophysical and mechanistic 
studies have been conducted for the ESIPT-photocycloadditions revealing the possibility 
for exergonic electron transfer from the excited triplet state of 3-hydroxyflavone 1 to 
dipolarophiles with appropriate redox potentials including methyl cinnamate 32 and 
DPBD’s including 4 (and 37).  ESIPT photocycloaddition of 3-HF 1 with substituted, 
unsymmetrical trans,trans-1,4-diphenyl-1,3-butadienes and stilbenes has also been 
conducted leading to site-selective photocycloadditions in some cases based on presumed 
π-π stacking (donor-acceptor) interactions. 
While we have been able to demonstrate enantioselective ESIPT 
photocycloaddition of 3-HF 1 with DPBD 4 in the synthesis of (+)-foveoglin A, 
enantioselective synthesis of related exo-aglain natural products, such as perviridisin B is 
still challenging due to the high endo-diastereoselectivity of the photocycloaddition. In 
order to achieve asymmetric exo-aglain natural product synthesis, an achiral ESIPT 
photocycloaddition followed by kinetic resolution using asymmetric transfer 
hydrogenation (cf. Section 1.3.2) on chiral racemic aglain ketone compound may provide 
a solution to this problem (Scheme 2.8).  






2.8 Experimental Section 
General Information: 1H NMR spectra were recorded at 400 or 500 MHz at ambient 
temperature with CDCl3 (Cambridge Isotope Laboratories, Inc.) as the solvent unless 
otherwise stated. 13C NMR spectra were recorded at 100 or 125 MHz at ambient 
temperature with CDCl3 as the solvent unless otherwise stated. Chemical shifts are reported 
in parts per million relative to CDCl3 (
1H, δ 7.26; 13C, δ 77.16). Data for 1H NMR are 
reported as follows: chemical shift, integration, multiplicity (br = broad, ovrlp = 
overlapping, s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet) and coupling 
constants. All 13C NMR spectra were recorded with complete proton decoupling. Infrared 
spectra were recorded on a Nicolet Nexus 670 FT-IR spectrophotometer. High-resolution 
mass spectra were obtained at the Boston University Chemical Instrumentation Center 
using a Waters Q-TOF mass spectrometer. Melting points were recorded on a Mel-temp 
apparatus (Laboratory Devices).  Analytical LCMS was performed on a Waters Acquity 
UPLC (Ultra Performance Liquid Chromatography (Waters MassLynx Version 4.1) with 
a Binary solvent manager, SQ mass spectrometer, Water 2996 PDA (PhotoDiode Array) 
detector, and ELSD (Evaporative Light Scattering Detector). An Acquity UPLC BEH C18 
1.7μm column was used for analytical UPLC-MS. Preparative HPLC was performed on a 
Gilson PLC2020 using a Waters SunFire™ Prep C18 OBD™ 5µm 1950 mm column. 
Analytical thin layer chromatography (TLC) was performed using 0.25 mm silica gel 60-
F plates (Silicycle, Inc.). Flash chromatography was performed using 200-400 mesh silica 




µm or 1000 µm silica gel 60-F plates (Silicycle, Inc.). Preparative HPLC was conducted 
using a PLC 2020 Personal Purification System (Gilson, Inc.). Yields refer to 
chromatographically and spectroscopically pure compounds, unless otherwise stated. 
Photochemistry experiments were performed using a Rayonet RPR-100 photochemical 
reactor equipped with RPR-3500Å irradiation lamps ( > 330 nm, max = 350 nm).  For the 
Rayonet photoflow reactor, a Rayonet RPR-100 photobox was used as light source and a 
Thermo Scientific™ Neslab CC65 Immersion Cooler was using as a cooling system. The 
PTFE Tubing (1/32"ID x 1/16"OD) (Cole-Parmer Instrument Company) twined around a 
500 mL Pyrex graduated cylinder and connected to a peristaltic pump (Benchtop pump 
with 114DV flip top single channel pumphead, model: 120S, Waston Marlow Fluid 
Technology Group) using 2 conical adapter assemblies (IDEX Health & Science, P-798). 
Two needle adapters (IDEX Health & Science, Flangeless Ferrule Tefzel®, P-300X; 
Flangeless Short Nut, P-335X; Luer Adapters, P-655) were also installed to connect the 
reaction flask with the peristaltic pump and reaction tubing.   For the purple-LED reactor, 
the LED strip was purchased from Amazon (Lumcrissy 12V Flexible LED Strip Lights 
Waterproof 3528 SMD 5M 300LED 300 Units LEDs Light Strip (Purple)). All other 
reactions were carried out in oven-dried glassware under an argon/nitrogen atmosphere 
unless otherwise noted. The Scilligence ELN Reaction Planner (Scilligence Corp.) was 
used for experimental procedure planning. Spectrophotometric solvents (Sigma-Aldrich®) 
were used whenever necessary unless or otherwise mentioned. UV quality fluorimeter cells 
(with range until 190 nm) were purchased from Luzchem®. Absorbance measurements 




recorded on a Horiba Scientific® Fluorolog 3 spectrometer (FL3-22) equipped with double-
grating monochromators, dual lamp housing containing a 450-watt CW xenon lamp and a 
UV xenon flash lamp (FL-1040), Fluorohub/MCA/MCS electronics and R928 PMT 
detector. Emission and excitation spectra were corrected in all the cases for source intensity 
(lamp and grating) and emission spectral response (detector and grating) by standard 
instrument correction provided in the instrument software. Fluorescence emission spectra 
were processed by FluorEssence® software. Fluorescence lifetimes were determined by 
time correlated single photon counting using a pulsed diode (NanoLED) emitting at 263 
nm and processed using DAS6® V6.4 software. The goodness-of-fit was assessed by 
minimizing the reduced chi squared function and was further judged by the symmetrical 
distribution of the residuals. Cyclic voltammetry was performed using HPLC grade 
acetonitrile as the solvent on a CH instrument. HPLC grade tetrahydrofuran, methylene 
chloride, diethyl ether, toluene, acetonitrile, and benzene were purchased from Fisher and 
VWR and were purified and dried by passing through a PURE SOLV® solvent purification 
system (Innovative Technology, Inc.). Reagents were purchased from Sigma Aldrich, 





Endo-10R-aglain 13: A 100 mL round bottom flask was charged with 3-hydroxyflavone 
5 (500 mg, 1.52 mmol, 1 equiv), DPBD 8 (1.57 g, 7.61 mmol, 5 equiv), and 75 mL of a 
CHCl3/TFE(7:3) mixture (0.02 M for 3-HF 5). The flask was connected with the continuous 
photoflow reactor and placed into a sonicator with an ice-bath. Subsequently, the peristaltic 
pump was turned on to circulate the reaction mixture and argon bubbling with sonication 
was continued for another 20 min before the UV-lamp (Rayonet, λmax = 350 nm) was turned 
on. After 6 h, the reaction mixture was collected back to the flask and concentrated in 
vacuo. Purification via flash chromatography using a gradient of hexanes/EtOAc (10:1 to 
3:1) afforded cyclopenta[bc]benzopyrans 11-12 as mixture of isomers which were used in 
next step without further purification. The isomeric ratio (11 : 12) was determined by 1H 
NMR analysis to be 5:1 (545 mg, 67% yield, 1.02 mmol).  
A flame-dried 100 mL flask was charged with a mixture of 11 and 12 (545 mg, 1.02 mmol, 
1 equiv) and THF (6.8 mL, 0.15 M). Subsequently, NaBH4 (232 mg, 6.12 mmol, 6 equiv) 
was added to the reaction at rt in one portion. The resulting mixture was then stirred for 12 
h and was quenched with ice-cooled saturated ammonium chloride. The mixture was 
extracted with CH2Cl2 (10 mL  3), washed with saturated sodium bicarbonate, and dried 
over sodium sulfate. The filtrate was concentrated in vacuo and 1H NMR analysis of the 
crude extract was obtained. NMR analysis indicated that the reduction was 
diastereoselective to favor the 10R-isomer (d.r.=5:1). Column chromatography purification 
using hexanes/EtOAc (5:1 to 3:1) afforded the aglain derivative 13 (360 mg, 44% over 2 
steps) as a white solid. After recrystallization from EtOAc, trace amounts of impurities 




13: Rf: 0.41 (hexanes: EtOAc = 1:1). m.p. = 223 °C (CH2Cl2). 
1H NMR (500 MHz, CDCl3)  7.57 (d, J = 8.9 Hz, 2H), 7.18 
(m, 3H), 7.10 (m, 3H), 6.97 (m, 2H), 6.94 (d, J = 8.9 Hz, 2H), 
6.90 (m, 2H), 6.28 (d, J = 2.3 Hz, 1H), 5.98 (d, J = 15.6 Hz, 1H), 5.87 (d, J = 2.3 Hz, 1H), 
5.49 (dd, J1 = 15.6 Hz, J2 = 8.7 Hz, 1H), 5.42 (s, 1H, OH), 4.75 (d, J = 4.8 Hz, 1H), 3.796 
(s, 3H), 3.793 (s, 3H), 3.48 (dd, J1 = 9.4 Hz, J2 = 8.7 Hz, 1H), 3.28 (d, J =9.4 Hz, 1H), 2.36 
(d, J = 4.8 Hz, 1H, OH); 13C NMR (125 MHz, CDCl3)  160.8, 160.3, 159.2, 153.4, 137.0, 
136.7, 130.1, 129.6, 129.6, 128.7, 128.2, 128.2, 127.7, 127.0, 126.9, 126.1, 113.8, 104.0, 
94.0, 92.9, 86.8, 82.0, 73.3, 61.6, 55.5, 55.4, 55.3, 53.7; IR υmax (film): 3498, 2968, 1618, 
1456, 1254, 1148, 1101, 831 cm-1. HRMS-ESI (m/z) calculated [M+Na]+ C34H32O6Na, 
559.2097, found 559.2091. 
 
Para-bromobenzoate 14: To a flame dried test tube were added aglain 13 (120 mg, 0.22 
mmol, 1 equiv), Et3N (37 L, 0.27 mmol, 1.2 equiv), DMAP (2.7 mg, 0.02 mmol, 0.1 
equiv), and dry CH2Cl2 (7.5 mL, 0.1 M) at 0 °C. Subsequently, 4-bromobenzoyl chloride 
(51.5 mg, 0.23 mmol, 1.05 equiv) was added in one portion. The resulting mixture was 
allowed to warm to room temperature and was stirred for 12 h before being quenching with 
10 mL of saturated NaHCO3 (aq.). The mixture was extracted with CH2Cl2 (5 mL  3), 





purification using hexanes/EtOAc (7:1 to 4:1) afforded the para-bromobenzoate 14 (121 
mg, 75% yield) as a white solid. 
14: Rf: 0.61 (hexanes: EtOAc = 3:1). m.p. = 244 °C (CH2Cl2). 1H 
NMR (500 MHz, CDCl3)  7.70 (d, J = 8.7 Hz, 2H), 7.54 (d, J = 
9.0 Hz, 2H), 7.42 (d, J = 8.7 Hz, 2H), 7.20 (m, 3H), 7.10 (m, 3H), 
7.01 (m, 2H), 6.91 (m, 2H), 6.88 (d, J = 9.0 Hz, 2H), 6.50 (s, 1H), 
6.36 (d, J = 2.4 Hz, 1H), 6.51 (d, J = 15.6 Hz, 1H), 5.86 (d, J = 2.4 
Hz, 1H), 5.53 (dd, J1 = 8.4 Hz, J2 = 15.6 Hz, 1H), 5.32 (s, 1H, OH), 3.86 (s, 3H), 3.74 (s, 
3H), 3.54 (dd, J1 = 9.4 Hz, J2 = 8.4 Hz, 1H), 3.49 (d, J = 9.4 Hz, 1H), 3.06 (s, 1H); 
13C 
NMR (125 MHz, CDCl3)  165.2, 160.7, 159.7, 159.2, 153.6, 136.9, 136.3, 131.5, 131.5, 
130.5, 129.2, 129.0, 128.7, 128.7, 128.2, 128.1, 127.7, 127.5, 127.1, 127.0, 126.1, 113.8, 
104.6, 93.9, 92.5, 86.5, 81.4, 72.6, 61.6, 55.5, 55.4, 55.2, 54.5; IR υmax (film): 3499, 2918, 
1726, 1617, 1589, 1266, 1148, 1099, 1012, 753 cm-1. HRMS-ESI (m/z) calculated 
[M+Na]+ C41H36O7Br 719.1644, found 719.1643. 
 
Forbaglin aldehyde 15: To a flame dried test tube were added aglain 13 (50 mg, 0.093 
mmol, 1 equiv), MnO2 (24 mg, 0.28 mmol, 3 equiv), and dry CH2Cl2 (1 mL, 0.1 M) at rt. 
The mixture was stirred at rt for 12 h before the insoluble oxidant was removed by 





using hexanes/EtOAc (4:1 to 2:1) to afford forbaglin aldehyde 15 (45 mg, 90% yield) as a 
colorless oil. 
15: Rf: 0.21 (hexanes: EtOAc = 7:3). 1H NMR (500 MHz, CDCl3) 
 9.29 (s, 1H), 7.35 (m, 2H), 7.31 (s, 2H), 7.29 (d, J = 8.9 Hz, 2H), 
7.21 (m, 4H), 7.12 (m, 2H), 6.82 (d, J = 8.9 Hz, 2H), 6.44 (d, J = 
2.3 Hz, 1H), 6.15 (dd, J1 = 15.8 Hz, J2 = 9.5 Hz, 1H), 6.06 (d, J = 15.8 Hz, 1H), 6.08 (d, J 
= 2.3 Hz, 1H), 4.22 (d, J = 9.5 Hz, 1H), 4.11 (dd, J1 = J2 = 9.5 Hz, 1H), 3.85 (s, 3H), 3.76 
(s, 3H), 3.60 (s, 3H); 13C NMR (125 MHz, CDCl3)  165.2, 160.7, 159.7, 159.2, 153.6, 
136.9, 136.3, 131.5, 131.5, 130.5, 129.2, 129.0, 128.7, 128.7, 128.2, 128.1, 127.7, 127.5, 
127.1, 127.0, 126.1, 113.8, 104.6, 93.9, 92.5, 86.5, 81.4, 72.6, 61.6, 55.5, 55.4, 55.2, 54.5; 
IR υmax (film): 3499, 2918, 1726, 1617, 1589, 1266, 1148, 1099, 1012, 753 cm
-1. HRMS-
ESI (m/z) calculated [M+Na]+ C41H36O7Br 719.1644, found 719.1643. 
 
TMS-aglain 17: A flame dried test tube was charged with aglain 13 (200 mg, 0.37 mmol, 
1 equiv) and dry CH2Cl2 (2.5 mL, 0.15 M). The solution was cooled to 
 -78 °C before Et3N (130 L, 0.93 mmol, 2.5 equiv) and TMSOTf (148 L, 0.82 mmol, 
2.2 equiv) were added. The resulting mixture was stirred at -78 °C for another 10 min 
before warming up to 0 °C. After 1 h, the reaction was quenched with 5 mL of saturated 
NaHCO3 (aq.). The mixture was extracted with CH2Cl2 (3 mL  3), washed with saturated 





hexanes/EtOAc (20:1 to 15:1) afforded TMS-aglain 17 (249 mg, 98% yield) as a colorless 
oil.  
17: Rf: 0.67 (hexanes: EtOAc = 4:1). 1H NMR (500 MHz, CDCl3) 
 7.53 (d, J = 8.9 Hz, 2H), 7.11 (m, 5H), 7.05 (m, 1H), 7.00 (m, 
2H), 6.93 (d, J = 8.9 Hz, 2H), 6.19 (d, J = 2.4 Hz, 1H), 5.92 (d, J = 
15.9 Hz, 1H), 5.73 (d, J = 2.4 Hz, 1H), 5.50 (dd, J1 = 15.9 Hz, J2 = 
7.4 Hz, 1H), 4.60 (s, 1H, OH), 3.82 (s, 3H), 3.80 (s, 3H), 3.39 (d, J = 10.7 Hz, 1H), 3.33 
(dd, J1 = 10.7 Hz, J2 = 7.4 Hz, 1H), 2.94 (s, 3H), 0.04 (s, 9H), -0.22 (s, 9H); 
13C NMR (125 
MHz, CDCl3)  194.8, 192.7, 163.2, 160.1, 159.4, 159.0, 136.5, 136.2, 135.3, 130.4, 129.7, 
128.4, 128.2, 127.8, 127.3, 126.4, 125.5, 123.9, 115.0, 114.5, 98.0, 94.4, 91.7, 62.1, 56.1, 
55.7, 55.2, 52.0; IR υmax (film): 2937, 2848, 1696, 1607, 1512, 1456, 1403, 1260, 1155, 
1104, 830, 751, 698 cm-1. HRMS-ESI (m/z) calculated [M+H]+ C40H49O6Si2, 681.3068, 
found 681.3069. 
 
Endo-10R-TMS-aldehyde 18: A test tube was charged with TMS-aglain 17 (249 mg, 0.37 
mmol, 1 equiv), THF (4.7 mL) and t-BuOH (4.7 mL). Subsequently, 0.93 mL OsO4 (aq., 
10 mg/mL) (9.3 mg, 0.036 mmol, 0.1 equiv) was added to the solution followed by addition 
of N-methylmorpholine oxide (NMO) (128.5 mg, 1.1 mmol, 3 equiv). The resulting 
mixture was stirred at room temperature for 12 h before 10 mL of saturated NaCl (aq.) was 





and dried over sodium sulfate. The filtrate was concentrated in vacuo to afford the diol 
compound as a brown oil which was subjected to next step without further purification. 
The brown oil was dissolved in a test tube with 10 mL of CH2Cl2. Subsequently, Pb(OAc)4 
(243 mg, 0.55 mmol, 1.5 equiv) was added. The resulting solution was stirred at room 
temperature for 20 min before 20 mL saturated Na2S2O3 was added to quench the reaction. 
The mixture was extracted with CH2Cl2 (10 mL  3), washed with saturated NaCl (aq.), 
and dried over sodium sulfate. Column chromatography purification using hexanes/EtOAc 
(15:1 to 10:1) afforded endo-TMS-aldehyde 18 (158 mg, 71% yield) as a colorless oil. 
18: Rf: 0.35 (hexanes:EtOAc = 3:17). 1H NMR (500 MHz, 
CDCl3)  8.94 (d, J = 2.8 Hz, 1H), 7.54 (d, J = 8.8 Hz, 2H), 7.11 
(m, 3H), 6.98 (d, J = 8.8 Hz, 2H), 6.92 (m, 2H), 6.21 (d, J = 1.2 
Hz, 1H), 5.76 (d, J = 1.2 Hz, 1H), (d, J = 1.2 Hz, 1H), 4.53 (s, 
1H, OH), 3.88 (d, J = 10.6 Hz, 1H), 3.84 (s, 3H), 3.82 (s, 3H), 3.52 (dd, J1 = 10.6 Hz, J2 = 
2.8 Hz, 1H), 2.94 (s, 3H), 0.04 (s, 9H), -0.22 (s, 9H); 13C NMR (125 MHz, CDCl3)  160.7, 
160.0, 158.9, 154.1, 137.6, 137.3, 130.8, 130.1, 130.0, 128.9, 128.1, 127.7, 126.84, 126.77, 
126.2, 126.0, 113.1, 106.7, 92.7, 91.4, 86.2, 83.4, 78.7, 59.7, 55.3, 55.1, 53.9, 52.4, 2.1, 
1.3; IR υmax (film): 2957, 1721, 1613, 1587, 1516, 1465, 1250, 1195, 1151, 1110, 1035, 







TMS-foveoglin A 20: A flame-dried test tube was charged with endo-TMS-aldehyde 18 (150 mg, 
0.25 mmol, 1 equiv), amine 1958 (238 mg, 1.24 mmol, 5 equiv) and dry toluene (2.5 mL, 0.1 M) 
under argon. The mixture was stirred at room temperature for 5 min before NaH2PO4 (104 mg, 0.87 
mmol, 3.5 equiv), 2-methyl-2-butene (0.26 mL, 2.5 mmol, 10 equiv) and NaClO2 (72 mg, 0.79 
mmol, 3.2 equiv) were consecutively added. The resulting heterogeneous mixture was stirred for 
48 h at room temperature. The reaction mixture was then filtered to remove insoluble inorganic 
salts. And the filtrate was concentrated in vacuo. Column chromatography purification using 
hexanes/EtOAc (6:1 to 3:1) afforded TMS-foveoglin A 20 (147 mg, 71% yield) as a colorless oil.  
20: Rf: 0.37 (hexanes: EtOAc = 1:1). 1H NMR (500 MHz, CDCl3) 
 7.82 (m, 2H), 7.58 (d, J = 8.8 Hz, 2H), 7.50 (m, 1H), 7.44 (m, 
2H), 7.08 (m, 3H), 6.92 (m, 2H), 6.85 (d, J = 8.8 Hz, 2H), 6.64 
(t, J = 5.8 Hz, 1H, NH), 6.15 (d, J = 2.5 Hz, 1H), 5.73 (d, J = 2.5 
Hz, 1H), 5.23 (t, J = 5.7 Hz, 1H, NH), 4.65 (s, 1H, OH), 4.02 (d, J = 10.2 Hz, 1H), 3.79 (s, 3H), 
3.77 (s, 3H), 3.25 (m, 1H), 3.12 (m, 1H), 3.07 (d, J = 10.2 Hz, 2H), 2.93 (s, 3H), 2.74 (m, 1H), 2.49 
(m, 1H), 1.07 (m, 2H), 0.84 (m, 2H), 0.03 (s, 9H), -0.27 (s, 9H); 13C NMR (125 MHz, CDCl3)  
169.8, 167.4, 160.8, 160.0, 159.3, 153.5, 137.6, 134.6, 131.3, 130.2, 128.9, 128.4, 128.0, 127.0, 
126.9, 126.3, 113.0, 107.0, 92.8, 91.8, 84.7, 83.1, 78.5, 58.8, 55.4, 55.1, 53.9, 39.4, 38.9, 26.23, 
26.21, 2.1, 1.2; IR υmax (film): 3308, 2958, 2904, 1642, 1614, 1615, 1520, 1151, 1112, 1040, 905, 






Foveoglin A 9: A flame dried test tube was charged with TMS-foveoglin A 20 (120 mg, 
0.15 mmol, 1 equiv) and dry THF (2 mL). Subsequently, TBAF (1 M THF solution, 0.36 
mL, 0.36 mmol, 2.4 equiv) was added dropwise. The resulting mixture was stirred for 12 
h before 5 mL of saturated NaCl (aq.) was added to quench the reaction. The mixture was 
extracted with EtOAc (5 mL  3), washed with saturated NaCl (aq.), and dried over sodium 
sulfate. The filtrate was concentrated in vacuo. Column chromatography purification using 
hexanes/EtOAc (2:1 to 1:2) afforded foveoglin A 9 (94 mg, 96% yield) as an amorphous 
solid.  
9: Rf: 0.51 (EtOAc). m.p. = 153 °C (CH2Cl2). 1H NMR (500 
MHz, CDCl3)  7.81 (d, J = 7.5 Hz, 2H), 7.61 (d, J = 8.9 Hz, 
2H), 7.52 (t, J = 7.3 Hz, 1H), 7.47 (t, J = 7.8 Hz, 2H), 7.16 
(m, 3H), 6.93 (m, 2H), 6.89 (d, J = 8.9 Hz, 2H), 6.47 (brt, J 
= 5.7 Hz, 1H, NH), 6.25 (d, J = 2.3 Hz, 1H), 5.85 (d, J = 2.3 Hz, 1H), 5.54 (brt, J = 5.9 Hz, 
1H, NH), 5.43 (s, 1H, OH), 4.91 (d, J = 5.5 Hz, 1H), 4.00 (d, J = 9.0 Hz, 1H), 3.78 (s, 3H), 
3.77 (s, 3H), 3.29 (m, 1H), 3.23 (d, J = 9.0 Hz, 1H), 3.15 (m, 1H), 3.10 (s, 3H), 2.92 (m, 
1H), 2.60 (m, 1H), 2.31 (d, J = 5.5 Hz, 1H, OH), 1.14 (m, 2H), 0.96 (m, 2H); 13C NMR 
(125 MHz, CDCl3)  169.9, 167.4, 160.8, 160.3, 159.3, 152.9, 136.9, 134.6, 131.4, 129.2, 





57.1, 55.5, 55.4, 39.4, 39.0, 26.3, 26.2; IR υmax (film): 3375, 2955, 1641, 1618, 1517, 1492, 
1458, 1305, 1254, 1148, 1105, 1037, 833 cm-1. HRMS-ESI (m/z) calculated [M+H]+ 






natural (–)-3 synthetic (±)-3 
(this work) 
Positions 
δ lit (CDCl3) 
(JH-H in Hz) 
δ (500 MHz, CDCl3) 
(JH-H in Hz) 
2   
3 3.22, d (9.0) 3.23, d (9.0) 
4 4.00, d (9.0) 4.00, d (9.0) 
5   
5-OH 5.44, s 5.43, s 
5a   
6   
7 5.86, d (2.2) 5.85, d (2.3) 
8   
9 6.26, d (2.2) 6.25, d (2.3) 
9a   
10 4.91, s 4.91, d (5.5) 
10-OH  2.31, d (5.5) 
11   






14 0.98, m 0.96, m 








NH-17 6.46, brt (5.5) 6.47, brt (5.7) 
18   
19   
20, 24 7.82, d (8.0) 7.81, d (7.5) 
21, 23 7.47, t (7.7) 7.47, t (7.8) 
22 7.53, t (7.2) 7.52, t (7.3) 
1’   
2’, 6’ 7.62, d (8.9) 7.61, d (8.9) 
3’, 5’ 6.89, d (8.7) 6.89, d (8.9) 
4’   
1’’   
2’’, 6’’ 6.93, m 6.93 m 
3’’, 5’’ 7.16, m 7.16, m 
4’’ 7.16, m 7.16, m 
OCH3-6 3.11, s 3.10, s 
OCH3-8 3.79, s 3.78, s 





natural (–)-3 synthetic (±)-3 
(this work) 
Positions δ lit. (CDCl3) δ (125 MHz, CDCl3) 
2 85.6 85.6 
3 59.0 59.0 
4 57.1 57.1 
5 81.8 81.8 
5-OH   
5a 104.2 104.3 
6 160.3 160.3 
7 93.0 93.0 
8 160.8 160.8 
9 93.9 94.0 
9a 152.8 152.9 
10 73.5 73.5 
10-OH   
11 170.0 170.0 
NH-12   




14 26.2 26.2 
15 26.3 26.3 
16 39.4 39.4 
NH-17   
18 167.5 167.4 
19 134.5 134.6 
20, 24 127.0 127.0 
21, 23 128.6 128.6 
22 131.5 131.4 
1’ 129.2 129.2 
2’, 6’ 128.0 128.0 
3’, 5’ 113.6 113.5 
4’ 159.3 159.3 
1’’ 136.8 140.7 
2’’, 6’’ 128.6 128.5 
3’’, 5’’ 127.7 127.7 
4’’ 127.0 127.0 
OCH3-6 55.5 55.5 
OCH3-8 55.4 55.4 
OCH3-4’ 55.4 55.4 
 
 
Exo-10S-TMS-aglain 22: A 100 mL round bottom flask was charged with 3-
hydroxyflavone 1 (500 mg, 1.52 mmol, 1 equiv) and DPBD 4 (1.57 g, 7.61 mmol, 5 equiv) 
in 75 mL of CH2Cl2/i-PrOH (2:1) (0.02 M for 3-HF 5). The flask was connected with the 
continuous photoflow reactor followed by degassing with argon gas for 10 min. 
Subsequently, the peristaltic pump was turned on to circulate the reaction mixture and the 
argon gas was kept for another 10 min before the UV-lamp (Rayonet, λ > 315 nm) was 




under vacuum. Purification via flash chromatography using a gradient of hexanes/EtOAc 
(10:1 to 3:1) afforded cyclopenta[bc]benzopyrans 7 and 8 as mixture of isomers which 
were used in next step without further purification. The isomeric ratio was determined 
using 1H NMR analysis to be 1:1 (426 mg, 52% yield, 0.8 mmol). A flame-dried 100 mL 
flask was charged with NaBH(OAc)3 (1.01 g, 4,78 mmol, 6 equiv) and HOAc (0.27 mL, 
4.78 mmol) in PhCF3 (20 mL) at rt under argon. The mixture was then sonicated briefly 
and stirred at rt for 10 min. A mixture of 7 and 8 (426 mg, 0.8 mmol, 1 equiv) in 20 mL of 
PhCF3 (0.02 M) was then added at rt at one portion under argon. The resulting mixture was 
then stirred for 14 h and was quenched with saturated ammonium chloride. The mixture 
was extracted with CH2Cl2, washed with saturated sodium bicarbonate, dried over sodium 
sulfate, and the filtrate concentrated in vacuo. 1H NMR analysis of the crude extract 
indicated that the reduction was diastereoselective in favor of the 10S-isomer (d.r.= 10:1). 
Column chromatography purification using hexanes/EtOAc (5:1) afforded an inseparable 
mixture of isomeric aglains (4 isomers combined, 406 mg, 95% yield) which was used in 
the next step without further purification. Preparative thin layer chromatography 
purification of 20 mg mixture material using hexanes/EtOAc (9:1) afforded pure 21 (15 
mg, 0.028 mmol). 
To a flame dried test tube were added the mixture of isomeric aglains (406 mg, 0.76 mmol, 
1 equiv), Et3N (0.33 mL, 2.39 mmol, 3 equiv) and CH2Cl2 (7.5 mL, 0.1 M). After the 
resulting mixture was cooled to -78 °C, TMSOTf (290 L, 1.6 mmol, 2 equiv) was added 
dropwise before the temperature was raised to 0 °C for 1 h. Ice-cooled saturated sodium 




extraction. The combined organic layer was washed with saturated sodium chloride and 
dried over sodium sulfate. The filtrate was concentrated in vacuo and purified by column 
chromatography using a gradient of hexanes/Et2O (30:1 to 20:1). Exo-10S-TMS-aglain 22 
(186 mg, 0.35 mmol) was obtained in 23% yield from the 3-HF 1 as a colorless oil.  
21: Rf: 0.30 (hexanes: EtOAc = 7:3). 1H NMR (500 MHz, CDCl3) 
 7.74 (d, J = 9.0 Hz, 2H), 7.49 (d, J = 7.3 Hz, 2H), 7.36 (t, J = 7.3 
Hz, 2H), 7.28 (d, J = 7.3 Hz, 1H), 7.20 (m, 4H), 7.12 (m, 1H), 6.96 
(d, J = 9.0 Hz, 2H), 6.83 (dd, J1 = 16 Hz, J2 = 8.3 Hz, 1H), 6.28 (d, 
J = 2.3 Hz, 1H), 6.25 (d, J = 16 Hz, 1H), 6.14 (d, J = 2.3 Hz, 1H), 5.18 (s, 1H, OH), 4.40 
(s, 1H, OH), 4.37 (dd, J1 = 8.3 Hz, J2 = 7.7 Hz, 1H), 3.88 (s, 3H), 3.82 (s, 3H), 3.81 (s, 3H), 
3.65 (d, J = 7.7 Hz, 1H), 2.90 (s, 1H, OH); 13C NMR (125 MHz, CDCl3)  160.5, 159.3, 
155.9, 153.9, 140.4, 137.2, 132.1, 130.2, 130.1, 128.8, 128.2, 128.1, 127.8, 127.1, 126.7, 
126.2, 113.6, 113.3, 94.2, 92.3, 88.3, 81.6, 79.7, 64.9, 57.2, 56.1, 55.5, 55.2; IR υmax (film): 
3497, 3027, 2939, 1615, 1589, 1515, 1456, 1253, 1150, 1097, 1050, 830, 749, 698 cm-1. 
HRMS-ESI (m/z) calculated [M+Na]+ C34H32O6Na, 559.2097, found 559.2095. 
 
Exo-10S-TMS-aglain aldehyde 23: A flame dried test tube was charged with 22 (150 mg, 
0.25 mmol, 1 equiv), N-methylmorpholine-N-oxide (86.6 mg, 0.74 mmol, 3 equiv) and 
mixture of THF/t-BuOH (1:1) (6.4 mL, 0.04 M). After formation of a homogeneous 





was added. The solution immediately turned brown and was stirred for 12 h before 5 mL 
of saturated sodium chloride was added to quench the reaction. The reaction mixture was 
extracted with Et2O (5 mL  3), the combined organic layer was washed with 10 mL of 
saturated sodium chloride, and dried over sodium sulfate. The filtrate was concentrated in 
vacuo. The crude diol product was used in the next step without further purification. 
Subsequently, the crude diol product was dissolved in 5 mL of CH2Cl2. Pb(OAc)4 (164 mg, 
0.37 mmol, 1.5 equiv) was added. The resulting mixture was stirred for 0.5 h before 5 mL 
of saturated Na2S2O3 was added to quench the reaction. The combined organic layer from 
extraction with CH2Cl2 (3 mL  3) was washed with 10 mL of saturated sodium chloride 
and dried over sodium sulfate. The filtrate was concentrated in vacuo and purified by 
column chromatography using a gradient of hexanes/CH2Cl2/EtOAc (20:1:1 to 15:1:1) to 
afford the exo-10S-TMS-aglain aldehyde 23 (95.4 mg, 0.18 mmol, 73% yield) as a 
colorless oil. 
23: Rf: 0.19 (EtOAc). 1H NMR (500 MHz, CDCl3)  9.69 (d, J = 0.8 
Hz, 1H), 7.71 (d, J = 8.8 Hz, 2H), 7.54 (d, J = 7.5 Hz, 2H), 7.32 (t, 
J = 7.5 Hz, 2H), 7.23 (t, J = 7.5 Hz, 1H), 7.00 (d, J = 8.8 Hz, 2H), 
6.14 (d, J = 2.3 Hz, 1H), 6.13 (d, J = 2.3 Hz, 1H), 5.04 (s, 1H, OH), 
4.34 (d, J = 6.2, 1H), 4.24 (dd, J1 = 6.2 Hz, J2 = 0.8 Hz, 1H), 4.19 (s, 1H), 3.87 (s, 3H), 
3.85 (s, 3H), 3.77 (s, 3H), -0.16 (s, 9H); 13C NMR (125 MHz, CDCl3)  200.1, 160.4, 
159.6, 156.4, 153.1, 140.9, 130.6, 129.6, 128.7, 127.8, 126.5, 113.5, 113.2, 93.8, 93.0, 88.7, 





1617, 1515, 1459, 1253, 1152, 1089, 840 cm-1. HRMS-ESI (m/z) calculated [M+H]+ 
C30H35O7Si, 535.2152, found 535.2144. 
 
Boc-protected hydroxytiglic amide 25: Compound 24 was prepared using a reported 
procedure.59 Subsequently, a 100 mL round bottom flask was charged with compound 24 
(2.0 g, 13.9 mmol, 1 equiv), LiOH (3.32g, 139 mmol, 10 equiv), and 50 mL of THF/H2O 
(2:1) as solvent. The mixture was stirred for 9 h at 75 °C. After the reaction was cooled to 
room temperature, 1M HCl (aq.) was added to acidify the pH of the solution to 4. The 
mixture was then extracted with EtOAc (20 mL  3). The combined organic layers were 
washed with saturated sodium chloride and dried over sodium sulfate. After concentration 
in vacuo, the crude material was purified by column chromatography using a gradient of 
hexanes/EtOAc (1:1 to 1:4). The hydroxytiglic acid (1.6 g, quantitative) was obtained as a 
white solid. Next, a 50 mL flame-dried flask was charged with hydroxytiglic acid (1.6, 8.5 
mmol, 1 equiv), HOBt (1.26 g, 9.35 mmol, 1.1 equiv), EDCI (1.79 g, 9.35 mmol, 1.1 
equiv), mono-Boc-protected diaminobutane (1.09 g, 9.35 mmol, 1.1 equiv), Et3N (1.3 mL, 
9.35 mmol, 1.1 equiv), and CH2Cl2 (57 mL, 0.15 M). The resulting mixture was stirred at 
room temperature for 8 h. Then, 50 mL of saturated ammonium chloride was added to 
quench the reaction. The reaction mixture was extracted with CH2Cl2 (50 mL  3). The 
combined organic layer was washed with saturated sodium chloride and dried over sodium 




gradient of hexanes/EtOAc (1:2 to 1:5) afforded compound 25 (2.25 g, 7.86 mmol) in 92% 
yield as a white solid. 
25: Rf: 0.19 (EtOAc). m.p. = 80 °C (CH2Cl2). 1H NMR (500 
MHz, CDCl3)  6.35 (td, J1 = 6.1 Hz, J2 = 1.1 Hz, 1H), 6.22 
(brs, 1H, NH), 4.73 (brs, 1H, NH), 4.29 (d, J = 6.1 Hz, 2H), 3.31 (m, 2H), 3.11 (m, 2H), 
1.84 (d, J = 1.1 Hz, 3H), 1.53 (m, 4H), 1.42 (s, 9H); 13C NMR (125 MHz, CDCl3)  169.4, 
156.2, 133.9, 132.4, 79.3, 59.3, 40.1, 39.4, 28.4, 27.6, 26.6, 13.0; IR υmax (film): 3338, 
2934, 1690, 1621, 1533, 1366, 1281, 1169, 1017 cm-1. HRMS-ESI (m/z) calculated 
[M+Na]+ C14H26O4N2Na, 309.1790, found 309.1799. 
 
 
Tiglic amide acetate 27: A 50 mL flame-dried round bottom flask was charged with 
compound 25 (2.0 g, 7.0 mmol, 1 equiv), Et3N (1.1 mL, 7.7 mmol, 1.1 equiv), DMAP (85 
mg, 0.7 mmol, 0.1 equiv), and CH2Cl2 (47 mL, 0.15 M). After the mixture was cooled to 0 
°C by ice bath, Ac2O (0.75 mL, 7.7 mmol, 1.1 equiv) was added dropwise. The reaction 
was warmed to rt and stirred for 5 h before 20 mL of saturated sodium bicarbonate was 
added. The mixture was extracted with CH2Cl2 (50 mL  3), washed with saturated sodium 
chloride (50 mL), and dried over anhydrous sodium sulfate. Purification by column 





(2.1 g, 6.4 mmol) as a white solid (92% yield). Subsequently, compound 26 (2.1 g, 6.4 
mmol, 1 equiv) was redissolved by CH2Cl2 (43 mL, 0.15 M) in a 25 mL flame-dried round 
bottom flask. Trifluoroacetic acid (4.9 mL, 64 mmol, 10 equiv) was then added dropwise 
to the solution and the reaction was stirred for 5 h. The reaction mixture was concentrated 
in vacuo. The remaining TFA was removed by azeotrope with benzene (15 mL  3). The 
material was reconstituted with 50 mL of EtOAc and washed with sat. sodium chloride and 
aqueous 1M NaOH . After the aqueous layer was discarded, the organic layer was washed 
with saturated sodium chloride (50 mL) and dried over sodium sulfate to afford tiglic amide 
acetate 27 (1.05 g, 4.6 mmol, 72% yield) as a colorless oil. Compound 27 was found to 
undergo acyl transfer to afford byproduct. Accordingly, compound 27 was used in the next 
step without further purification after preparation. 
26: Rf: 0.19 (EtOAc/hexanes = 1:1). m.p. = 64 °C (CH2Cl2). 1H 
NMR (500 MHz, CDCl3)  6.30 (brs, 1H, NH), 6.23 (td, J1 = 6.3 
Hz, J2 = 1.3 Hz, 1H), 4.80 (brs, 1H, NH), 4.63 (d, J = 6.3 Hz, 
2H), 3.26 (m, 2H), 3.05 (m, 2H), 1.99 (s, 3H), 1.83 (d, J = 1.3 Hz, 3H), 1.47 (m, 4H), 1.35 
(s, 9H); 13C NMR (125 MHz, CDCl3)  169.4, 156.2, 133.9, 132.4, 79.3, 59.3, 40.1, 39.4, 
28.4, 27.6, 26.6, 13.0; IR υmax (film): 3338, 2933, 1694, 1627, 1529, 1365, 1228, 1168, 







Protected perviridisin B 28: A flame-dried test tube was charged with aldehyde 23 (95.4 
mg, 0.18 mmol, 1 equiv) and amine 27 (259 mg, 0.9 mmol, 5 equiv), and 2 mL of dry 
toluene (0.09 M). After stirring for 5 min, NaClO2 (52 mg, 0.57 mmol, 3.2 equiv), 
NaH2PO4 (75 mg, 0.62 mmol, 3.5 equiv) and 2-methyl-2-butene (0.19 mL, 1.78 mmol, 10 
equiv) were added. The resulting mixture was stirred for 48 h at room temperature before 
filtration to remove solids. The filtrate was concentrated in vacuo and purified by column 
chromatography using a gradient of hexanes/EtOAc (2:1 to 1:2) to afford silyl-protected 
perviridisin B 28 (111 mg, 0.15 mmol, 82%) as a colorless oil. 
28: Rf: 0.2 (EtOAc/hexanes = 2:1). 1H NMR (500 
MHz, CDCl3)  7.71 (d, J = 8.7 Hz, 2H), 7.57 (d, J = 
7.8 Hz, 2H), 7.31 (m, 2H), 7.22 (m, 1H), 6.98 (d, J = 
8.7 Hz, 2H), 6.28 (td, J1 = 6.5 Hz, J2 = 1.3 Hz, 1H), 
6.15 (d, J = 2.6 Hz, 1H), 6.12 (d, J = 2.6 Hz, 1H), 5.94 (brs, 1H, NH), 5.22 (brt, J = 5.8 Hz, 
1H, NH), 4.99 (s, 1H, OH), 4.70 (d, J = 6.5 Hz, 2H), 4.34 (d, J = 6.8 Hz, 1H), 4.14 (s, 1H), 
4.12 (d, J = 6.8 Hz, 1H), 3.86 (s, 3H), 3.83 (s, 3H), 3.77 (s, 3H), 3.19 (m, 3H), 2.87 (m, 
1H), 2.08 (s, 3H), 1.86 (d, J = 1.3 Hz, 3H), -0.14 (s, 9H); 13C NMR (125 MHz, CDCl3)  
170.8, 169.8, 168.4, 160.2, 159.5, 156.4, 153.1, 141.5, 134.9, 130.6, 130.2, 128.6, 128.2, 
128.1, 127.7, 126.4, 113.6, 113.5, 93.9, 92.7, 88.0, 83.3, 80.1, 60.8, 60.7, 58.5, 56.1, 55.4, 





1516, 1458, 1253, 1152, 1091, 839 cm-1. HRMS-ESI (m/z) calculated [M+Na]+ 
C41H52O10N2SiNa, 783.3289, found 783.3279. 
 
Perviridisin B 10: A flame dried test tube was charged with compound 28 (111 mg, 0.15 
mmol, 1 equiv), 1 mL THF and tetra-n-butylammonium fluoride (1M solution in THF, 0.44 
mL, 0.44 mmol, 3 equiv). The resulting solution was stirred for 3 h. 3 mL of saturated 
sodium chloride and 10 mL EtOAc then was added to form a bilayer mixture and the 
aqueous layer was discarded. The organic layer was washed with 5 mL saturated sodium 
chloride and dried over sodium sulfate. The filtrate was concentrated in vacuo and was 
redissolved in 2 mL of MeOH which was followed by addition of 0.2 mL of saturated 
sodium bicarbonate. The mixture was stirred for 12 h and concentrated in vacuo. 
Purification by preparative TLC using EtOAc as solvent afforded perviridisin B 10 (86 mg, 
0.12 mmol, 82% yield) as a white solid. 
10: Rf: 0.11 (EtOAc). m.p. = 269 - 271 °C (CH2Cl2). 
1H NMR (500 MHz, CDCl3)  7.84 (d, J = 8.5 Hz, 
2H), 7.52 (d, J = 7.5 Hz, 2H), 7.35 (t, J = 7.5 Hz, 2H), 
7.28 (m, 1H), 7.04 (d, J = 8.5 Hz, 2H), 6.26 (td, J1 = 6.5 Hz, J2 = 1.5 Hz, 1H), 6.16 (d, J = 
2.5 Hz, 1H), 6.14 (d, J = 2.5 Hz, 1H), 6.09 (brs, 1H), 5.22 (s, 1H, OH), 5.22 (brt, d = 6.4 
Hz, 1H, NH), 4.39 (d, J = 6.5 Hz, 1H), 4.28 (d, J = 6.5 Hz, 1H), 4.26 (d, J = 5.1 Hz, 2H), 





1H), 2.61 (s, 1H, OH), 1.81 (d, J = 1.5 Hz, 3H), 1.64 (m, 2H), 1.31 (m, 2H); 13C NMR (125 
MHz, CDCl3)  169.5, 169.1, 160.4, 150.6, 156.1, 153.0, 140.6, 133.1, 132.9, 129.9, 129.6, 
128.2, 126.8, 114.0, 112.1, 94.0, 92.6, 87.1, 82.4, 79.8, 60.3, 59.4, 58.1, 55.4, 39.3, 38.6, 
27.3, 25.7, 13.0; IR υmax (film): 3408, 2937, 1669, 1619, 1591, 1516, 1459, 1440, 1255, 
1252, 1201, 1152, 1098, 1034, 834, 755 cm-1. HRMS-ESI (m/z) calculated [M+H]+ 





natural (+)-10 synthetic (±)-10 
(this work) 
Positions 
δ lit (CDCl3) 
(JH-H in Hz) 
δ (500 MHz, CDCl3) 
(JH-H in Hz) 
2   
3 4.28, d (6.7) 4.28, d (6.5) 
4 4.40, d (6.5) 4.39, d (6.5) 
5   
5-OH 5.23, s 5.22, s 
5a   
6   
7 6.14, d (2.1) 6.14, d (2.5) 
8   
9 6.16, d (2.2) 6.16, d (2.5) 
9a   
10 4.20, s 4.19, s 
10-OH 2.97, brs 2.98, brs 
11   









14 1.33, m 1.31, m 
15 1.60, m 1.64, m 
16 3.26, m 3.26, m 
NH-17 6.10, brt (5.2) 6.09, brs 
18   
19   
20 6.27, brt (6.0) 6.26, td (6.5, 1.5 
21 4.27 4.26 
22 1.82, s 1.81, d (1.5) 
1’   
2’, 6’ 7.84, d (8.9) 7.84, d (8.5) 
3’, 5’ 7.05, d (8.9) 7.04, d (8.5) 
4’   
1’’   
2’’, 6’’ 7.52, d (7.3) 7.52 d (7.5) 
3’’, 5’’ 7.36, t (7.4) 7.35, t (7.5) 
4’’ 7.29 (overlapped) 7.28 (overlapped) 
OCH3-6 3.89, s 3.89, s 
OCH3-8 3.77, s 3.77, s 




natural (+)-10 synthetic (±)-10 
(this work) 
Positions δ lit. (CDCl3) δ (125 MHz, CDCl3) 
2 87.1 87.1 
3 60.3 60.3 
4 58.1 58.1 
5 79.9 79.8 
5-OH   
5a 112.0 112.1 
6 156.2 156.1 
7 92.6 92.6 
8 160.4 160.4 
9 94.0 94.0 
9a 153.0 153.0 
10 82.4 82.4 
10-OH   
11 169.5 169.5 
NH-12   
13 38.5 38.6 
14 27.3 27.3 




16 39.4 39.3 
NH-17   
18 169.1 169.1 
19 133.0 133.0 
20 133.1 133.1 
21 59.4 59.4 
22 13.0 13.0 
1’ 129.6 129.6 
2’, 6’ 128.3 128.2 
3’, 5’ 114.0 114.0 
4’ 159.6 159.6 
1’’ 140.7 140.7 
2’’, 6’’ 129.9 129.9 
3’’, 5’’ 128.3 128.3 
4’’ 126.8 126.8 
OCH3-6 56.2 56.2 
OCH3-8 55.4 55.4 














29 49% yield 
52% ee 









3 12 h, -
70 °C 
Rayonet CH2Cl2 29 56% yield 
69% ee 
4 12 h, -
70 °C 
Rayonet CH2Cl2 31 30% yield 
49% ee 
5 2 h, -30 °C Rayonet 
Photoflow 
CH2Cl2 29 67% yield 
31% ee 
6 10 h, -
78 °C 
UV-LED CH2Cl2 30 65% yield 
49% ee 




29 31% yield 
71% ee 
8 10 h, -
78 °C 
UV-LED CH2Cl2  29 67% yield 
83% ee 
9 10 h, -
78 °C 
UV-LED CH2Cl2 31 41% yield 
71% ee 
 
General procedure for asymmetric ESIPT photocycloaddition of 3-HF 1 with DPBD 
4: 
A flame-dried 100 mL photoreaction tube was charged with 3-hydroxyflavone 1 (50 mg, 
0.15 mmol, 1 equiv), DPBD 4 (1.57 g, 7.61 mmol, 5 equiv) and 1.0 equivalent of hydrogen-
bonding additive in 30 mL of dry CH2Cl2 (0.005 M for 3-HF 1). Subsequently, the reaction 
mixture was degassed by argon gas bubbling combined with sonication for 10 min. During 
degassing, the reaction mixture should be put in an ice bath to prevent solvent evaporation. 
In order to conduct low temperature photochemistry experiments, a UV-LED (max = 365 
nm) was introduced as light source and a special dewar flask with a transparent window 
was used as temperature control.41 The dewar was filled with dry ice and isopropanol to 
achieve -78 °C and then the reaction tube was inserted into the dry ice bath. Due to the low 




previously described 0.03 M concentration. The reaction was then irradiated for 10 h. The 
solvent was concentrated in vacuo and redissolved in 10 mL dry THF. Subsequently, 
NaBH4 (29 mg, 0.76 mmol, 5 eq) was then added to directly reduce the mixture. After 5 h, 
saturated NH4Cl (aq.) was added to the reaction mixture to quench the reaction. The 
reaction was extracted with EtOAc (30 mL  3), washed with saturated NaCl (aq.) and 
dried with anhydrous Na2SO4. The filtrate was then concentrated in vacuo and purified by 
column chromatography using a gradient of hexanes/EtOAc (20:1 to 10:1 to remove DPBD 
and hydrogen-bonding additive, then 8:1 to 3:1). Aglain derivative (+)-13 was obtained as 
a white solid. The enantioselectivity was determine using analytical chiral HPLC. [α]D
20= 
+ 71.4 (c = 1.0, CHCl3). (+)-13 was further converted to (+)-14 using the previously 
described method. [α]D
20= + 92.3 (c = 1.0, CHCl3). 
 
Chiral HPLC Analysis of aglain 13: Chiralcel OD column with an isocratic mobile phase 
of isopropanol/hexanes (10:90), with a flow rate of 1.0 mL/min for 40 min. 
 
 






Enantiomeric excess after recrystallization of aglain (+)-13 obtained from photoreaction 
with TADDOL 29: 
 
 










With (+)-13 in hand, silylation, oxidative cleavage of the double bond followed by 
oxidative amidation was performed using previously described procedure to furnish the 
core of foveoglin A in 53% yield and 95% ee, []D
20 +43.1 (c 0.1, CHCl3). Silyl group 
deprotection by TBAF provided us (+)-foveoglin A 9 in 95% yield and 96% ee, []D23 
+25.3 (c 0.16, CHCl3). 
Chiral HPLC Analysis of aglain 20: Chiralpak AD column with an isocratic mobile phase 






Enantiomeric excess of (+)-20: 
 
Chiral HPLC Analysis of (±)-foveoglin A 9: Chiralpak AD column with an isocratic mobile 





Enantiomeric excess of (+)-foveoglin A 9: 
 
Determination of absolute configuration of para-bromo benzoate (+)-14 by VCD 
(vibrational circular dichroism): 
Experimental VCD: 
VCD and IR spectra for (+)-14 were recorded using a KBr pellet on a Bruker FT-IR 
TENSOR II spectrometer with 8 cm-1 spectral resolution, polarization modulation 
efficiency set to 1300 cm-1, and a 1900 cm-1 optical filter used to improve the signal-to-
noise ratio.  The VCD spectrum was collected from 1950 to 800 cm-1 at six different 
orientations of the tablet in the holder, with a 20 minutes acquisition time for each 
orientation. An averaged spectrum was calculated for the six orientations. 
Predicted VCD: 
Theoretical VCD calculations were performed using the “VCD Workflow” in Schrodinger, 
Inc.’s Maestro software.60 Conformers were generated via a Macromodel conformational 




energy window) followed by quantum mechanical screening for conformer retention (0.5 
Angstrom deviation, 5.0 kcal/mol QM energy window), followed by DFT geometry 
optimizations (B3LYP/LACVP**) and VCD/IR spectrum predictions on the retained 
conformers. DFT calculations were performed in the absence of solvent. From the VCD 
Workflow module, seven conformers were obtained with final gas phase energies within 
2.7 kcal/mol of the lowest energy conformer. The conformers and their gas phase energies 
are depicted in Figure 2.6. Due to the highly rigid fused bicyclic structure of 14, the 
differences in conformers mainly arose from bond rotations at the aryl methoxy groups and 
the styryl substituent. The VCD workflow was also repeated on the enantiomer of 14, with 
seven similar enantiomeric conformers also obtained (not shown). Single-point energy 
calculations with vibrational frequencies and VCD prediction were then performed on the 
enantiomeric sets of seven conformers querying alternative functional and basis set 
combinations. It was determined that B3PW91/TZV** gave the best agreement with the 
experimental IR/VCD spectra with respect to signal location and intensities. 
 
VCD Analysis: 
Following the DFT calculations, average computed VCD and IR spectra for the seven 
output conformers (B3PW91/TZV*) were generated using Boltzmann weighting based on 
calculated gas phase energies, with a Lortentzian line shape at 8 cm-1 resolution. For the 
purpose of visual comparison, the experimental IR and VCD intensities have been scaled 
by 1,000-fold and 10,000-fold, respectively, and the predicted IR and VCD frequencies 
have been offset by -20.0 cm-1, based on a direct comparison of the predicted and 
experimental IRs (Figure 2.7A/B).61 A qualitative assessment of the measured vs. 
predicted VCD spectra for 14 (Figure 2.7C/D) and ent-14 (Figure 2.7E/F) strongly 













Figure 2.6 Seven Conformers and Relative Gas Phase Energies (B3PW91/TZV**) Obtained for 











Figure 2.7 Predicted (red) and Measured (blue) IR and VCD Spectra Comparisons For 14 and ent-14. 
All Predicted Spectra Are Offset by 20 cm-1 Based on the IR Comparisons.  
 
A) IR comparisons, stacked; B) IR comparisons, overlaid; C) VCD comparisons for 14, 
stacked; D) VCD comparisons for 14, overlaid; E) VCD comparisons for ent-14, stacked; 





ESIPT Photocycloaddition of 3-HF 1 with Unsymmetrical DPBDs: 
 
A 100 mL round bottom flask was charged with 3-hydroxyflavone 1 (300 mg, 0.91 mmol, 
1 equiv), pentafluoro-DPBD 3762 (1.35 g, 4.6 mmol, 5 equiv), and 90 mL of CH2Cl2 (0.01 
M for 3-HF 1). The flask was connected with the continuous photoflow reactor followed 
by degassing of the reaction at 0 oC with argon bubbling for 5 min with sonication. 
Subsequently, the peristaltic pump was turned on to circulate the reaction mixture and 
argon bubbling with sonication was continued for an additional 15 min before the UV-
lamp (Rayonet, λmax = 350 nm) was turned on. After 6 h, the reaction mixture was collected 
back into the flask and was concentrated in vacuo. Purification via flash chromatography 
using a gradient of hexanes/EtOAc (10:1 to 3:1) afforded the cyclopenta[bc]benzopyran 
products as a mixture of isomers (photocycloadducts were identified based on a 1H NMR 
spectrum of the crude product) which were used in the next step without further 
purification. A flame-dried 100 mL flask was charged with the mixture of compounds (338 
mg, 0.54 mmol, 1 equiv) and THF (4 mL, 0.14 M) was added. Subsequently, NaBH4 (123 
mg, 3.25 mmol, 6 equiv) was added at rt in one portion. The resulting mixture was then 




mixture was extracted with CH2Cl2 (10 mL  3), washed with saturated sodium 
bicarbonate, and dried over sodium sulfate. The filtrate was concentrated in vacuo. Column 
chromatography purification using hexanes/EtOAc (5:1 to 3:1) afforded an inseparable 
mixture of aglain products (321.6 mg), which was redissolved in CH2Cl2 (5 mL) and cooled 
to -78 °C. Subsequently, Et3N (188 L, 1.35 mmol, 2.5 equiv) and TMSOTf (210 L, 1.14 
mmol, 2.1 equiv) were added. The resulting mixture was stirred at -78 °C for an additional 
10 min and was then to warmed to 0 °C for another 20 min before 10 mL of saturated 
Na2CO3 (aq.) was added to quench the reaction. The reaction mixture was further extracted 
with CH2Cl2 (3 mL  3). The combined organic layer was washed with 10 mL saturated 
NaCl (aq.), dried over anhydrous Na2SO4, and concentrated in vacuo. Subsequently, the 
crude compound mixture was redissolved in 13 mL of THF/t-BuOH (1:1). Subsequently, 
1.3 mL OsO4 (10 mg/mL, aq., 0.1 equiv) solution was added followed by addition of NMO 
(190 mg, 1.62 mmol, 3 equiv). The resulting mixture was stirred at room temperature for 
12 h, before being extracted with Et2O (5mL  3). The combined organic layers were 
washed with saturated NaCl (aq.), dried over anhydrous Na2SO4, and concentrated in 
vacuo. The obtained brown oil was redissolved in CH2Cl2 (5 mL) and Pb(OAc)4 (360 mg, 
0.81 mmol, 1.5 equiv) was added. The reaction mixture was stirred at room temperature 
for 20 min before 10 mL of saturated Na2S2O3 (aq.) was added to quench the reaction. The 
reaction mixture was extracted with CH2Cl2 (5 mL  3), washed with 10 mL saturated NaCl 
(aq.), dried over anhydrous Na2SO4, and concentrated in vacuo. Purification via column 




aglain aldehyde 40 (126 mg, 25% overall yield) as a colorless oil and compound 17 (45.3 
mg, 8.2 % overall yield) (for characterization data for 17, see page S10).  
40: Rf: 0.37 (EtOAc/hexanes = 1:4). 1H NMR (500 MHz, CDCl3) 
 9.01 (d, J = 1.5 Hz, 1H), 7.50 (d, J = 8.9 Hz, 2H), 6.98 (d, J = 8.9 
Hz, 2H), 6.30 (d, J = 1.1 Hz, 1H), 5.97 (d, J = 1.1 Hz, 1H), 5.54 (s, 
1H, OH), 4.55 (s, 1H), 4.34 (d, J = 4.7 Hz, 1H), 4.01 (dd, J1 = 4.7 
Hz, J2 = 1.5 Hz, 1H), 3.83 (s, 3H), 3.80 (s, 3H), 3.48 (s, 3H), 0.002 (s, 9H); 
13C NMR (125 
MHz, CDCl3)  198.0, 160.9, 159.6, 158.9, 154.3, 147.6, 145.2, 138.5, 136.0, 127.9, 127.4, 
114.2, 111.0, 103.8, 94.3, 92.5, 84.4, 81.4, 73.6, 58.5, 55.8, 55.32, 55.30, 44.2, 0.6; IR υmax 
(film): 3497, 2959, 1720, 1619, 1496, 1378, 1253, 1149, 1098, 1098, 1029, 875, 841 cm-1. 
HRMS-ESI (m/z) calculated [M+H]+ C30H29F5O7Si, 647.2969, found 647.2970. 
 
The previously mentioned general procedure for mechanistic validation reactions was 
employed using 3-HF 1 (300 mg, 0.91 mmol, 1 equiv.) and DPBD 4163 (1.56 g, 4.6 mmol, 
5 equiv.). Aldehyde 42 (132 mg, 22 % overall yield) was isolated as a colorless oil and 





42: Rf: 0.43 (EtOAc/hexanes = 1:4). 1H NMR (500 MHz, CDCl3) 
 9.04 (d, J = 1.8 Hz, 1H), 7.69 (s, 1H), 7.52 (d, J = 8.8 Hz, 2H), 
7.35 (s, 2H), 6.99 (d, J = 8.8 Hz, 2H), 6.33 (d, J = 2.2 Hz, 1H), 
5.83 (d, J = 2.2 Hz, 1H), 5.42 (s, 1H, OH), 4.59 (s, 1H, OH), 3.97 
(d, J = 9.0 Hz, 1H), 3.83 (s, 3H), 3.78 (s, 3H), 3.57 (dd, J1 = 9 Hz, J2 = 1.8 Hz, 1H), 3.14 
(s, 3H), 0.01 (s, 9H); 13C NMR (125 MHz, CDCl3)  197.6, 161.0, 159.6, 159.1, 153.0, 
140.0, 130.8, 128.6, 127.7, 127.4, 124.3, 122.2, 120.7, 114.2, 103.5, 94.6, 94.5, 92.3, 84.2, 
82.0, 74.4, 61.2, 55.4, 55.3, 55.2, 52.7, 0.6; IR υmax (film): 3498, 2960, 2843, 1722, 1619, 
1589, 1518, 1383, 1378, 1174, 1134, 1100, 1027, 875, 844 cm-1. HRMS-ESI (m/z) 
calculated [M+H]+ C32H33F6O7Si2, 671.1900, found 671.1906. 
 
The previously mentioned general procedure for mechanistic validation reactions was 
employed using 3-HF 1 (300 mg, 0.91 mmol, 1 equiv.) and stilbene 4361 (1.23 g, 4.6 mmol, 
5 equiv.). After photocycloaddition, the inseparable mixture was purified via flash column 
chromatography using a gradient of hexanes/EtOAc (10:1 to 3:1) to afford 252 mg of a 
white solid. The crude product was reduced with NaBH4 (96 mg, 2.52 mmol, 6 equiv.) in 





(9:1 to 4:1) afforded a mixture of compounds 44 and 45. The mixture was further purified 
via preparative thin layer chromatography using hexanes/EtOAx/CH2Cl2 (7:1.5:1.5) 
afforded compound 44 (142 mg, 26 % overall yield) as a white solid and 45 (51 mg, 9.3 % 
overall yield) as a colorless oil. 
44: Rf: 0.13 (EtOAc/hexanes = 3:7). m.p. = 224 - 225 °C (CH2Cl2). 
1H NMR (500 MHz, CDCl3)  7.31 (d, J = 8.7 Hz, 2H), 7.01 (t, J = 
7.2 Hz, 2H), 6.95 (t, J = 7.2 Hz, 1H), 6.90 (d, J = 7.2 Hz, 2H), 6.68 
(d, J = 8.7 Hz, 2H), 6.31 (d, J = 2.1 Hz, 1H), 6.04 (d, J = 2.1 Hz, 
1H), 5.63 (s, 1H, OH), 4.92 (d, J = 3.3 Hz, 1H), 4.39 (d, J = 10.6 Hz, 1H), 4.10 (d, J = 10.6 
Hz, 1H), 3.80 (s, 3H), 3.69 (s, 3H), 3.51 (s, 3H), 2.63 (brs, 1H, OH); 13C NMR (125 MHz, 
CDCl3)  161.3, 159.3, 158.8, 154.4, 147.5, 140.7, 139.3, 138.2, 136.2, 129.0, 128.9, 128.5, 
128.2, 126.8, 113.2, 110.8, 102.8, 94.6, 92.8, 87.7, 81.5, 73.0, 55.7, 55.5, 55.1, 54.5, 54.3; 
IR υmax (film): 3495, 2944, 1713, 1617, 1519, 1493, 1375, 1146, 1097, 998, 828, 701, 652 
cm-1. HRMS-ESI (m/z) calculated [M+H]+ C32H26F5O6, 601.1650, found 601.1659.  
45: Rf: 0.13 (EtOAc/hexanes = 3:7). 1H NMR (500 MHz, CDCl3) 
 7.45 (d, J = 8.6 Hz, 2H), 7.19 (m, 3H), 7.00 (m, 2H), 6.80 (d, J 
= 8.6 Hz, 2H), 6.28 (d, J = 2.2 Hz, 1H), 5.89 (d, J = 2.2 Hz, 1H), 
5.48 (s, 1H, OH), 5.17 (s, 1H), 4.45 (d, J = 10.9 Hz, 1H), 3.79 (s, 
3H), 3.76 (s, 3H), 3.74 (d, J = 10.9 Hz, 1H), 3.10 (s, 3H); 13C NMR (125 MHz, CDCl3)  
161.0, 160.3, 159.4, 153.2, 145.4, 143.4, 140.8, 138.3, 135.9, 135.4, 128.7, 128.1, 127.9, 
127.5, 144.0, 113.5, 103.1, 94.3, 93.2, 86.6, 82.2, 72.1, 58.7, 55.43, 55.37, 55.21, 55.16, 






1100, 1027, 875, 844 cm-1. IR υmax (film): 3495, 2944, 1713, 1617, 1519, 1493, 1375, 1146, 
1097, 998, 828, 701, 652 cm-1. HRMS-ESI (m/z) calculated [M+H]+ C32H26F5O6, 
601.1650, found 601.1655.  
X-ray crystallographic data for compound 14: 
 
Crystals of compound 14 suitable for X-ray analysis were obtained by slow evaporation 
from dichloromethane/hexanes. Crystallographic data have been deposited with the 
Cambridge Cystallograhic Data Centre (CCDC#1523489). Copies of the data can be 
obtained free of charge on application to the CCDC, 12 Union Road, Cambridge CB21EZ, 





Data collection: APEX2 (Bruker, 2006); cell refinement: SAINT (Bruker, 2006); data 
reduction: SAINT (Bruker, 2006); program(s) used to solve structure: SHELXS97 
(Sheldrick, 1990); program(s) used to refine structure: SHELXL (Sheldrick, 2008); 
molecular graphics: Olex2 (Dolomanov et al., 2009); software used to prepare material for 
publication: Olex2 (Dolomanov et al., 2009). 
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(Compound 14) 
Crystal data 
C41H35BrO7 F(000) = 2976 
Mr = 719.60 Dx = 1.411 Mg m
-3 
Monoclinic, P21/c Cu K radiation,  = 1.54178 Å 
a = 22.603 (2) Å Cell parameters from 9408 reflections 
b = 20.3183 (19) Å  = 3.9–66.7° 
c = 14.8174 (13) Å  = 2.08 mm-1 
 = 95.493 (4)° T = 100 K 




Z = 8 0.22 × 0.09 × 0.08 mm 
 
Data collection 
Bruker Proteum-R  
diffractometer 
11948 independent reflections 
Radiation source: rotating anode 10807 reflections with I > 2(I) 
Multilayer monochromator Rint = 0.055 
 &  scans max = 66.8°, min = 2.0° 
Absorption correction: multi-scan  
SADABS (Sheldrick, 1997) 
h = -2626 
Tmin = 0.646, Tmax = 0.753 k = -2424 
133915 measured reflections l = -1717 
 
Refinement 
Refinement on F2 932 restraints 
Least-squares matrix: full Hydrogen site location: inferred from 
neighbouring sites 
R[F2 > 2(F2)] = 0.055 H-atom parameters constrained 
wR(F2) = 0.150  w = 1/[2(Fo
2) + (0.0923P)2 + 7.6376P]   
where P = (Fo
2 + 2Fc
2)/3 
S = 1.05 (/)max = 0.002 
11948 reflections max = 2.89 e Å
-3 




Geometry. All esds (except the esd in the dihedral angle between two l.s. planes)  
are estimated using the full covariance matrix.The cell esds are taken into account 
individually in the estimation of esds in distances, angles and torsion angles; 




by crystal symmetry. An approximate (isotropic)  treatment of cell esds is used for 
estimating esds involving l.s. planes. 
Fractional atomic coordinates and isotropic or equivalent isotropic displacement 
parameters (Å2) for (compound 14) 
 x y z Uiso*/Ueq 
Br1A 0.97710 (2) 0.53306 (2) -0.20398 (2) 0.04010 (12) 
Br1 0.51754 (2) 0.44864 (2) 0.69611 (2) 0.03416 (11) 
O2A 0.87551 (7) 0.55160 (9) 0.21092 (11) 0.0232 (4) 
O6A 0.95160 (8) 0.55620 (10) 0.35916 (12) 0.0288 (4) 
O3A 0.79380 (7) 0.65392 (9) 0.27061 (11) 0.0239 (4) 
H3A 0.8002 0.6944 0.2659 0.036* 
O4A 0.85823 (8) 0.76389 (10) 0.29108 (13) 0.0318 (4) 
O5A 1.07190 (9) 0.74106 (13) 0.35515 (15) 0.0475 (6) 
O7A 0.91566 (10) 0.25004 (11) 0.37981 (16) 0.0473 (6) 
O1A 0.79113 (9) 0.51226 (13) 0.13760 (14) 0.0430 (5) 
O2 0.63002 (7) 0.43773 (8) 0.28899 (11) 0.0214 (4) 
O6 0.55489 (7) 0.43391 (8) 0.13652 (11) 0.0205 (3) 
O3 0.71734 (8) 0.34668 (9) 0.22227 (12) 0.0259 (4) 
H3 0.7165 0.3056 0.2154 0.039* 
O4 0.66788 (8) 0.23558 (9) 0.15981 (14) 0.0332 (4) 
O5 0.45908 (8) 0.22425 (9) 0.10366 (14) 0.0348 (4) 
O7 0.55952 (10) 0.74087 (10) 0.16014 (16) 0.0455 (5) 
O1 0.70742 (8) 0.49126 (10) 0.36401 (12) 0.0300 (4) 
C1A 0.93542 (12) 0.53365 (14) -0.09829 (17) 0.0292 (6) 
C2A 0.88247 (14) 0.49994 (19) -0.0993 (2) 0.0434 (8) 
H2A 0.8670 0.4769 -0.1521 0.052* 
C3A 0.85220 (13) 0.50006 (19) -0.0225 (2) 0.0440 (8) 
H3AA 0.8152 0.4777 -0.0232 0.053* 
C4A 0.87541 (11) 0.53266 (13) 0.05584 (17) 0.0253 (5) 




C8A 0.84965 (11) 0.55479 (13) 0.29565 (16) 0.0229 (5) 
H8A 0.8115 0.5297 0.2924 0.027* 
C12A 0.89412 (11) 0.52826 (14) 0.37171 (17) 0.0263 (6) 
C11A 0.87237 (12) 0.56072 (14) 0.46042 (17) 0.0273 (6) 
H11A 0.9064 0.5877 0.4882 0.033* 
C26A 0.85717 (13) 0.51332 (15) 0.53201 (18) 0.0326 (6) 
H26A 0.8827 0.4764 0.5417 0.039* 
C27A 0.81306 (12) 0.51653 (14) 0.58286 (18) 0.0306 (6) 
H27A 0.7859 0.5520 0.5721 0.037* 
C28A 0.80180 (11) 0.46959 (14) 0.65585 (18) 0.0281 (6) 
C29A 0.76281 (12) 0.48665 (14) 0.71995 (18) 0.0293 (6) 
H29A 0.7436 0.5283 0.7162 0.035* 
C30A 0.75187 (12) 0.44329 (15) 0.78920 (18) 0.0328 (6) 
H30A 0.7246 0.4551 0.8314 0.039* 
C31A 0.78042 (13) 0.38309 (16) 0.7969 (2) 0.0364 (6) 
H31A 0.7734 0.3540 0.8449 0.044* 
C5A 0.92904 (11) 0.56607 (13) 0.05532 (17) 0.0244 (5) 
H5A 0.9452 0.5884 0.1084 0.029* 
C6A 0.95912 (12) 0.56712 (14) -0.02190 (18) 0.0297 (6) 
H6A 0.9955 0.5905 -0.0224 0.036* 
C18A 0.95274 (11) 0.62277 (15) 0.34670 (16) 0.0285 (6) 
C13A 0.90073 (11) 0.66008 (14) 0.32741 (16) 0.0258 (5) 
C9A 0.84085 (11) 0.62479 (13) 0.32637 (16) 0.0229 (5) 
C10A 0.82361 (11) 0.61011 (13) 0.42431 (16) 0.0241 (5) 
H10A 0.7850 0.5857 0.4178 0.029* 
C32A 0.81955 (13) 0.36527 (16) 0.7339 (2) 0.0360 (6) 
H32A 0.8397 0.3242 0.7393 0.043* 
C33A 0.82910 (12) 0.40769 (15) 0.66296 (19) 0.0314 (6) 
H33A 0.8545 0.3945 0.6188 0.038* 
C20A 0.81465 (12) 0.67072 (14) 0.47981 (16) 0.0266 (5) 




H21A 0.9012 0.6990 0.5080 0.043* 
C22A 0.85007 (16) 0.76905 (16) 0.5607 (2) 0.0431 (7) 
H22A 0.8821 0.7962 0.5841 0.052* 
C23A 0.79223 (16) 0.78704 (16) 0.57198 (19) 0.0429 (8) 
H23A 0.7846 0.8265 0.6032 0.051* 
C24A 0.74603 (15) 0.74796 (16) 0.5382 (2) 0.0400 (7) 
H24A 0.7063 0.7604 0.5461 0.048* 
C25A 0.75686 (13) 0.69018 (15) 0.49239 (18) 0.0324 (6) 
H25A 0.7244 0.6635 0.4693 0.039* 
C14A 0.90889 (11) 0.72741 (15) 0.31388 (17) 0.0283 (6) 
C19A 0.86490 (13) 0.82991 (15) 0.2582 (2) 0.0383 (7) 
H19A 0.8787 0.8588 0.3089 0.057* 
H19B 0.8265 0.8458 0.2300 0.057* 
H19C 0.8940 0.8301 0.2133 0.057* 
C15A 0.96509 (12) 0.75720 (16) 0.32294 (18) 0.0338 (6) 
H15A 0.9692 0.8033 0.3152 0.041* 
C16A 1.01493 (12) 0.71736 (17) 0.34367 (18) 0.0365 (7) 
C41A 1.07965 (13) 0.8102 (2) 0.3543 (2) 0.0499 (9) 
H41A 1.0622 0.8279 0.2963 0.075* 
H41B 1.1222 0.8205 0.3623 0.075* 
H41C 1.0599 0.8299 0.4038 0.075* 
C17A 1.00901 (12) 0.65061 (17) 0.35386 (18) 0.0347 (6) 
H17A 1.0432 0.6237 0.3657 0.042* 
C34A 0.90172 (12) 0.45486 (15) 0.37292 (17) 0.0287 (6) 
C39A 0.95644 (13) 0.42596 (16) 0.40050 (17) 0.0337 (6) 
H39A 0.9899 0.4532 0.4170 0.040* 
C38A 0.96302 (13) 0.35773 (16) 0.40435 (18) 0.0370 (7) 
H38A 1.0006 0.3390 0.4236 0.044* 
C37A 0.91483 (14) 0.31731 (16) 0.3802 (2) 0.0379 (7) 
C40A 0.97115 (15) 0.21840 (18) 0.4014 (2) 0.0483 (8) 




H40B 0.9659 0.1706 0.3962 0.072* 
H40C 0.9865 0.2296 0.4636 0.072* 
C36A 0.85988 (13) 0.34547 (16) 0.3525 (2) 0.0409 (7) 
H36A 0.8266 0.3181 0.3357 0.049* 
C35A 0.85365 (12) 0.41311 (16) 0.3494 (2) 0.0364 (7) 
H35A 0.8158 0.4316 0.3309 0.044* 
C1 0.56037 (12) 0.45366 (13) 0.59212 (18) 0.0254 (5) 
C6 0.61621 (12) 0.48257 (14) 0.59970 (18) 0.0299 (6) 
H6 0.6326 0.5001 0.6561 0.036* 
C5 0.64780 (12) 0.48566 (14) 0.52427 (18) 0.0280 (6) 
H5 0.6860 0.5056 0.5288 0.034* 
C4 0.62389 (11) 0.45977 (12) 0.44203 (17) 0.0203 (5) 
C7 0.65918 (11) 0.46523 (12) 0.36280 (17) 0.0205 (5) 
C8 0.65590 (11) 0.44216 (12) 0.20495 (16) 0.0202 (5) 
H8 0.6922 0.4705 0.2115 0.024* 
C12 0.61051 (11) 0.46915 (12) 0.13144 (16) 0.0200 (5) 
C11 0.63722 (11) 0.44790 (12) 0.04082 (16) 0.0206 (5) 
H11 0.6057 0.4247 0.0009 0.025* 
C26 0.66014 (11) 0.50423 (13) -0.01067 (17) 0.0242 (5) 
H26 0.6955 0.5251 0.0148 0.029* 
C27 0.63548 (11) 0.52715 (13) -0.08810 (17) 0.0251 (5) 
H27 0.5995 0.5070 -0.1123 0.030* 
C28 0.65858 (12) 0.58148 (13) -0.14130 (17) 0.0270 (5) 
C29 0.62960 (13) 0.59710 (13) -0.22570 (18) 0.0302 (6) 
H29 0.5942 0.5746 -0.2470 0.036* 
C30 0.65237 (15) 0.64563 (14) -0.2790 (2) 0.0375 (7) 
H30 0.6330 0.6552 -0.3372 0.045* 
C31 0.70264 (14) 0.67977 (15) -0.2479 (2) 0.0381 (7) 
H31 0.7183 0.7124 -0.2849 0.046* 
C3 0.56806 (11) 0.43017 (12) 0.43620 (17) 0.0223 (5) 




C2 0.53612 (11) 0.42692 (12) 0.51107 (18) 0.0254 (5) 
H2 0.4981 0.4066 0.5069 0.030* 
C18 0.55909 (11) 0.36621 (12) 0.13964 (15) 0.0217 (5) 
C13 0.61362 (11) 0.33457 (13) 0.15492 (16) 0.0229 (5) 
C9 0.67001 (11) 0.37548 (12) 0.16646 (16) 0.0215 (5) 
C10 0.68705 (10) 0.39772 (13) 0.07198 (16) 0.0215 (5) 
H10 0.7250 0.4230 0.0823 0.026* 
C32 0.73053 (14) 0.66647 (15) -0.1625 (2) 0.0374 (7) 
H32 0.7645 0.6911 -0.1400 0.045* 
C33 0.70884 (13) 0.61737 (14) -0.11013 (19) 0.0336 (6) 
H33 0.7285 0.6080 -0.0520 0.040* 
C20 0.69847 (11) 0.34031 (13) 0.01135 (17) 0.0249 (5) 
C25 0.65643 (12) 0.31261 (15) -0.05128 (19) 0.0332 (6) 
H25 0.6188 0.3332 -0.0637 0.040* 
C24 0.66873 (13) 0.25466 (16) -0.0964 (2) 0.0390 (7) 
H24 0.6395 0.2364 -0.1395 0.047* 
C23 0.72293 (14) 0.22360 (15) -0.0789 (2) 0.0373 (7) 
H23 0.7305 0.1832 -0.1080 0.045* 
C22 0.76610 (14) 0.25189 (16) -0.0187 (2) 0.0376 (7) 
H22 0.8039 0.2315 -0.0073 0.045* 
C21 0.75418 (12) 0.31008 (15) 0.02508 (19) 0.0312 (6) 
H21 0.7844 0.3298 0.0652 0.037* 
C14 0.61349 (12) 0.26527 (13) 0.15020 (17) 0.0269 (5) 
C19 0.66994 (14) 0.16698 (14) 0.1368 (2) 0.0382 (7) 
H19D 0.6513 0.1411 0.1821 0.057* 
H19E 0.7114 0.1532 0.1358 0.057* 
H19F 0.6486 0.1599 0.0769 0.057* 
C15 0.56102 (12) 0.23043 (13) 0.13503 (18) 0.0292 (6) 
H15 0.5616 0.1837 0.1338 0.035* 
C16 0.50743 (12) 0.26422 (13) 0.12160 (17) 0.0277 (6) 




H41D 0.3967 0.2815 0.1454 0.059* 
H41E 0.3716 0.2216 0.0830 0.059* 
H41F 0.4008 0.2838 0.0383 0.059* 
C17 0.50532 (11) 0.33243 (13) 0.12380 (16) 0.0238 (5) 
H17 0.4686 0.3553 0.1148 0.029* 
C34 0.59630 (11) 0.54114 (12) 0.13893 (17) 0.0221 (5) 
C39 0.63764 (12) 0.58551 (14) 0.1799 (2) 0.0322 (6) 
H39 0.6756 0.5701 0.2037 0.039* 
C38 0.62410 (13) 0.65139 (14) 0.1862 (2) 0.0379 (7) 
H38 0.6526 0.6809 0.2149 0.046* 
C37 0.56861 (13) 0.67483 (13) 0.15044 (19) 0.0329 (6) 
C40 0.50080 (15) 0.76470 (16) 0.1374 (2) 0.0454 (8) 
H40D 0.4907 0.7611 0.0718 0.068* 
H40E 0.4985 0.8109 0.1558 0.068* 
H40F 0.4728 0.7385 0.1690 0.068* 
C36 0.52761 (12) 0.63166 (13) 0.10826 (17) 0.0269 (5) 
H36 0.4900 0.6472 0.0828 0.032* 
C35 0.54172 (11) 0.56536 (13) 0.10331 (16) 0.0230 (5) 




















































































































































































Syntheses of Aza-rocaglates via ESIPT Photocycloaddition 
3.1 Synthetic Approaches Towards Rocaglate Analogues 
As previously demonstrated, cyclopenta[b]benzofuran (rocaglate) scaffolds have 
been found to show excellent biological activities64 by targeting the RNA helicase 
eukaryotic initiation factor 4A (eIF4A), an integral protein involved in the initiation of 
protein translation65 (cf. Scetion 1.4.3). Due to the intriguing structural complexity and 
biological activities of the rocaglates, a number of synthetic chemists have undertaken the 
synthesis of natural rocaglates as well as targeted derivatives with improved66 or novel 
biological properties.67 In this chapter, we present our efforts towards synthesis of nitrogen-
containing rocaglate analogs, aza-rocaglates, via ESIPT photocycloaddition of 3-
hydroxylquinolinones (3-HQ’s). Aza-rocaglates are not only synthetically challenging 
scaffolds but also should provide further structure activity relationship (SAR) information 
for rocaglate class of natural products. 
Before proceeding with our synthetic studies, it is important to highlight relevant 
literature describing syntheses of unnatural rocaglate analogues. For example, Bruce and 
coworkers reported the synthesis of a carbocyclic analogue of rocaglamide (Scheme 3.1).68 
Starting from 2-(p-anisyl)-2-cyclopentenone 1, copper-mediated Michael addition of 
phenylmagnesium bromide gave anti-biarylcyclopentanone 2 in 76% yield by epimerizing 
the initially formed syn-product during workup. Selective enolate alkylation by 3,5-
dimethoxybenzyl chloride using sodium hydride provided the 2,2,3-trisubstituted 




polyphosphoric acid (PPA) and methanesulfonic acid produced the tricyclic core 
compound 4 which was further converted to ketone 6 by dihydroxylation and oxidation. 
Treating ketone 6 with the Stiles reagent (magnesium methyl carbonate)69 at elevated 
temperature followed by acidic hydrolysis yielded carboxylic acid 7. Amide coupling 
followed by hydroxyl-directed reduction furnished the carbocyclic rocaglate analogues 9 
and 10. The biological properties of the carbocyclic analogues were not reported. 
Scheme 3.1 Synthesis of Carbocyclic Analogues of Rocaglamide 
 
Additionally, Désaubry and coworkers reported a bioisosteric modification of 
flavagline scaffolds to synthesize amino-rocaglaol derivatives.70 Treatment of rocaglaol 
derivative 11 with thionyl chloride afforded a cyclic sulfite 12 in quantitative yield. SN2 




reduced to amino-rocaglaol compound 14. Additionally, compound 14 was converted to 
formide 15 and mesylamide 16. After this modification was achieved, the cytotoxicity of 
compound 15 and 16 were tested on human cancer cell lines by the MTS assay after a 72 
h treatment. However, both compounds did not show any significant cytotoxicity in Hep3B 
and HuH7 cancer cell lines. 
Scheme 3.2 Bioisosteric Modification of Flavagline Scaffold 
 
Another modification which incorporated hetereocycles into rocaglate scaffold was 
reported by Ishibashi and coworkers.71 An array of 2-hetereocycle-3-hydroxyflavones (17 
to 20) was synthesized and subjected to ESIPT photocycloaddition conditions to produce 
(3+2) photocycloadducts, which were subjected to NaOMe-mediated -ketol 
rearrangement and diastereoselective reduction to yield various hetereocycle-containing 
rocaglate derivatives 21 to 24. The corresponding rocaglaic acid 25 to 28 were also 
synthesized be saponification using lithium hydroxide. Subsequently, 21, 22, 23, and 27 
were tested to showed potent Wnt signal inhibitory activities. The Wnt signal plays crucial 
roles in the differentiation and proliferation of many types of cells, and inactivation of this 




many cancers and diseases. Therefore, inhibitors of this signal pathway could be used as 
drug candidates or useful biological tools. 
Scheme 3.3 Hetereocycle-Containing Rocaglate Analogues 
 
Porco and coworkers reported their investigations of a nitrogen analogue of 3-
hydroxyflavone, 1-methyl-2-methyl-3-hydroxyquinolinone 29 (DMQ) and its utility in 
ESIPT photocycloadditions.72 Upon photoexcitation, Porco and coworkers hypothesized 
that excited state intramolecular proton transfer (ESIPT) of DMQ could occur to generate 
3-oxidoquinolinium intermediate 29* which could be quenched with various 
dipolarophiles to afford photocycloadducts. Accordingly, a parallel screening approach 
was performed to discover suitable dipolarophiles for ESIPT photocycloaddition with 
DMQ 29. As the ESIPT process for DMQ could be observed by fluorescence spectroscopy 
(Figure 3.1), quenching of the fluorescence signal of transient intermediate 29* in the 
presence of a collection of dipolarophiles should provide an indication of 








Figure 3.1 Absorption and Fluorescence Spectra of DMQ 29 
 
When subjected to irradiation in 1,4-dioxane, dipolarophiles 30 and 21 showed 
photoreactivity with DMQ 29 (Scheme 3.4) to afford moderate yields of 
photocycloadducts 31 and 32. The structure of 31 was further confirmed by X-ray 
crystallographic analysis of bis-p-bromobenzoate 33. Using methyl butynoate 34 as 
dipolarophile, the presumed photocycloadduct 35 was not detected but the isomeric ketol 
36 was instead isolated, presumably because the doubly-conjugated enone of 36 provides 
a strong, thermodynamic driving force for -ketol rearrangement. Under similar 
photochemical reaction conditions, two major products were isolated from the 
photocycloaddition of 29 with electron-rich or electron-neutral dipolarophiles including 








Scheme 3.4 ESIPT Photocycloaddition of DMQ 29 with Dipolarophiles 
 





Taken together, Porco and coworkers demonstrated the feasibility for use of 3-
hydroxyquinolinones in ESIPT photocycloadditions. Although ESIPT photocycloaddition 
of DMQ 29 with methyl cinnamate 21 showed the opposite regioselectivity in comparison 
to reaction with 3-hydroxyflavone, we hypothesized that by using 2-aryl-3-
hydroxyquinolinone 47 instead of 29, π-π stacking interaction between the 2-aryl 
substituent and methyl cinnamate may orient the regioselectivity of the presumed ESIPT 
photocycloaddition to furnish photocycloadduct 48. -Ketol rearrangement of 48 followed 
by diastereoselective reduction should afford the hexahydrocyclopenta[b]-indole scaffold 
of aza-rocaglate 50 (Scheme 3.5). 
3.2 ESIPT Photocycloaddition of 3-HQ’s with Methyl Cinnamate 
Based on our synthetic proposal, a series of 2-aryl-3-hydroxyquinolinones were 
synthesized from phenacyl anthranilates using previously reported procedures.72,73 Upon 
photoirradiation of 3-hydroxyquinolinones (N-H-3-HQ’s 47, 51-52) in presence of methyl 
cinnamate, no detectable formation of photocycloadducts was found (Scheme 3.6a). As 
the previous studies were performed using an N-methyl-3-HQ substrate, 1-methyl-2-aryl-
3-hydroxyquinolinone (N-Me-3-HQ, 56)73 was chosen as a modified substrate for ESIPT 









Scheme 3.6 ESIPT Photocycloaddition of 3-HQ’s with Methyl Cinnamate. 
 
Using the reported literature procedure, treatment of phenacyl anthranilate 55 with 
formic acid and ammonium formate under microwave irradiation, or iteratively heating 55 
in neat polyphosphoric acid (PPA) provided N-Me-3-HQ 56. After subjection of 56 to 
photoirradiation in the presence of methyl cinnamate 21, photocycloadducts 57 and 58 
were obtained. However, only limited production of photocycloadducts was observed with 
significant decomposition of N-Me-3-HQ 56 and a very long period of photo-irradiation 











Table 3.2  Condition Optimization of ESIPT Photocycloaddition N-Me-3-HQ with Methyl 
Cinnamate. 
 










(1 : 1, 0.02 M) 
24, 0 Rayonet 1 : 1.4 27 
2 CHCl3/TFE 
(4 : 1, 0.02 M)  
24, 0 Rayonet 3 : 1 39 
3 CHCl3 (0.02 M) 24, 0 Rayonet 2 : 1 31 
4 PhCF3/TFE 
(7 : 3, 0.035 M) 
48, 0 Rayonet 5 : 1 40 
5 PhCF3/TFE 
(7 : 3, 0.06 M) 
14, 5  Hanovia N/A Deco
mp. 
6 PhCF3/TFE 
(7 : 3, 0.04 M) 
14, -20 Hanovia 
(Pyrex) 
3 : 1 19% 
7 PhCF3/TFE 
(7 : 3, 0.06 M) 
14, 0  Rayonet 
photoflow 
4 : 1 43% 
8 PhCF3/TFE  
(7 : 3, 0.04 M) 
14, -20 Rayonet 
photoflow 
4.5 : 1 44% 
9 CHCl3/TFE 
(7 : 3, 0.035 M) 
10, 0 Rayonet 
photoflow 
4 : 1 43% 
10 PhCF3/TFE 
(4 : 1, 0.035 M) 
9, 0 Rayonet 
photoflow 
5 : 1 43% 
11 PhCF3: TFE = 
7 : 3 (0.05 M) 
9, 0 Rayonet 
photoflow 




[a] Diastereoselectivity was determined by 1H NMR integration; [b] Isolated yield of 
purified 57. 
 
Optimization of reaction conditions was conducted to improve the ESIPT 
photocycloaddition (Table 3.1). A Rayonet photobox (350 nm) was found to be the optimal 
light source, as increased decomposition of 56 was observed using a Hanovia light (entry 
5). Using a 7:3 mixtures of trifluorotoluene and trifluoroethanol provided 
photocycloadducts 57:58 in 40% yield and 5:1 selectivity, however 48 h of irradiation was 
required for complete ESIPT photocycloaddition (entry 4). Accordingly, the 
aforementioned Rayonet continuous photoflow reactor74 was introduced to further improve 
the photocycloaddition. In general, we were able to achieve improvement of yield in a 
much shorter reaction period along with significantly less decomposition in comparison to 
batch reactions (46% yield, 57:58 = 5:1).  





With larger amounts of 57 and 58 in hand, the minor isomer 58 was reduced with 
lithium aluminum hydride to afford an unstable diol derivative which was directly acylated 
to afford the bis-para-bromobenzoate 60. The structure and relative stereochemistry of 60 
was confirmed using HMBC and NOESY experiments. Using the major isomer 57, sodium 
methoxide-mediated -ketol rearrangement followed by a hydroxyl-directed 
diastereoselective reduction yielded aza-rocaglate 51 in 77% yield (Scheme 3.7a). The 
structure of 51 was unambiguously confirmed by X-ray crystal structure analysis of the 
derived bromobenzoate 62 (Scheme 3.7b). Interestingly, inspection of the X-ray structure 
reveals that the N-methyl moiety is coplanar to the adjacent aryl group indicating a non-
pyramidalized nitrogen.75 This is likely due to steric interaction of N-methyl moiety with 
the two nearby aryl substituents which appears to prevent nitrogen pyramidalization. 
In order to provide a plausible explanation for the differential reactivity of 3-
hydroxyquinolinones 51 and 56, we measured their UV-Vis absorption spectra. We found 
that in CH2Cl2:MeOH (2:1), both substrates possess an absorption band at approximately 
370 nm which can be attributed to nπ* photo excitation.76 More interestingly, we 
observed an additional absorption peak at 310 nm for substrate 51 (Figure 3.2) which 
indicates that N-H-3-HQ substrate 51 may exhibit a tautomerization in solution.77 
Therefore, we hypothesized that in solution, 51 may also be represented by an aromatic, 
dihydroxyquinoline tautomeric form 64 which in principle may diminish its 
photoreactivity.  In order to support this assertion, we found that treatment of 51 with TMS 
diazomethane resulted in formation of 3,4-dimethoxyquinoline 63.78 Furthermore, by 




also observed for compound 63 which provides supportive information on the existence of 
tautomeric form 64 in solution. 
Figure 3.2 UV Absorption Spectra of 3-Hydroxyquinolinones 51 and 56 in Comparison to 
Dimethoxyquinoline 63 
 
3.3 Synthesis of N-Methyl-3-hydroxyquinolinones Using Basic Conditions 
In order to synthesize more highly functionalized aza-rocaglate scaffolds, we next 
turned our attention to prepare N-methyl-3-hydroxyquinolinones with increased 
substitution. Although various methods were reported to synthesize 3-
hydroxyquinolinones, these methods were all very similar and most reports only focused 
on N-H substrates. Namely, by heating the corresponding phenacyl anthranilate precursors 
in the presence of acid (cf. Scheme 3.6), N-H-3-HQs may be obtained. A series of simple 
N-Me-3-HQs were also synthesized using this protocol. Accordingly, we planned to 




methodology (Scheme 3.8). Dimethoxy anthranilic acid 6579 was first converted to isatoic 
anhydride 66 by treatment with triphosgene which was directly deprotonated by sodium 
hydride and methylated with methyl iodide. Subsequent hydrolysis by aqueous 
hydrochloric acid then yielded mono-methylated dimethoxy anthranilic acid 67. We 
subsequently treated 67 with potassium carbonate to form the corresponding potassium salt 
followed by addition of 2,4'-dibromo-acetophenone to achieve an SN2 reaction which 
efficiently provided access to phenacyl anthranilate 68. However, after evaluation of all 
reported conditions for conversion of 68 to N-Me-3-HQ 69, the best condition identified 
involved thermolysis of 68 to 180 °C in the presence of polyphosphoric acid (PPA) for 24 
h which led to the production of only a 5% isolated yield of 69.80 All other reported 
conditions failed to provide access to N-Me-3-HQ 69. After a thorough condition 
screening, we were able to identify that treatment of 68 with sodium hydride and heating 
led to the formation ofN-Me-3-HQ 69 in 78% yield. A previously demonstrated substrate 
55 was also reacted under similar conditions and afforded an 83% isolated yield of 56. 
After further investigation, we also learned that sodium hydride could provide 
access to N-Me-3-HQs. Other bases, including LDA, tBuOK, MeONa, and LiHMDS all 
failed to provide the desired product, which led us to believe that the initiation of this 
reaction did not involvet enolate formation upon reaction with base. Therefore, a proposed 
mechanism (Scheme 3.8c) may proceed through formation of hemiaminal 70 followed by 
rearrangement to alkoxide 71.81 3,1-Benzoxazin-4-ones related to 71 have previously been 
reported from treatment of phenacyl anthranilates with acetic acid.82 Additionally, 




failed to yield any corresponding 3-HQ compounds under our reaction conditions which is 
consistent with our mechanistic proposal, as electron withdrawing groups on nitrogen 
could decrease the nucleophilicity of the nitrogen and introduce steric hindrance for the 
hemiaminal formation.83 Further conversion of 71 to iminium 72 followed by isomerization 
may generate the intramolecular hydrogen bond-stabilized enolate 73 (Scheme 3.8c).84  
Cyclization of 73 to benzoxazepine 74 followed by rearrangement to zwitterion 75, 
elimination, and acidic workup provides 3-hydroxyquinolinone 56. Similar benzoxazepine 
structures have also been synthesized previously in the literature by treatment of phenacyl 
anthranilates with phosphoryl chloride.85 






Alternatively, sodium hydride could directly deprotonate 55 to afford sodium 
enolate 75, which may undergo 3-exo-trig cyclization86 to generate an unstable 
hydroxyepoxide intermediate 76. Further rearrangement of 76 to diketone 77. Hemiaminal 
formation and subsequent dehydration afforded product 56. 
Scheme 3.9 Substrate Scope for Sodium Hydride-mediated N-Alkyl-3-HQ Synthesis 
 
Taking advantage of this methodology, we were also able to synthesize several N-
alkyl-3-hydroxyquinolinones from the corresponding phenacyl anthranilates (Scheme 
3.9). From this study, we were able to see that fluorinated phenacyl anthranilate and 
heterocycle-containing phenacyl anthranilates could be used to synthesize N-Me-3-HQ 85-
87, as well as the dimethylamino-substrate 88. More importantly, we also demonstrated 
that other N-alkyl substituted 3-hydroxyquinolinones may by prepared using this novel 




3.4 Synthesis of Highly Functionalized Aza-rocaglates  
With various N-alkyl-3-HQs in hand, we subsequently subjected these compounds 
to ESIPT photocycloadditions for the syntheses of more highly functionalized aza-
rocaglates. Using the previously optimized photoflow conditions N-Me-3-HQ 69 was 
photo-irradiated with methyl cinnamate 21 in 7:3 trifluorotoluene : trifluoroethanol for 12 
hours. Photocycloadduct 91 was produced in high diastereoselectivity which was subjected 
to sodium methoxide-mediated -ketol rearrangement and subsequent hydroxyl-directed 
diastereoselective reduction to afford aza-rocaglate 93 (Scheme 3.10a). Saponification 
using lithium hydroxide followed by amide coupling yielded the corresponding 
hydroxamate 94, the nitrogen-containing analogue of the corresponding synthetic 
cyclopenta[b]benzofuran compound which was found to be a highly potent protein 
translatioinhibitor (vide infra).87  
In order to synthesize our original synthetic target, N-H-aza-rocaglate 50, we chose 
to use N-allyl-3-HQ 90 as our ESIPT photocycloaddition reactant in which the allyl moiety 
could serve as a removable protecting group. The previously described photoflow 
condition was applied to perform the ESIPT photocycloaddition first, but significant 
decomposition of 90 was observed. We reasoned that use of the mildly acidic solvent 
trifluoroethanol may lead to photo-decomposition in which case the aprotic solvent toluene 
was chosen for the photocycloaddition. Gratifyingly, we could observe formation of the 
photocycloadduct 95 in 43% yield and in 10:1 diastereoselectivity (Scheme 3.10b).  N-
allyl-aza-rocaglate 97 was next accomplished via -ketol rearrangement and 




we found that using Pd (0) /1,4-bis(diphenylphosphino)-butane complex with Meldrum's 
acid as nucleophile and proton source,88,89 N-H-aza-rocaglate 50 could be obtained in 45% 
yield. Other N-deallylation conditions such as thio radical promoted-tautomerization90 and 
oxidative condition91 reported in the literature all failed to provide the desired product. 
Furthermore, we also demonstrated the possibility for further functionalization of the N-
allyl moiety by introducing an olefin via a cross metathesis reaction on of 97 with methyl 
acrylate to produce aza-rocaglate 98.92 





3.5 Biological Activity Studies of Aza-rocaglates  
Rocaglates have been shown to behave as potent inhibitors of translation by 
interfering with the activity of eukaryotic initiation factor (eIF) 4A,87 an RNA helicase 
necessary for cap-dependent protein synthesis. We therefore assessed the biological 
activities of compounds 50, 93, 94, 97, and 98 in vitro in a translation assay programmed 
with the bicistronic mRNA, FF/HCV/Ren (Figure 3.3a). In this system firefly luciferase 
(FF) production is eIF4A-dependent whereas Renilla luciferase (Ren) is not. Silvestrol 
(101) and rocaglates CR-1-31B 100 and (-)-SDS-1-021 99 potently inhibited FF production 
(5-10 fold) at 5 M. The only aza-rocaglate to affect FF production was the N-methyl 
derivative 77, showing a ~30% reduction in FF production at 20 M (Figure 3.3a). To 
assess activity towards cellular protein synthesis, HeLa cells were incubated with silvestrol 
(101), CR-1-31B 100, or 93 for 1 h and metabolic protein synthesis quantitated (Figure 
3.3b). Whereas 100 nM silvestrol (101) or CR-1-31B 100 completely blocked protein 
synthesis, compound 100 showed modest activity only at 50 M (~20% inhibition). 
Figure 3.3 a. Effect of Aza-rocaglates on in vitro Translation of FF/HCV/Ren. b. Assessing 





Consistent with these findings, we also found no evidence for translation inhibition 
over a 24 h period at concentrations up to 10 M using a whole cell assay based on 
constitutive expression of the rapidly turned-over reporter protein firefly luciferase (Figure 
3.4a). Likewise, the compounds had minimal cytotoxic activity in a standard 3-day growth 
assay over the same concentration range (Figure 3.4b). Together, these results indicate 
that aza-rocaglates do not possess the same inhibitory potency towards protein synthesis 
in comparison to related rocaglates such as RHT 102. 
Figure 3.4 a. Translation Inhibition (10 M) in Whole Cells Based on Constitutive Expression of 
Firefly Luciferase. b. 3-Day Growth Assay (Human 293T cancer cells) Over the Same Concentration. 
 
3.6 Summary  
To summarize, in this chapter we have employed ESIPT photocycloaddition 
methodology to synthesize aza-rocaglates. Our studies have uncovered differential 




hydroxyquinolinone substrates. A novel method to access 1-alkyl-2-aryl-3-
hydroxyquinolinones using sodium hydride was also developed for (3+2) 
photocycloaddition. Use of a continuous photoflow reactor facilitated synthesis of aza-
rocaglates with both N-alkyl and N-H substitution. Initial protein synthesis and translation 
inhibition data indicated that aza-rocaglates did not possess activity in comparison to 
related rocaglates which provided further information on the SAR of the natural product 
scaffold. 
3.7 Experimental Section 
General Information: 1H NMR spectra were recorded at 500 MHz at ambient temperature 
with CDCl3 (Cambridge Isotope Laboratories, Inc.) as solvent. Data for 
1H NMR are 
reported as follows: chemical shift, integration, multiplicity (brs = broad singlet, s = singlet, 
d = doublet, t = triplet, q = quartet, m = multiplet) and coupling constants in Hz. 13C NMR 
spectra were recorded at 125 MHz at ambient temperature with the same solvents unless 
otherwise stated. Chemical shifts are reported in parts per million relative to deuterated 
solvents. All 13C NMR spectra were recorded with complete proton decoupling. Infrared 
spectra were recorded on a Nicolet Nexus 670 FT-IR spectrophotometer. High-resolution 
mass spectra were obtained in the Boston University Chemical Instrumentation Center 
using a Waters Q-TOF API-US mass spectrometer. Melting points were recorded on a Mel-
Temp apparatus (Laboratory Devices). Analytical LC-MS was performed on a Waters 
Acquity UPLC (Ultra Performance Liquid Chromatography (Waters MassLynx Version 
4.1) with a Binary solvent manager, SQ mass spectrometer, Water 2996 PDA (PhotoDiode 




BEH C18 1.7 μm column was used for analytical UPLC-MS. The Scilligence ELN 
electronic laboratory notebook was used for experimental procedure planning.  
Analytical thin layer chromatography was performed using 0.25 mm silica gel 60-F plates. 
Flash chromatography was performed using 200-400 mesh silica gel (Scientific 
Absorbents, Inc.). Yields refer to chromatographically and spectroscopically pure 
materials, unless otherwise stated. HPLC grade tetrahydrofuran, methylene chloride, 
diethyl ether, toluene, acetonitrile, and benzene were purchased from Fisher and VWR and 
were purified and dried by passing through a PURE SOLV® solvent purification system 
(Innovative Technology, Inc.). Other ACS grade solvents for chromatography were 
purchased from Clean Harbors.  
Photochemistry experiments were performed using a Rayonet RPR-100 photochemical 
reator equipped with RPR-3500Å irradiation lamps ( > 330 nm, max = 350 nm). For the 
Hanovia photoflow reactor, a 450 medium pressure mercury lamp housed in quartz 
immersion well with a Pyrex absorption sleeve ( > 290 nm) was used. An A-40 
Refrigerated & Heating Circulator was used for Immersion well cooling (Anova Industries 
Inc.). For the Rayonet photoflow reactor, a Rayonet RPR-100 photobox was used as light 
source and a Thermo Scientific™ Neslab CC65 Immersion Cooler was using as a cooling 
system. A benchtop pump with 114DV flip top single channel pumphead (model: 120S) 
was chosen as the peristaltic pump for the continuous photoflow reactor (Waston Marlow 
Fluid Technology Group). Microwave experiments were performed using a CEM Discover 
microwave. All other reactions were carried out in oven-dried glassware under an argon 





N-Me-3-HQ 56: Method 1: A 20 mL microwave reaction tube was charged with 
anthranilate 55 (3.0 g, 10 mmol, 1 equiv) and ammonium formate (3.16 g, 50 mmol, 5 
equiv). Subsequently, 10 mL formic acid was added and the resulting mixture was stirred 
until all the solid was completely dissolved. The tube was then plugged into the microwave 
reactor and irradiated for 6 hours at 110 °C. The reaction mixture was next cooled to room 
temperature and poured into ice water for 10 min. The solid was collected by filtration 
which is the crude product. After recrystallization in acetone, N-Me-3-HQ 56 was obtained 
as a white solid (1.6 g, 57% yield).  
Method 2: A 100 mL Erlenmeyer flask was charged with 30 g polyphoric acid (PPA). 
Subsequently, the PPA was heated up to 180 °C and the stickiness of PPA was reduced 
after the temperature was reached. Anthranilate 55 (3.0 g, 10 mmol, 1 equiv) and a 
magnetic stir bar was added. After 10 min all the solid was completely dissolved. The 
reaction mixture was kept heated at 180 °C for 8 hours before 80 mL ice water was added. 
The mixture was put on sonication for 2 hours until all the gummy oil was fully dissolved 
by water. The dark green solid was then filtered and collected. After recrystallization in 
acetone, N-Me-3-HQ 56 was obtained as a white solid (2.1 g, 72% yield). 
Method 3: A 250 mL flame-dried, round bottom flask was charged with anthranilate 55 
(3.0 g, 10 mmol, 1 equiv) and 130 mL anhydrous THF and the reaction was purged with 




water condenser was installed and the solution was heated to 85 °C for 5 h before being 
cooled to room temperature and immersed in an ice bath. Saturated aqueous ammonium 
chloride solution was added to work up the reaction until pH < 7 was achieved (250 mL 
was added). Then CH2Cl2 80 mL  5 was used for extraction, and the combined organic 
layers were washed with saturated aqusous NaCl solution and dried with anhydrous 
Na2SO4. After concentrated in vacuo, 20 mL of cold acetone was added. The white 
precipitate was filtered and washed with cold acetone. Product 56 was obtained as a white 
solid (2.35 g, 83% yield). 
 
Batch photoreaction: To a Pyrex reaction tube was added N-Me-3-HQ 56 (500 mg, 1.78 
mmol, 1 equiv), methyl cinnamate 21 (2.88 g, 17.8 mmol, 10 equiv), α,α,α-trifluorotoluene 
(35 mL), and 2,2,2-trifluoroethanol (15 mL). The resulting mixture was first sonicated and 
then sparged with argon while sonicating for 10 min. The tube was then sealed and chilled 
to 0 °C. The resulting solution was irradiated using a Rayonet RPR-100 photochemical 
reactor for 48 h at 0 °C using ice bath. In order to maintain the reaction temperature at 0 
°C, every 2 hours the ice bath needed to be refilled. The reaction mixture was then 
concentrated and purified via column chromatography (EtOAc/hexanes = 1:10 to first 
remove methyl cinnamate then EtOAc/hexanes = 1:6 to EtOAc/hexanes = 1:4) to elute 
products. Compound 57 (633 mg, 40%) was obtained as a white solid and compound 58 




57: Rf = 0.19 (EtOAc / hexanes = 1 : 4); mp 103 - 105°C (CH2Cl2); IR 
(thin film): νmax 3438, 2950, 1708, 1612, 1500, 1209, 1151, 1078, 1010, 
815.73, 736 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.29  (d, J = 7.5 Hz, 
1H), 7.21 (m, 3H), 7.06 (m, 3H), 6.90 (m, 3H), 6,79 (d, J = 8.5 Hz, 1H), 
6.65 (d, J = 7 Hz, 2H), 4.63 (d, J = 7 Hz, 1H), 3.70 (s, 3H), 3.54 (s, 1H), 3.50 (s, 3H), 3.35 
(d, J = 7 Hz, 1H), 2.60 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 210.2, 170.5, 158.6, 145.6, 
141.5, 131.5, 130.8, 129.8, 128.8, 128.4, 126.7, 126.6, 124.3, 120.7, 117.7, 113.0, 80.4, 
72.9, 59.9, 55.1, 51.1, 38.8, 29.7; HRMS-ESI (m/z): [M+H]+ calculated for C27H25NO5 
444.1811, found 444.1809. 
58: Rf = 0.27 (EtOAc / hexanes = 1 : 4); IR (thin film): νmax 3507, 3065, 
2950, 1738, 1601, 1487, 1255, 1181, 1088, 737, 702 cm-1; 1H NMR 
(500 MHz, CDCl3) δ 7.57 (m, 2H), 7.42 (d, J = 10 Hz, 1H), 7.30 (m, 
3H), 7.22 (m, 1H), 7.03 (d, J = 11.5 Hz, 2H), 6.98 (d, J = 11.5 Hz, 2H), 
6.82 (t, J = 10 Hz, 1H), 6.52 (d, J = 10 Hz, 1H), 4.55 (d, J = 7.5 Hz, 1H), 4.10 (d, J = 7.5 
Hz, 1H), 3.88 (s, 3H), 3.67 (s, 3H), 2.60 (s, 1H, OH), 2.53 (s, 3H); 13C NMR (125 MHz, 
CDCl3) δ 210.1, 171.4, 159.7, 144.3, 139.5, 129.5, 129.2, 128.9, 128.5, 127.7, 125.8, 122.8, 
118.5, 113.8, 111.2, 79.1, 77.2, 73.9, 55.3, 53.8, 53.4, 52.5, 35.7; HRMS-ESI (m/z): 
[M+H]+ calculated for C27H25NO5 444.1811, found 444.1811. 
Continuous Photoflow Reactor:  
In a 200 mL flame dried flask, N-Me-3-HQ 56 (1 g, 3.56 mmol, 1 equiv), methyl cinnamate 
21 (8.64 g, 53.25 mmol, 15 equiv), 50 mL α,α,α-trifluorotoluene, and 21 mL 2,2,2-






reaction flask was connected to the continuous photoflow reactor. After the solvent pump 
started, nitrogen gas was bubbled into the reaction mixture for another 10 min to further 
purge the remaining air out of the reaction system. The reaction mixture cooled to 0 °C and 
was kept circulating and irradiated (Rayonet, λ > 330 nm) at 0 °C for 9 h. After being 
concentrated in vacuo, the reaction mixture was purified by silica gel column 
chromatography (gradient of EtOAc/hexane 1:10 to remove the methyl cinnamate first, 
then EtOAc/hexane from 1:6 to 1:4 to obtain the product). Compound 57 (483.5 mg, 46%) 
was obtained as a white solid. and compound 58 (97 mg, 9%) was isolated as a colorless 
oil. 
 
Bis-p-bromobenzoate 59: A 50 mL flask was charged with compound 57 (50 mg, 0.11 
mmol, 1 equiv) and a stir bar in 20 mL of dry THF. The solution was cooled to -78 °C 
before LiAlH4 (19.1 mg, 0.56 mmol, 5 equiv) was added. The reaction mixture was warmed 
to room temperature and stirred overnight before saturated NH4Cl (20 mL) and potassium 
sodium tartrate tetrahydrate (20 mL) aqueous solution were added to quench the reaction. 
20 mL  3 CH2Cl2 was used for extraction and the organic layers were combined. After 
drying the organic layers with anhydrous Na2SO4, filtration, and concentration in vacuo, 
the resulting brown oil was used in the next step without further purification. The brown 
oil was dissolved in 50 mL of dry CH2Cl2 and was cooled to 0 °C before 4-bromobenzoyl 




room temperature for 3 h. Saturated aqueous Na2CO3 (20 mL) solution was added to 
quench the reaction. CH2Cl2 (320 mL) was used for extraction and the combined organic 
layers were washed with saturated aqueous NaCl and dried with anhydrous sodium sulfate. 
After filtration, and concentration in vacuo, the crude product was purified via SiO2 gel 
column chromatography (1:10 EtOAc/hexanes to 1:5 EtOAc/hexanes) to afford compound 
59 (36 mg, 41% yield) as a white solid. 
59: Rf = 0.63 (EtOAc / hexanes = 3 : 7); mp 151-152 °C (CH2Cl2); IR 
(thin film): νmax 3062, 2927, 1719, 1590, 1513, 1265, 1102, 1012, 752 
cm-1; 1H NMR (500 MHz, CDCl3) δ 7.49 (m, 6H), 7.32 (m, 11H), 
6.85 (d, J = 8.5 Hz, 2H), 6.76 (t, J = 7.5 Hz, 1H), 6.73 (d, J = 8 Hz, 
1H), 5.70 (s, 1H), 4.78 (dd, J1 = 6 Hz, J2 = 11 Hz), 4.33 (dd, J1 = 8.5 Hz, J2 = 11 Hz), 4.02 
(ddd, J1 = 6 Hz, J2 = 8 Hz, J3 = 8.5 Hz), 3.79 (s, 3H), 3.53 (d, J = 8 Hz), 2,79 (s, 3H), 2.16 
(s, 1H); 13C NMR (125 MHz, CDCl3) δ 165.6, 165.3, 159.3, 144.5, 139.3, 131.7, 131.4, 
131.2, 131.0, 130.1, 130.0, 129.8, 129.3, 129.2, 128.5, 128.4, 128.3, 128.1, 127.7, 122.1, 
116.8, 114.1, 109.8, 78.7, 77.4, 69.0, 65.9, 59.1, 55.3, 50.9, 36.9; HRMS-ESI (m/z): 
[M+H]+ calculated for C40H33Br2NO6 782.0953, found 782.0771. 
 
A 100 mL flame dried flask was charged with compound 58 (100 mg, 0.225 mmol, 1 equiv) 
and a stir bar. Then 20 mL of dry methanol were added to form a pale yellow solution. A 





10 mL of dry methanol was added to the solution of compound 58 and the resulting mixture 
was heated to 60 °C for 20 min before being quenched with saturated NH4Cl aqueous (20 
mL). The reaction was diluted and extracted with EtOAc (3 x 10 mL), then washed with 
saturated aqueous NaCl (20 mL), dried with anhydrous sodium sulfate, filtered, and 
concentrated in vacuo. Crude 1H NMR analysis of the crude product 60 (CDCl3, ratio = 2 
: 1)showed a mixture of keto and enol tautomers in solution. To a 25 mL flame dried flask 
was added, crude product 60 (85 mg), tetramethylammonium triacetoxyborohydride (356 
mg, 1.35 mmol, 6 equiv), acetic acid (65 μL, 1.13 mmol, 6 equiv) and 10 mL of dry 
acetonitrile. The resulting yellow solution was stirred for 14 h at room temperature before 
being quenched with sat. NH4Cl solution (10 mL) and saturated aqueous potassium sodium 
tartrate tetrahydrate (Rochelle salt) (10 mL) to remove boron compounds by complexation. 
The mixture was then extracted with CH2Cl2 (3 x 5 mL) and the combined organic layers 
were washed with sat. NaHCO3 (20 mL), dried over Na2SO4, filtered, and concentrated in 
vacuo. The crude product was purified by flash chromatography (gradient of 
EtOAc/hexane from 1:4 to 1:2) to afford pure N-Me-aza-rocaglate 61 (77 mg, 77% over 2 
steps) as a white solid. 
61: Rf = 0.12 (EtOAc / hexanes = 1 : 4); mp 85 - 86°C (CH2Cl2); IR 
(thin film): νmax 3401, 2927, 1711, 1628, 1514, 1254, 1185, 1112, 
1036, 773 cm-1; 
1H NMR (500 MHz, CDCl3) δ 7.47 (d, J = 7.5 Hz, 
2H), 7.37 (d, J = 7.5 Hz, 1H), 7.22 (m, 4H), 6.83 (d, J = 9 Hz, 2H), 6.80 (d, J = 7.5 Hz, 
1H), 6.60 (d, J = 9 Hz, 2H), 6.31 (d, J = 8 Hz, 1H), 4.77 (dd, J1 = 9 Hz, J2 = 10.5 Hz, 





(dd, J1 = 3 Hz, J2 = 9 Hz, 1H), 2.61 (bs, 1H), 2.40 (s, 3H); 
13C NMR (125 MHz, CDCl3) 
δ 172.4, 158.7, 151.2, 140.9, 130.3, 129.6, 129.4, 129.3, 128.2, 127.6, 126.4, 125.1, 
117.7, 113.3, 106.0, 90.6, 85.9, 79.6, 55.0, 52.7, 52.6, 51.6, 29.6; HRMS-ESI (m/z): 
[M+Na]+ calculated for C27H27NO5Na 468.1787, found 468.1779. 
 
Para-Bromo benzoate 62: A 25 mL flame dried flask was charged with compound 61 
(52 mg, 0.12 mmol, 1 equiv), 4-bromobenzoyl chloride (27 mg, 0.12 mmol, 1 equiv), 
triethylamine (18 μL, 0.13 mmol, 1.1 equiv), and CH2Cl2 (10 mL). The resulting 
mixture was stirred at room temperature for 12 h before being quenched with sat. 
Na2CO3 solution. The mixture was then extracted with CH2Cl2 (3 x 5 mL) and the 
combined organic layers were washed with sat. NaCl (20 mL), dried over Na2SO4, 
filtered, and concentrated in vacuo. The crude material was purified by flash 
chromatography (gradient of EtOAc/hexane from 1:6 to 1:4) to afford compound 62 
(48 mg, 67%) as a white solid.  
62: Rf = 0.41 (EtOAc / hexanes = 3 : 7); mp 218 - 219 °C (CH2Cl2); IR 
(thin film): νmax 3491, 2952, 2837, 1733, 1161, 1511, 1269, 1121, 1038, 
741 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.52 (d, J = 9 Hz, 2H), 7.45 (d, 
J = 9 Hz, 2H), 7.28 (d, J = 8 Hz, 2H), 7.21 (t, J = 9 Hz, 2H), 7.12 (m, 
3H), 6.79 (d, J = 9 Hz, 2H), 6.62 (d, J = 9 Hz, 2H), 6,53 (t, J = 7.5 Hz, 1H), 6.41 (d, J = 7.5 





Hz, 1H), 3.67 (s, 3H), 3.55 (s, 3H), 3.12 (s, 3H), 1.85 (bs, 1H);  13C NMR (125 MHz, 
CDCl3) δ 170.5, 164.8, 158.6, 150.9, 138.5, 131.5, 131.0, 130.6, 130.4, 129.0, 128.5, 128.2, 
128.1, 126.5, 126.2, 125.8, 125.0, 116.7, 113.1, 104.3, 93.0, 85.8, 80.6, 55.0, 54.4, 52.1, 
52.0, 30.9; HRMS-ESI (m/z): [M+H]+ calculated for C34H31BrNO6 628.1335, found 
628.1348. 
 
3,4-Dimethoxyquinoline 63: A flame dried test tube was charged with compound 51 
(50 mg, 0.19 mmol, 1 equiv). Anhydrous CH2Cl2/ MeOH = 1:1 (5 mL) was added to 
afford a heterogeneous solution. Then, TMSCHN2 (0.95 mL, 2M ether solution, 5 
equiv) was added which led to slow dissolution of compound 51. The resulting mixture 
was stirred at room temperature for 12 h before 10 mL of 10% aqueous AcOH solution 
was added dropwise to quench the reaction. The mixture was then extracted with 
CH2Cl2 (3 x 5 mL) and the combined organic layers were washed with sat. NaCl (20 
mL), dried over Na2SO4, filtered, and concentrated in vacuo. Purification by silica gel 
column chromatography (gradient of EtOAc/hexane from 1:4 to 1:2) afforded 
compound 63 (32 mg, 58%) as a colorless oil. 
63: Rf = 0.44 (EtOAc / hexanes = 1 : 4); IR (thin film): νmax  2936, 
2837, 1607, 1515, 1378, 1252, 1177, 1107, 1045, 838 cm-1; 1H NMR 
(500 MHz, CDCl3) δ 8.11 (d, J = 10.5 Hz, 1H), 8.06 (d, J = 10.5 Hz, 
1H), 7.99 (d, J = 11 Hz, 2H), 7.62 (t, J = 10.5 Hz, 1H), 7.48 (t, J = 10.5 Hz, 1H), 7.02 (d, J 





154.1, 145.9, 142.4, 130.8, 130.6, 129.1, 128.5, 125.7, 123.9, 121.6, 113.6, 61.1, 60.8, 55.3; 
HRMS-ESI (m/z): [M+H]+ calculated for C18H17NO3 296.1287, found 296.1287. 
 
N-methyl-anthranilic acid 67: To a flame dried 250 mL flask, dimethoxyanthranilic acid 
65 (5.5 g, 27.9 mmol, 1 equiv) and 150 mL of anhydrous THF was added. After the 
resulting solution was cooled to 0 °C in an ice bath, triphosgene (2.81 g, 9.5 mmol, 0.34 
equiv) was added and a precipitate formed immediately. The reaction mixture was warmed 
to room temperature and stirred overnight before being concentrated in vacuo. Then 
CH2Cl2 was added and the remaining solid was separated by filtration. The solid obtained 
(dimethoxy isatoic anhydride 66) was washed with cold CH2Cl2, dried, and was then 
redissolved in 150 mL of dry DMA in a 250 mL flask. Then NaH (60 % dispersion in 
mineral oil) (2.23g, 55.8 mmol, 2 equiv) was added. The mixture was stirred for 10 min at 
room temperature before MeI (1.74 mL, 27.9 mmol, 1 equiv) was added. The reaction was 
stirred at room temperature for 10 h before 15 mL of H2O was added to quench the reaction 
which was stirred at room temperature for 0.5 h to facilitate hydrolysis of the N-methyl 
isatoic anhydride to N-methyl anthranilic acid 67. Then 1M aqueous HCl was added 
dropwise to acidify the reaction to pH 6 - 7. The mixture was extracted with 150 mL  3 




the remaining DMA and was then washed with sat. NaCl (200 mL), dried over Na2SO4, 
filtered, and concentrated in vacuo. Purification by silica gel column chromatography 
(gradient of EtOAc/hexane from 1:4 to 1:2) afforded N-methyl dimethoxyanthranilic acid 
67 (4.91 g 83%) as a white solid. 
67: Rf = 0.32 (EtOAc / hexanes = 3 : 7); mp 131 - 133 °C (CH2Cl2); IR 
(thin film): νmax 3322, 3202, 2948, 1686, 1620, 1414, 1223, 1154, 1049, 
803 cm-1; 1H NMR (500 MHz, CDCl3) δ 11.11 (s, 1H, OH), 8.88 (d, J = 
5Hz, 1H, NH), 5.78 (s, 2H), 3.97 (s, 3H), 3.84 (s, 3H), 2.88 (d, J = 5 Hz, 3H); 13C NMR 
(125 MHz, CDCl3) δ 168.6, 164.6, 161.4, 155.9, 92.5, 88.1, 86.8, 56.6, 55.2, 29.8; HRMS-
ESI (m/z): [M+H]+ calculated for C10H13NO4 211.0845, found 211.0842. 
N-Methyl dimethoxyanthranilate 68: A 250 mL flame dried flask was charged with 
N-methyl dimethoxyanthranilic acid 67 (4.5 g, 31.3 mmol, 1 equiv), K2CO3 (1.62 g, 
11.7 mmol, 0.55 equiv), 135 mL dry DMF and a stir bar. The reaction mixture was 
heated to 90 °C for 0.5 h before being cooled to room temperature. Then 2,4′-
dibromoacetophenone (5.92 g, 21.3 mmol, 1 equiv) was added and the reaction mixture 
was stirred at room temperature overnight and added to ice water. After 5 min, 
compound 68 precipitated from the solution. The solid was filtered and dried. (If no 
precipitate was formed, extraction with CH2Cl2 can be used to obtain the crude product.) 
Purification by silica gel column chromatography (gradient of EtOAc/hexane from 1:4 
to 1:1) afforded N-methyl dimethoxyanthranilate 68 (8.33g, 96%) as a white solid. 
Product recrystallization from MeOH was also found to be effective for purification of 





to 80 °C for 20 min before being cooled to 0 °C. Filtration and drying of the solid 
product afforded 68 7.5 g (87% yield) product as a white solid. 
68: Rf = 0.36 (EtOAc / hexanes = 3 : 7); mp 126 - 127 °C 
(CH2Cl2); IR (thin film): νmax 3396, 2937, 1698, 1587, 1416, 
1261, 1159, 1104, 1009, 807 cm-1; 1H NMR (500 MHz, CDCl3) 
δ 7.85 (d, J = 9 Hz, 2H), 7.54 (d, J = 9 Hz, 2H), 7.40 (d, J = 4 Hz, 1H, NH), 5.80 (d, J = 2 
Hz, 1H), 5.76 (d, J = 2 Hz, 1H), 5.43 (s, 2H), 3.83 (s, 3H), 3.80 (s, 3H), 2.88 (d, J = 4 Hz, 
3H); 13C NMR (125 MHz, CDCl3) δ 192.8, 167.3, 164.6, 163.0, 154.0, 133.1, 132.1, 129.5, 
129.0, 95.4, 87.6, 87.4, 65.9, 56.0, 55.1, 30.1; HRMS-ESI (m/z): [M+H]+ calculated for 
C18H19BrNO5 408.0447, found 408.0445. 
 
1-Methyl-2-(4-bromophenyl)-3-hydroxydimethoxyquinolinone 69:  
Method 1: A 25 mL glass tube was charged with 10 g polyphoric acid (PPA). Subsequently, 
the PPA was heated up to 180 °C and the stickiness of PPA was reduced after the 
temperature was reached. Anthranilate 68 (0.2 g, 0.49 mmol, 1 equiv) and a magnetic stir 
bar was added. After 10 min all the solid was completely dissolved. The reaction mixture 
was kept heated at 180 °C for 24 hours before 80 mL ice water was added. The mixture 
was put on sonication for 2 hours until all the gummy oil was fully dissolved by water. The 
dark green solid was then filtered and collected. Purification by silica gel column 





acetone/CH2Cl2 from 1:2 to 1:1 to elute products) afforded N-Me-3-HQ 69 as a light yellow 
solid (9.3 mg, 5% yield). 
Method 2: A 500 mL flame dried flask was charged with N-methyl dimethoxyanthranilate 
68 (2 g, 4.9 mmol, 1 equiv), 250 mL dry THF and a stir bar. Then NaH (60 % dispersion 
in mineral oil) (0.17 g, 5.9 mmol, 1.2 equiv) was added to the solution at room temperature. 
The reaction mixture was heated to 80 °C for 8 h and was then cooled to 0 °C using an ice 
bath. Subsequently, the cold reaction mixture was added slowly at 0 °C to 400 mL of a sat. 
solution of NH4Cl solution. Then 1 M aqueous HCl solution was added to acidify the 
mixture to pH = 6. The mixture was extracted 3  200 mL with CH2Cl2, the combined 
organic layers were washed with Sat. NaCl (20 mL), dried over Na2SO4, filtered, and 
concentrated in vacuo. Purification by silica gel column chromatography (gradient of 
EtOAc/hexane from 1:2 to 1:1 to remove byproducts, then acetone/CH2Cl2 from 1:2 to 1:1 
to elute products) afforded compound 69 (1.5 g, 78%) as a light yellow solid. 
69: Rf = 0.41 (CH2Cl2 / acetone = 2 : 1); mp 192 - 193 °C 
(CH2Cl2); IR (thin film): νmax 3401, 3268, 2939, 1617, 1581, 
1489, 1458, 1301, 1265, 1166, 1092, 1013 cm-1; 1H NMR (500 
MHz, CDCl3) δ 7.66 (d, J = 8.5 Hz, 2H), 7.32 (d, J = 8.5 Hz, 2H), 
6.35 (s, 2H), 3.99 (s, 3H), 3.92 (s, 3H), 3.48 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 169.4, 
162.9, 162.0, 143.5, 139.7, 132.2, 131.5, 130.8, 130.7, 123.7, 108.8, 93.7, 89.5, 56.3, 55.4, 






General Method for Preparation of Phenacyl Anthranilate: A 250 mL flame dried flask 
was charged with N-methyl anthranilic acid 80a (1.0 g, 5.9 mmol, 1 equiv), K2CO3 (0.45 
g, 3.25 mmol, 0.55 equiv), 65 mL dry DMF and a stir bar. The reaction mixture was heated 
to 90 °C for 0.5 h before being cooled to room temperature. Then bromoacetophenone 
(1.76 g, 6.2 mmol, 1.05 equiv) was added and the reaction mixture was stirred at room 
temperature overnight and added to ice water. After 5 min, compound 80 precipitated from 
the solution. The solid was filtered and dried. (If no precipitate was formed, extraction with 
CH2Cl2 can be used to obtain the crude product.) Purification by silica gel column 
chromatography (gradient of EtOAc/hexane from 1:4 to 1:1) afforded N-methyl phenacyl 
anthranilate 80 (2.04 g, 93%) as a white solid. 
General Method for Preparation of 3-Hydroxyquinolinones: A 250 mL flame dried 
flask was charged with anthranilate 80 (2 g, 5.4 mmol, 1 equiv), 130 mL dry THF and a 
stir bar. Then NaH (60 % dispersion in mineral oil) (0.65 g, 16.1 mmol, 3 equiv) was added 
to the solution at room temperature. The reaction mixture was heated to 80 °C for 11 h and 
was then cooled to 0 °C using an ice bath. Subsequently, the cold reaction mixture was 
added slowly at 0 °C to 200 mL of a sat. solution of NH4Cl solution. Then 1 M aqueous 
HCl solution was added to acidify the mixture to pH = 6. The mixture was extracted 3  
200 mL with CH2Cl2, the combined organic layers were washed with Sat. NaCl (20 mL), 




chromatography (gradient of EtOAc/hexane from 1:2 to 1:1 to remove byproducts, then 
acetone/CH2Cl2 from 1:2 to 1:1 to elute products) afforded compound 86 (1.04 g, 55%) as 
a light yellow solid. 
86: Rf = 0.32 (EtOAc / hexanes = 2 : 1); mp 230 °C decomposed 
(CH2Cl2); IR (thin film): νmax 3510, 3032, 2951, 1736, 1609, 1457, 
1291, 1209, 1071, 816, 737 cm-1; 1H NMR (500 MHz, CDCl3) δ 1H 
NMR (500 MHz, ) δ 8.01 (s, OH, 1H), 7.62 (m, 1H), 7.54 (d, J = 9.1 Hz, 1H), 7.29 (d, J = 
8.3 Hz, 2H), 7.07 (d, J = 8.3 Hz, 2H), 7.03 (m, 1H), 3.75 (m, 4H), 3.52 (s, 3H), 3.21 (m, 
4H); 13C NMR (125 MHz, DMSO) δ 168.3, 162.1, 160.1, 151.6, 141.4, 140.5, 136.1, 131.7, 
131.2, 122.2, 114.8, 113.5, 108.2, 66.5, 48.2, 38.5; HRMS-ESI (m/z): [M+H]+ calculated 
for C20H20FN2O3 354.1380, found 354.1377.  
87: Rf = 0.26 (EtOAc / hexanes = 2 : 1); mp 210 °C decomposed 
(CH2Cl2); IR (thin film): νmax 3502, 2966, 1690, 1628, 1480, 
1310, 1250, 1060, 885, 726 cm-1; 1H NMR (500 MHz, CDCl3) 
δ 1H NMR (400 MHz, ) δ 7.33 (d, J = 8.0 Hz, 2H), 7.02 (d, J = 8.0 Hz, 2H), 6.36 (d, J = 
4.0 Hz, 2H), 3.99 (s, 3H), 3.91 (s, 3H), 3.88 (m, 4H), 3.52 (s, 3H), 3.25 (m, 4H); 13C NMR 
(100 MHz, CDCl3) δ 169.29, 162.53, 161.86, 151.50, 143.31, 139.94, 132.31, 130.84, 
122.51, 115.05, 108.79, 93.50, 89.58, 66.80, 56.24, 55.41, 48.46, 38.09; HRMS-ESI (m/z): 
[M+H]+ calculated for C22H25N2O5 397.1763, found 397.1765. 
89: Rf = 0.28 (EtOAc / hexanes = 2 : 1); mp 216 °C decomposed 
(CH2Cl2); IR (thin film): νmax 3518, 3092, 2968, 1625, 1576, 1444, 







CDCl3) δ 8.54 (d, J = 8.2 Hz, 1H), 7.51 (m, 1H), 7.38 (d, J = 8.2 Hz, 1H), 7.34 (t, J = 8.2 
Hz, 1H), 7.27 (s, 1H), 6.96 (d, J = 8.2 Hz, 2H), 6.84 (d, J = 12.9 Hz, 2H), 6.79 (d, J = 12.9, 
2H), 5.26 (s, 2H), 3.83 (s, 3H), 3.76 (s, 3H); 13C NMR (100 MHz, ) δ 170.10, 160.41, 
158.87, 139.35, 138.80, 135.79, 131.59, 130.61, 128.29, 126.59, 126.23, 123.29, 123.10, 
122.67, 117.15, 114.30, 55.30, 55.25, 51.38; HRMS-ESI (m/z): [M+H]+ calculated for 
C24H22NO4 388.1549, found 388.1552. 
 
N-Methyl aglain ketone 90:  The general procedure for (3+2) photocycloaddition using 
continuous photoflow system was used. Compound 69 (800 mg, 2.05 mmol, 1 equiv), 
methyl cinnamate 21 (4.99 g, 30.8 mmol, 15 equiv), 35 mL α,α,α-trifluorotoluene and 
15 mL 2,2,2-trifluoroethanol were used for the reaction. The reaction mixture was 
purified by silica gel column chromatography (gradient of EtOAc/hexane 1:10 to first 
remove methyl cinnamate, then EtOAc/hexane from 1:4 to 1:2 to elute the product). 
Additional impurities were also removed by recrystallization from diethyl ether. 
Compound 90 (484 mg, 43%) was obtained as a white solid.  
90: Rf = 0.29 (EtOAc / hexanes = 3 : 7); mp 172 - 173 °C (CH2Cl2); 
IR (thin film): νmax 3510, 3032, 2951, 1736, 1609, 1457, 1291, 1209, 
1071, 816, 737 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.21 (d, J = 8.5 
Hz, 2H), 7.18 (d, J = 8.5 Hz, 2H), 6.98 (m, 3H), 6.81 (m, 3H), 6.15 





3.82 (s, 3H), 3.78 (s, 3H), 3.56 (s, 3H), 3.36 (d, J = 9.5 Hz, 1H), 2.53 (s, 3H); 13C NMR 
(125 MHz, CDCl3) δ 206.6, 170.7, 161.4, 158.0, 148.4, 139.5, 134.0, 131.4, 130.7, 129.5, 
128.1, 126.8, 121.4, 111.8, 99.4, 93.7, 82.1, 71.2, 56.0, 55.3, 52.6, 52.0, 41.4; HRMS-ESI 
(m/z): [M+H]+ calculated for C28H27BrNO6 552.1022, found 552.1005. 
 
N-Me-aza-aglain 90a: A flame-dried test tube was charged with aza-aglain ketone 90 (40 
mg, 0.072mmol, 1.0 equiv) and 2.5 mL dry THF. Then NaBH4 (13.7 mg, 0.36 mmol, 5.0 
equiv) was added. The resulting mixture was stirred at room temperature for 12 h before 5 
mL of a sat. NH4Cl aqueous solution was added. The reaction mixture was extracted with 
3  2 mL CH2Cl2, and the combined organic layers were washed with sat. NaCl (10 mL), 
dried over anhydrous Na2SO4, filtered, and concentrated in vacuo. Purification by silica gel 
column chromatography (gradient of EtOAc/hexane from 1:5 to 1:2) afforded compound 
90a (38 mg, 95%) as a white solid.  
90a: Rf = 0.4 (EtOAc / hexanes = 1 : 1); mp 235-236 °C (CH2Cl2); 
IR (thin film): νmax 3496, 2949, 1735, 1610, 1583, 1456, 1343, 1244, 
1207, 1072, 1010, 734 cm-1; 1H NMR (500 MHz, CDCl3) 7.19 (d, J 
= 9 Hz, 2H), 7.12 (d, J = 9 Hz, 2H), 6.98 (m, 3H), 6.73 (m, 2H), 6.15 
(d, J = 2.5 Hz, 1H), 6.02 (d, J = 2.5 Hz, 1H), 6.015 (s, 1H, OH), 4.67 (d, J = 5 Hz, 1H), 
4.00 (d, J = 9.75 Hz, 1H), 3.85 (s, 3H), 3.81 (s, 3H), 3.56 (s, 3H), 3.06 (d, J = 9.75 Hz, 1H), 





144.9, 136.8, 132.9, 127.2, 125.8, 123.3, 121.4, 116.3, 99.0, 91.3, 85.6, 75.9, 72.5, 70.2, 
66.0, 58.9, 51.8, 50.9, 50.4, 46.9, 36.7; HRMS-ESI (m/z): [M+H]+ calculated for 
C28H29BrNO6 554.1178, found 554.1163. 
  
N-Me-Br-aza-rocaglate 93: A 100 mL flame dried flask was charged with compound 91 
(200 mg, 0.362 mmol, 1 equiv) and a stir bar. Then 20 mL of dry methanol were added to 
form a pale yellow solution. A sodium methoxide solution prepared from sodium metal (84 
mg, 3.6 mmol, 10 equiv) and 10 mL of dry methanol was added to the solution of 
compound 91 and the resulting mixture was heated to 60 °C for 20 min before being 
quenched with saturated NH4Cl aqueous (20 mL). The reaction was diluted and extracted 
with EtOAc (3 x 10 mL), then washed with saturated aqueous NaCl (20 mL), dried with 
anhydrous sodium sulfate, filtered, and concentrated in vacuo. Crude 1H NMR analysis of 
the crude product 92 (CDCl3, ratio = 2 : 1) showed a mixture of keto and enol tautomers in 
solution. To a 25 mL flame dried flask was added, crude product 92 (197 mg), 
tetramethylammonium triacetoxyborohydride (571 mg, 2.2 mmol, 6 equiv), acetic acid 
(125 μL, 2.17 mmol, 6 equiv) and 15 mL of dry acetonitrile. The resulting yellow solution 
was stirred for 14 h at room temperature before being quenched with sat. NH4Cl solution 
(10 mL) and saturated aqueous potassium sodium tartrate tetrahydrate (Rochelle salt) (10 
mL) to remove boron compounds by complexation. The mixture was then extracted with 




mL), dried over Na2SO4, filtered, and concentrated in vacuo. The crude product was 
purified by flash chromatography (gradient of EtOAc/hexane from 1:5 to 1:2) to afford 
pure N-Me-aza-rocaglate 93 (157 mg, 78% from 91) as a white solid. 
93: Rf =0.36 (EtOAc / hexanes = 1 : 1); mp 217 - 219 °C (CH2Cl2); 
IR (thin film): νmax 3534, 2950, 1712, 1618, 1500, 1252, 1210, 1150, 
1079, 736 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.40 (d, J = 13.5 Hz, 
2H), 7.19 (m, 5H), 6.92 (d, J = 9 Hz, 2H), 5.94 (d, J = 2 Hz, 1H), 5.61 (d, J = 2 Hz, 1H), 
4.78 (dd, J1 = 7 Hz, J2 = 9 Hz, 1H), 4.46 (d, J = 5 Hz, 1H), 3.92 (d, J = 9 Hz, 1H) 3.88 (s, 
3H), 3.80 (s, 3H), 3.67 (s, 1H, OH), 3.63 (s, 3H), 3.33 (dd, J1 = 5 Hz, J2 = 7 Hz, 1H), 2.44 
(s, 3H); 13C NMR (125 MHz, CDCl3) δ 172.3, 163.7, 157.4, 152.9, 140.1, 134.5, 130.7, 
130.3, 129.6, 128.2, 126.5, 121.4, 106.1, 91.5, 88.3, 87.0, 86.2, 81.2, 55.7, 55.4, 52.9, 52.7, 
51.7, 30.0; HRMS-ESI (m/z): [M+H]+ calculated for C28H29BrNO6 554.1178, found 
554.1188. 
 
Hydroxamate 94: To a flame-dried test tube was added N-Me-Br-aza-rocaglate 93 (30.0 
mg, 0.05 mmol, 1.0 equiv), LiOH (6.4 mg, 0.27 mmol, 5 equiv), and 2.5 mL of anhydrous 
THF. The mixture was heated to 65 °C for 12 h. Subsequently, after the reaction was cooled 
to room temperature, 1 M HCl (5 mL) was added to acidify the solution (pH = 6). After 
extraction with 3  2 mL CH2Cl2, the combined organic layers were washed with sat. NaCl 





rocaglaic acid was subjected to the next step without further purification. To a flame-dried 
test tube was added the acid and 2.5 mL of dry CH2Cl2, methoxyamine hydrochloride (22.6 
mg, 0.27 mmol, 5 equiv), Et3N (45 μL, 0.32 mmol, 6 equiv), HOBt (8.8 mg, 0.065 mmol, 
1.2 equiv), and EDCI (13.5 mg, 0.07 mmol, 1.3 equiv). The resulting mixture was sonicated 
for 3 min to dissolve the methoxyamine hydrochloride before being stirred at room 
temperature for 12 h. The 1 mL 1M HCl and 5 mL sat. NaCl was added to quench the 
reaction. After being extracted with 3  2 mL CH2Cl2, the combined organic layers were 
washed with sat. NaCl (10 mL), dried over anhydrous Na2SO4, filtered, and concentrated 
in vacuo. Purification by preparative thin layer chromatography (EtOAc/ CH2Cl2 = 1 : 2 
with 5% MeOH) afforded hydoxamate 94 (15.8 mg, 51% over 2 steps) as a white solid. 
94: Rf = 0.27 (EtOAc / CH2Cl2 = 1 : 1); mp 238 - 239 °C 
(CH2Cl2); IR (thin film): νmax 3372, 2933, 1615, 1500, 1254, 
1149, 1076, 707 cm-1; 1H NMR (500 MHz, CDCl3) δ 9.50 (s, 1H, 
NH), 7.41 (d, J = 7.5 Hz, 2H), 7.20 (d, J = 8.5 Hz, 2H), 7.19 (m, 
3H), 6.89 (d, J = 8.5 Hz, 2H), 5.91 (d, J = 1.5 Hz, 1H), 5.60 (d, J = 1.5 Hz, 1H), 4.97 (d, J 
= 7 Hz, 1H), 4.68 (d, J = 2.5 Hz, 1H), 3.91 (s, 3H), 3.78 (s, 3H), 3.51 (s, 1H, OH), 3.44 (s, 
3H), 3.15 (s, 1H, OH), 3.06 (dd, J1 = 7 Hz, J2 = 2.5 Hz, 1H), 2.41 (s, 3H); 
13C NMR (125 
MHz, CDCl3) δ 167.6, 164.1, 156.5, 153.2, 141.3, 135.3, 130.5, 130.4, 129.7, 128.2, 126.4, 
121.4, 105.3, 91.2, 87.6, 86.8, 85.3, 80.9, 64.1, 55.54, 55.49, 52.7, 51.0, 29.4; HRMS-ESI 






N-allyl-dimethoxyanthranilic acid 84a: To a flame dried 250 mL flask, 
dimethoxyanthranilic acid 65 (5.5 g, 27.9 mmol, 1 equiv) and 150 mL of anhydrous THF 
was added. After the resulting solution was cooled to 0 °C in an ice bath, triphosgene (2.81 
g, 9.5 mmol, 0.34 equiv) was added and a precipitate formed immediately. The reaction 
mixture was warmed to room temperature and stirred overnight before being concentrated 
in vacuo. Then CH2Cl2 was added and the remaining solid was separated by filtration. The 
solid obtained (dimethoxy isatoic anhydride) was washed with cold CH2Cl2, dried, and was 
then redissolved in 150 mL of dry DMA in a 250 mL flask. Then NaH (60 % dispersion in 
mineral oil) (2.23g, 55.8 mmol, 2 equiv) was added. The mixture was stirred for 10 min at 
room temperature before MeI (1.74 mL, 27.9 mmol, 1 equiv) was added. The reaction was 
stirred at room temperature for 10 h before 15 mL of H2O was added to quench the reaction 
which was stirred at room temperature for 0.5 h to facilitate hydrolysis of the N-methyl 
isatoic anhydride to N-allyl anthranilic acid sodium salt. Then 1M aqueous HCl was added 
dropwise to acidify the reaction to pH 6 – 7 at 0 °C (high pH would cause decomposition 
of the product by decarboxylation to afford the N-allyl aniline). The mixture was extracted 
with 150 mL  3 CH2Cl2, and the combined organic layers were washed with 150 mL  3 




over Na2SO4, filtered, and concentrated in vacuo. Purification by silica gel column 
chromatography (gradient of EtOAc/hexane from 1:6 to 1:4) afforded N-allyl 
dimethoxyanthranilic acid 84a (5.0 g, 76 % yield) as a pale yellow oil. 
84a: Rf = 0.39 (EtOAc / hexanes = 3 : 7); IR (thin film): νmax 3303, 
2947, 2844, 1681, 1614, 1455, 1354, 1220, 1146, 923, 807 cm-1; 1H 
NMR (500 MHz, CDCl3) δ 11.52 (s, 1H, OH), 9.08 (s, 1H, NH), 5.88 
(ddt, J1 = 17 Hz, J2 = 10.5 Hz, J3 = 5.5 Hz, 1H), 5.76 (s, 1H), 5.75 (s, 1H), 5.24 (d, J = 17 
Hz, 1H), 5.14 (d, J = 10.5 Hz, 1H), 3.93 (s, 3H), 3.81 (t, J = 5.5 Hz, 2H), 3.76 (s, 3H); 13C 
NMR (125 MHz, CDCl3) δ 168.6, 164.5, 161.3, 154.8, 134.2, 116.1, 92.6, 89.1, 87.0, 56.6, 
55.2, 45.5; HRMS-ESI (m/z): [M+H]+ calculated for C12H15NO4 237.1001, found 237.997. 
N-Allyl dimethoxyanthranilate 84: A 250 mL flame dried flask was charged with N-allyl 
dimethoxyanthranilic acid 84a (5.0 g, 21 mmol, 1 equiv), K2CO3 (1.6 g, 11.6 mmol, 0.55 
equiv), 135 mL dry DMF and a stir bar. The reaction mixture was heated to 90 °C for 0.5 
h before being cooled to room temperature. Then 2-bromo-4′-methoxyacetophenone (5.1 
g, 22.13 mmol, 1.05 equiv) was added and the reaction mixture was stirred at room 
temperature overnight and added to ice water. After 5 min, compound 84 precipitated from 
the solution. The solid was filtered and dried. (If no precipitate was formed, extraction with 
CH2Cl2 can be used to obtain the crude product.) Purification by silica gel column 
chromatography (gradient of EtOAc/hexane from 1:6 to 1:2) afforded N-allyl 





84: Rf = 0.35 (EtOAc / hexanes = 1 : 2); mp 95-96 °C 
(CH2Cl2); IR (thin film): νmax 3370, 2937, 1683, 1602, 1459, 
1233, 1155, 1106, 1021, 806 cm-1; 1H NMR (500 MHz, 
CDCl3) δ 7.96 (d, J = 9 Hz, 2H), 7.54 (t, J = 5 Hz, 1H, NH), 
6.96 (d, J = 9 Hz, 2H), 5.95 (m, 1H), 5.81 (d, J = 2 Hz, 1H), 5.79 (d, J = 2 Hz, 1H), 5.48 (s, 
2H), 5.30 (ddd, J1 = 1.5 Hz, J2 = 3 Hz, J3 = 17 Hz, 1H), 5.17 (ddd, J1 = 1.5 Hz, J2 = 3 Hz, 
J3 = 10.5 Hz, 1H), 3.87 (s, 3H), 3.86 (tdd, J1 = 5 Hz, J2 = J3 = 1.5 Hz, 2H), 3.80 (s, 3H), 
3.79 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 191.8, 167.1, 164.2, 164.0, 162.7, 152.4, 
134.9, 130.3, 127.4, 116.0, 114.0, 96.5, 88.7, 87.6, 65.8, 56.0, 55.0, 46.0; HRMS-ESI 
(m/z): [M+H]+ calculated for C21H24NO6 386.1604, found 386.1595. 
N-Allyl-3-HQ 90: A 500 mL flame dried flask was charged with N-allyl 
dimethoxyanthranilate 84 (2.4 g, 6.2 mmol, 1 equiv), 200 mL dry THF and a stir bar. Then 
NaH (60 % dispersion in mineral oil) (0.747 g, 18.7 mmol, 3 equiv) was added to the 
solution at room temperature. The reaction mixture was heated to 80 °C for 8 h and was 
then cooled to 0 °C using an ice bath. Subsequently, the cold reaction mixture was added 
slowly at 0 °C to 400 mL of a sat. solution of NH4Cl solution. Then 1 M aqueous HCl 
solution was added to acidify the mixture to pH = 6. The mixture was extracted 3  200 
mL with CH2Cl2, the combined organic layers were washed with Sat. NaCl (20 mL), dried 
over Na2SO4, filtered, and concentrated in vacuo. Purification by silica gel column 
chromatography (gradient of EtOAc/hexane from 1:2 to 1:1 to remove byproducts, then 
acetone/CH2Cl2 from 1:5 to 1:3 to elute products) afforded compound 90 (1.32 g, 58%) as 





90: Rf = 0.33 (CH2Cl2 / acetone = 2 : 1); mp 159-161 °C 
(CH2Cl2); IR (thin film): νmax 3268, 2936, 2839, 1579, 1508, 
1239, 1205, 1165, 1033, 731 cm-1; 1H NMR (500 MHz, 
CDCl3) δ 7.34 (d, J = 8.5 Hz, 2H), 7.01 (d, J = 8.5 Hz, 2H), 6.37 (d, J = 2 Hz, 1H), 6.33 
(d, J = 2 Hz, 1H), 5.82 (m, 1H), 5.26 (d, J = 10.5 Hz, 1H), 4.98 (d, J = 17 Hz, 1H), 4.54 
(s, 2H), 3.99 (s, 3H), 3.85 (s, 6H); 13C NMR (125 MHz, CDCl3) δ 169.5, 162.5, 161.9, 
160.3, 142.6, 139.9, 132.2, 132.0, 130.8, 123.8, 117.6, 114.2, 109.0, 93.7, 90.6, 56.3, 
55.34, 55.29, 51.5; HRMS-ESI (m/z): [M+H]+ calculated for C21H22NO5 368.1498, 
found 368.1491. 
 
N-Me-Br-aza-rocaglate 97: In a 200 mL flame dried flask, N-allyl-3-HQ 90 (500 mg, 1.36 
mmol, 1 equiv), methyl cinnamate 21 (3.31 g, 20.4 mmol, 15 equiv), 40 mL toluene, were 
added. After degassing with argon for 10 min in a sonicator, the reaction flask was 
connected to the continuous photoflow reactor. After the solvent pump started, nitrogen 
gas was bubbled into the reaction mixture for another 10 min to further purge the remaining 
air out of the reaction system. The reaction mixture cooled to 0 °C and was kept circulating 
and irradiated (Rayonet, λ > 330 nm) at 0 °C for 13 h. We also found that compound 95 





chromatography (gradient of EtOAc / hexane 1:10 to remove methyl cinnamate first, then 
EtOAc / hexane 1 : 5 to 1 : 4) afforded crude compound 95 (296 mg, 41% combined with 
96) which was subjected to the next step directly.  
A 100 mL flame dried flask was charged with crude compound 95 (296 mg, 0.56 mmol, 1 
equiv) and a stir bar. Then 20 mL of dry methanol were added to form a pale yellow 
solution. A sodium methoxide solution prepared from sodium metal (129 mg, 6.6 mmol, 
10 equiv) and 10 mL of dry methanol was added to the solution of compound 95 and the 
resulting mixture was heated to 50 °C for 20 min before being quenched with saturated 
NH4Cl aqueous (20 mL). The reaction was diluted and extracted with EtOAc (3 x 10 mL), 
then washed with saturated aqueous NaCl (20 mL), dried with anhydrous sodium sulfate, 
filtered, and concentrated in vacuo, which was subjected to next step without any further 
purification. To a 25 mL flame dried flask was added, crude product 96 (120 mg), 
tetramethylammonium triacetoxyborohydride (882 mg, 3.4 mmol, 6 equiv), acetic acid 
(192 μL, 3.4 mmol, 6 equiv) and 15 mL of dry acetonitrile. The resulting yellow solution 
was stirred for 14 h at room temperature before being quenched with sat. NH4Cl solution 
(10 mL) and saturated aqueous potassium sodium tartrate tetrahydrate (Rochelle salt) (10 
mL) to remove boron compounds by complexation. The mixture was then extracted with 
CH2Cl2 (3 x 5 mL) and the combined organic layers were washed with sat. NaHCO3 (20 
mL), dried over Na2SO4, filtered, and concentrated in vacuo. The crude product was 
purified by flash chromatography (gradient of EtOAc/hexane from 1:5 to 1:2) to afford 




97: Rf = 0.33 (EtOAc / hexanes = 1 : 1); mp 86 - 88 °C (CH2Cl2); 
IR (thin film): νmax 3525, 2951, 1744, 1610, 1512, 1463, 1249, 
1151, 1039, 736 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.43 (d, J = 
7.5 Hz, 2H), 7.19 (t, J = 7.5 Hz, 2H), 7.12 (m, 1H), 6.95 (d, J = 9 
Hz, 2H), 6.61 (d, J = 9 Hz, 2H), 5.90 (d, J = 1.75 Hz, 1H), 5.72 (d, J = 1.75, 1H), 5.64 (m, 
1H), 5.31 (dd, J1 = 17.25 Hz, J2 = 1.25 Hz, 1H), 5.15 (dd, J1 = 10.25 Hz, J2 = 1.25 Hz, 1H), 
4.77 (m, 1H), 4.60 (d, J = 8.5 Hz, 1H), 3.84 (s, 3H), 3.79 (s, 3H), 3.76 (m, 2H), 3.69 (dd, 
J1 = 8.5 Hz, J2 = 5.5 Hz, 1H), 3.68 (s, 3H), 3.65 (s, 3H), 3.23 (d, J = 4 Hz, 1H, OH), 2.98 
(s, 1H, OH); 13C NMR (125 MHz, CDCl3) δ 172.4, 163.5, 158.5, 157.5, 153.1, 139.8, 134.4, 
130.5, 129.4, 128.03, 127.98, 126.4, 116.8, 112.6, 104.6, 92.5, 87.7, 87.1, 87.0, 80.2, 55.5, 
55.3, 55.0, 54.6, 53.0, 51.8, 48.8. HRMS-ESI (m/z): [M+H]+ calculated for C31H34NO7 
532.2342, found 532.2347. 
 
N-H-aza-rocaglate 50: In a flame-dried test tube, N-allyl-aza-rocaglate 97 (20 mg, 0.038 
mmol, 1 equiv) and Meldrum's acid (21.7 mg, 0.15 mmol, 4 equiv) was dissolved in DCE 
(1 mL). To another flame-dried test tube was added Pd2(dba)3 (6.89 mg, 7.52 μmol, 0.2 
equiv) and 1,4- bis(diphenyl-phosphino)butane (dppb, 7.22 mg, 0.017 mmol, 0.45 equiv) 
in DCE (2 mL). The test tube was then evacuated and backfilled with argon for three times 
and stirred for 0.5 h at room temperature. The two solutions were combined into one test 





heated to 80 °C. After 14 h, the reaction was cooled to room temperature and quenched 
with saturated Na2CO3 aqueous solution (3 mL). Then 5  2 mL CH2Cl2 was used for 
extraction, and the combined organic layer was washed with sat. NaCl (20 mL), dried over 
Na2SO4, filtered, and concentrated in vacuo. Purification by silica gel column 
chromatography (gradient of EtOAc / hexane from 1 : 4 to 1 : 1 to elute the product) 
afforded N-H-aza-rocaglate 50 (9.1 mg, 49%) as a colorless oil. 
50: Rf = 0.27 (EtOAc / hexanes = 1 : 1); IR (thin film): νmax 3466, 
2927, 2849, 1743, 1614, 1515, 1456, 1218, 1202, 1151, 1034 cm-
1; 1H NMR (500 MHz, CDCl3) δ 7.08 (m, 3H), 6.96 (d, J = 18.5 
Hz, 2H), 6.71 (d, J = 18.5 Hz, 2H), 6.69 (m, 2H), 6.09 (d, J = 1.5 
Hz, 1H), 6.01 (d, J = 1.5 Hz, 1H), 5.11 (d, J = 7.5 Hz, 1H), 4.72 (bs, 1H, OH), 4.16 (bs, 
1H, OH), 4.01 (d, J = 14 Hz, 1H), 3.88 (s, 3H), 3.85 (dd, J1 = 14 Hz, J2 = 7.5 Hz, 1H), 3.81 
(s, 3H), 3.75 (s, 3H), 3.61 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 170.7, 163.8, 158.4, 
157.2, 150.9, 137.4, 129.7, 128.1, 127.89, 127.87, 126.8, 112.8, 108.5, 94.4, 90.9, 89.6, 
80.9, 80.7, 56.4, 55.6, 55.5, 55.2, 51.7, 51.3. HRMS-ESI (m/z): [M+H]+ calculated for 
C28H29NO7 492.2022, found 492.2029. 
 
Aza-rocaglate 98: To a flame-dried test tube was added N-allyl-aza-rocaglate 97 (35 
mg, 0.066 mmol, 1 equiv) and methyl acrylate (60 μL, 0.66 mmol, 10 equiv) in dry 





Then, in a glove box, 2nd Generation Grubb's Catalyst (5.6 mg, 6.6 μmol, 0.1 equiv) 
was added to another flame-dried test tube and the former reaction solution was 
cannulated into the test tube. Then an additional 1 mL of dry DCE was used to wash 
the residue and the solution was combined together by cannulation. The reaction 
mixture was heated to 80 °C in darkness for 12 h before being cooled down to room 
temperature. Subsequently, 5 mL of brine was added to quench the reaction. After 
extraction with 3  2 mL CH2Cl2, the combined organic layers were washed with sat. 
NaCl solution (5 mL), dried over Na2SO4, filtered, and concentrated in vacuo. 
Purification by silica gel column chromatography (EtOAc / hexanes 3 : 2) afforded 
compound 98 (23.6 mg, 61%) as a colorless oil. 
98: Rf = 0.25 (EtOAc / hexanes = 1 : 1); IR (thin film): νmax 3525, 
2951, 1718, 1610, 1513, 1462,1351, 1251, 1152, 1040 cm-1; 1H 
NMR (500 MHz, CDCl3) δ 7.34 (d, J = 7.5 Hz, 2H), 7.20 (t, J = 
7.5 Hz, 2H), 7.14 (m, 1H), 6.94 (d, J = 9 Hz, 2H), 6.69 (m, 1H), 
6.60 (d, J = 9 Hz, 2H), 4.80 (dd, J1 = J2 = 7 Hz, 1H), 4.51 (d, J = 7 Hz, 1H), 3.865 (s, 3H), 
3.864 (m, 1H), 3.78 (s, 3H), 3.73 (m, 1H), 3.672 (s, 3H), 3.665 (s, 3H), 3.65 (s, 3H), 3.57 
(d, J = 7 Hz, 1H, OH), 3.55 (dd, J1 = J2 = 7 Hz, 1H), 3.25 (s, 1H, OH); 
13C NMR (125 MHz, 
CDCl3) δ 172.5, 166.4, 163.5, 158.7, 157.6, 152.3, 144.3, 139.9, 130.4, 129.4, 128.2, 128.0, 
126.5, 121.7, 112.8, 105.5, 91.9, 88.3, 87.3, 86.9, 80.5, 55.6, 55.4, 54.9, 54.3, 52.8, 51.9, 







X-ray Crystallographic Data for Compound 62: 
 
Crystals of compound 62 suitable for X-ray analysis were obtained by slow evaporation 
from hexanes/CH2Cl2. Crystallographic data have been deposited with the Cambridge 
Cystallograhic Data Centre (CCDC# 1457719). Copies of the data can be obtained free of 
charge on application to the CCDC, 12 Union Road, Cambridge CB21EZ, UK (fax: (+44)-
1223-336-033; e-mail: deposit@ccdc.cam.ac.uk). 
Computing details: Data collection: APEX2 (Bruker, 2006); cell refinement: SAINT 
(Bruker, 2006); data reduction: SAINT (Bruker, 2006); program(s) used to solve structure: 
SHELXT (Sheldrick, 2015); program(s) used to refine structure: SHELXL2014/7 
(Sheldrick, 2014); molecular graphics: Olex2 (Dolomanov et al., 2009); software used to 




Crystal Data:  
  C34H30BrNO6 Z = 2 
Mr = 628.50 F(000) = 648 
Triclinic, P¯1 Dx = 1.484 Mg m
-3 
a = 9.979 (4) Å Cu K radiation,  = 1.54178 Å 
b = 11.195 (4) Å Cell parameters from 9870 
reflections 
c = 13.087 (5) Å  = 4.1–74.4° 
 = 77.795 (15)°  = 2.40 mm-1 
 = 81.273 (19)° T = 100 K 
 = 83.202 (16)° Block, colorless 












  Refinement on F2 0 restraints 
  Bruker D8 Quest  
diffractometer 
5750 independent reflections 
Radiation source: Microfocus sealed 
tube 
5262 reflections with I > 2(I) 
Bruker MX Rint = 0.032 
 and phi scans max = 74.8°, min = 3.5° 
Absorption correction: multi-scan  
SADABS (Bruker, 2006) 
h = -12 12 
Tmin = 0.658, Tmax = 0.754 k = -13 13 




Least-squares matrix: full Hydrogen site location: mixed 
R[F2 > 2(F2)] = 0.031 H atoms treated by a mixture of 
independent and constrained 
refinement 
wR(F2) = 0.074  w = 1/[2(Fo
2) + (0.0298P)2 + 
1.3237P]   
where P = (Fo
2 + 2Fc
2)/3 
S = 1.04 (/)max = 0.001 
5750 reflections max = 0.62 e Å
-3 




Geometry: All esds (except the esd in the dihedral angle between two l.s. planes) 
are estimated using the full covariance matrix.  The cell esds are taken into account 
individually in the estimation of esds in distances, angles and torsion angles; 
correlations between esds in cell parameters are only used when they are defined by 
crystal symmetry. An approximate (isotropic) treatment of cell esds is used for 
estimating esds involving l.s. planes. 
Refinement: CheckCIF Alert and Discussion: 
 Alert level B PLAT420_ALERT_2_B D—H Without Acceptor O3 – H3. Please 
Check   Discussion:  While H3 does not have a strong H-bond acceptor due to packing 
constraints, there is a close OH-pi inter-action with C22 with the H3 – C22 distance at 
2.590 Angstroms. 
Fractional atomic coordinates and isotropic or equivalent isotropic displacement 
parameters (Å2) 
 x y z Uiso*/Ueq 




















0.80277 (9) 0.0161 (2) 



























H1A 1.6822 -0.1112 0.6258 0.035* 
H1B 1.6086 -0.0862 0.7377 0.035* 









































































































































H19A 1.1917 0.3882 0.6948 0.031* 
H19B 1.1462 0.4459 0.7980 0.031* 





























































0.45010 (8) 0.0210 (3) 





0.34832 (7) 0.0215 (4) 





0.31129 (6) 0.0185 (3) 
H29 1.1860 0.3030 0.2417 0.022* 
C30 1.17898 (9) 0.36963 (9) 0.37603 (8) 0.0186 (3) 
H30 1.2513 0.4207 0.3507 0.022* 
C31 1.11197 
(10) 
0.36481 (9) 0.47781 (7) 0.0160 (3) 















H33A 0.5189 0.3585 0.4435 0.036* 
H33B 0.4339 0.3618 0.5570 0.036* 



















































































































































































Computational Studies of TADDOL-Mediated Enantioselective 
ESIPT Photocycloadditions 
 
As described in section 1.3.2, 3-hydroxyflavone (3-HF, 1) and methyl cinnamate 2 
undergo enantioselective ESIPT photocycloaddition in the presence of tetrakis-1-pyrenyl 
TADDOL 3 or tetrakis-9-phenanthrenyl TADDOL 5 as chiral hydrogen bonding additives 
(Scheme 4.1). Although this methodology was an elegant enantioselective 
photocycloaddition strategy to access rocaglate natural products, the mechanism by which 
TADDOL imparts enantioselectivity in the reaction was still poorly understood, providing 
motivation for detailed inquiry. Furthermore, such mechanistic studies may provide 
additional insight for future development of a catalytic variant of this asymmetric ESIPT 
photocycloaddition. In this section, we will present our collaborative work with Prof. David 
Coker and coworkers (Boston University) to elucidate the enantio-determining transition 
state for the asymmetric ESIPT photocycloaddition employing Metadynamics calculations. 





4.1 Catalytic, Enantioselective Photochemical Reactions 
Before proceeding with our computational studies, it is important to highlight 
relevant literature describing the advancement of catalytic, enantioselective photochemical 
reactions.93 In 2005, Bach and coworkers presented the first catalytic, enantioselective 
photochemical cyclization using chiral benzophenone catalyst 9 which may form two 
hydrogen bonds with substrate 7 (Scheme 4.2a).94 Upon photoirradiation, the 
benzophenone moiety may trigger photoinduced electron transfer (PET) to generate radical 
intermediate 8. Subsequently, asymmetric cyclization affords the chiral spirocyclic 
pyrrolizidine product 10 in 38% ee They proposed a model wherein the bottom face of the 
substrate was blocked, thus leading to stereochemical induction. More recently, Bach and 
coworkers reported the utilization of a chiral xanthone catalyst 1295 which was selectively 
excited using a 366 nm light source followed by triplet energy transfer (ET  310 kJ/mol) 
to lactam 12 (max = 315 nm, ET  280 kJ/mol, with no absorbance at 366 nm) (Scheme 
4.2b). This efficient process was also assisted by a double hydrogen bonding interaction 
between catalyst 12 and lactam 11. Rapid intramolecular [2+2]-cycloaddition inside the 










Scheme 4.2 Catalytic, Enantioselective Photoreaction Using Double Hydrogen Bonding Catalysts 
 
Bathochromic shifts of the absorbance of a reactant’s chromophore to eliminate 
background photoreactions was also employed in catalytic, enantioselective 
photochemistry development. In 2013, Bach and coworkers applied this strategy to 
intramolecular [2+2]-cylcoaddition of the homoallylic alkene-tethered lactam 15 (Scheme 
4.3).96 Chiral Lewis acid 16 could sufficiently bind substrate 15 and lead to a bathochromic 
shift of the maximum absorption wavelength of 15 from 290 nm to 343 nm so that 
photoexcitation at 366 nm promoted the [2+2]-cycloaddition, leading to the formation of 
17 in 84% yield and 88% ee 





Additionally, Sivaguru and coworkers have reported a catalytic, enantioselective 
[2+2]-photocycloaddition of alkenyl coumarins to afford photocycloadducts in 96% ee 
with 10 mol% catalyst loading (Scheme 4.4).97 In this report, the authors proposed that 
thiourea catalyst 19 was donating neither its triplet nor its singlet energy to the ground state 
of coumarin 18 which is supported by fluorescence data (singlet energy) and 
phosphorescence (triplet energy) measurements. Because both the singlet and triplet 
energies of coumarin 18 were higher than that of catalyst 19, direct energy transfer from 
catalyst 19 to substrate 18 to introduce asymmetric photocycloaddition was ruled out. On 
the other hand, since the fluorescence signal of thiourea 19 was quenched by addition of 
coumarin substrate 18, exciplex formation between photoexcited 19* and 18 was proposed 
to be responsible for the observed catalysis. They also propose that the reaction most likely 
proceeded in the triplet state, as oxygen in the solvent could act as a triplet quencher 
resulting in lower conversions.  
Scheme 4.4 Catalytic, Enantioselective [2+2] Photocycloaddition via Exciplex Formation 
 
Melchiorre and coworkers reported a catalytic asymmetric quaternary carbon 
center formation via iminium ion trapping of photoinduced electron transfer-generated 
radicals.98 Upon photoirradiation, tetrabutylammonium decatungstate (TBADT) could 
generate a nucleophilic carbon-centered radical by homolytically cleaving the methylene 




radical addition to iminium intermediate 25 generate from condensation between 
cyclohexenone 21 and amine catalyst 23 to afford intermediate 26. Carbazole functionality 
was found to be an optimal moiety in the catalyst design because of its excellent electron-
donating capability and the high stability of the long-lived carbazole radical cation which 
should lead to formation of radical cation 27. After tautomerization, back electron transfer 
(BET) and hydrolysis, product 24 was produced in 69% yield and 97% ee. 
Scheme 4.5 Catalytic Asymmetric Iminium Ion Trapping of Radicals via Photoredox/Organocatalysis 
Combination 
 
Lastly, Yoon and coworkers disclosed a chiral Lewis acid complex catalyzed 




from an electronically excited photosensitizer (Scheme 4.6).99 In their reaction design, the 
triplet energy of 2′-hydroxychalcone 30 was determined to be 54 kcal/mol which is higher 
than the photocatalyst 32 (46 kcal/mol) indicating that electronically excited photocatalyst 
32 could not transfer its triplet energy to 2′-hydroxychalcone 30 to achieve 
photocycloaddition. By this means, the racemic background reaction can be minimized. 
However, when the reaction was conducted with various oxophilic Lewis acids, formation 
of [2+2] cycloadduct 33 was observed because chelation with Lewis acid could induce a 
dramatic decrease in the triplet energy of substrate 30 (33 kcal/mol) enabling the triplet 
energy transfer. Based on this discovery, use of a chiral Lewis acid complex should induce 
a highly enantioselective reaction. After condition optimization, using 10 mol% of a 
scandium/t-BuPyBox complex as catalyst, [2+2] photocycloadduct 33 was obtained in 
84% yield and 93% ee. 
 






4.2 Computational Studies of TADDOL-Mediated Enantioselective ESIPT 
Photocycloadditions 
It is likely that TADDOL 5 is inducing enantioselectivity by forming a hydrogen 
bond complex with the substrate, and we hoped to more accurately elucidate in the natural 
of the complex and the mechanism of stereochemical induction for the ESIPT 
photocycloadditions. Prior to our computational studies, it is also important to highlight 
pioneering computational study by Houk and coworkers on 1-naphthyl-TADDOL100-
catalyzed hetero-Diels-Alder (HDA) reaction.101 Using a combination of molecular 
mechanics and ONIOM(B3LYP/6-31G(d):AM1) as calculation method, Houk and 
coworkers elucidated that 1-naphthyl-TADDOL promotes the reaction by coordination of 
the carbonyl oxygen through a cooperative hydrogen bonding motif and orientation of the 
aldehyde by CH-π interaction (Scheme 4.7). Herein, in collaboration with Professor David 
Coker, Mr. Thomas Heavey, and Dr. Juan Ortiz-Sanchez (Boston University), we 
considered whether 9-phenanthrenyl TADDOL 5 was inducing enantioselectivity by first 
binding to 3-HF 1 in the ground state (Figure 4.1). To elucidate the hydrogen bonding 
mechanism of TADDOL in the enantioselective ESIPT photocycloaddition, we introduced 
a biased sampling approach using well-tempered metadynamics,102 an approach to 
calculating free energies in systems that exhibit rare events by choosing a set of collective 
variables as a function of coordinates in which free energy could be sampled. We employed 
metadynamics calculations103 under the assumption that a ground state equilibrium exists 
prior to photoexcitation, and that these ground state catalytic complexes ultimately take 




Scheme 4.7 Houk’s Computational Modeling of TADDOL-catalyzed HDA Reaction 
 
In order to exhaustively explore configurations in the ground state, we chose to use 
metadynamics simulations, which would allow us to sample molecular conformations that 
are not accessible by regular molecular dynamics simulation time-scales, and to map out 
the underlying free energy surface (FES) associated with the sampled configurations of 3-
HF 1 / methyl cinnamate 2 docking to the TADDOL 5 additive in solution. In addition, we 
chose a set of collective variables as a function of coordinates to sample the free energy. 
The collective variables (CVs) used in the metadynamics simulations consisted of the 
hydrogen bond distances between the carbonyl oxygen of 3-HF 1, one of alcohol proton of 
TADDOL 5 (CV1), and between the alcohol proton of 3-HF 1 and the second alcohol 
oxygen of TADDOL 5 (CV2) (Figure 4.1). To measure the enantioselectivity of the 
hydrogen bonding interaction in the ground state, we set up reactants in four distinct 
orientations. These experimentally relevant conformations are re-si-endo, si-re-endo, re-
si-exo and si-re-exo (Figure 4.2) which model the facial selectivity and diastereoselectivity 






Figure 4.1 Collective Variables Used in Metadynamics Trajectories 
 
Each studied system was set up following a standard molecular dynamics geometry 
optimization and equilibration procedure before full metadynamics production. The 
Gromacs 5.0.2 package104 and the all-atom Generalized Amber Force Field (GAFF)105 
were employed. The Antechamber software106 was used to generate the topologies from 
the coordinate files. The geometries of TADDOL 5, 3-HF 1, and methyl cinnamate 2 were 
optimized in the gas phase and atomic partial charges were computed at the Hartree-




atomic partial charges were constructed using the RESP (Restrained Electro Static 
Potential)107,108 scheme and constrained during the fit in accordance to the GAFF protocol, 
as implemented in Antechamber. 
We next examined our computation based on our definition of CVs (Figure 4.1) 
the formation of pre-reactant complexes (PRCs) between TADDOL 5 and 3-HF 1 at short 
distance values of CV1 and CV2 corresponding to the hydrogen-bonding interactions. The 
obtained FESs from the four considered systems revealed a set of FES topologies, such as 
Figure 4.2 for re-si-endo which would lead to formation of the major product based on our 
experimental observations. 
Figure 4.2 Free Energy Surfaces (FES) with TADDOL/3-HF/methyl cinnamate in re-si-endo  
 
A deeper analysis of the geometries sampled in the energy minima outlined in 
Figure 4.2 revealed a common trend across the four studied systems. At short CV distances 
(either CV1 or CV1 and CV2), 3-HF establishes one or two hydrogen-bonding interactions 
with TADDOL across the defined CVs or between atoms not defined in our set of CVs, for 




included in the corresponding CV definition. Simultaneously, these hydrogen-bonding 
interactions are reinforced by a π-π stacking interaction between one phenanthren-9-yl 
group of TADDOL and the phloroglucinol moiety of 3-HF 1. This particular interaction 
also blocked one face of 3-HF leaving the other open to enantioselective approch.  
As shown in Figure 4.2, the most relevant energy minima associated to TADDOL 
trajectories for our definition of CVs correspond to a combination of short distances 
CV1/CV2. In Figure 4.3 we highlight these minima by plotting the free energy profiles of 
the TADDOL 3-HF/methyl cinnamate system over CV1 along the cuts CV2 = 3 Å. The 
re-si-endo profiles clearly showed the deeper energy minima and the shape and depth of 
the energy minima for the re-si-endo and si-re-endo systems do not drastically change. 
Figure 4.3 Free Energy Profiles Across CV2 = 3 Å with TADDOL/3-HF/methyl cinnamate in a) re-si- 
endo, b) si-re-endo, c) re-si-exo and d) si-re-exo Orientations  
 
In order to identify chemically relevant PRCs, we have processed every sampled 
geometry contained in each energy minima and extracted those complexes that 
simultaneously exhibit hydrogen-bonding and π-π stacking interaction between TADDOL 




donor and acceptor pairs between TADDOL 5 and 3-HF 1 with a maximum of 2.5 Å, and 
the distance between the center of 3-HF and any phenanthren-9-yl group of TADDOL up 
to a maximum of 3.5 Å. Table 4.1 shows the percentages over the total of sampled 
geometries that fulfill these two conditions for each system.  
Table 4.1 Percentages of Sampled TADDOL/3-HTMF/methyl cinnamate Pre-reactant Complexes 
that Simultaneously Contain Hydrogen-bonding Interaction and a π- π Stacking Interaction Between 
TADDOL and 3-HF. 
Endo Exo 
re-si si-re re-si si-re 
98.6 74.3 90.3 89.5 
 
As is evident, at least 70% of the total sampled geometries in the most predominant 
energy minima for each system fulfill the specified conditions, indicating that hydrogen-
bonding and π-π stacking interactions significantly contribute to the stability of the PRCs. 
It is important to note that not all of these hydrogen-bonding or π-π stacking interactions 
were included in our definition of CVs. As it has been shown in previous studies, the 
sampling performed with metadynamics under a specific set of CVs can also provide useful 
insight on other relevant coordinates and interactions in the system under study. 
Nonetheless, we cannot ignore the involvement of excited electronic states in this reaction. 
The Coker group is currently investigating the energy barriers in both uncatalyzed and 
catalyzed reactions in both the ground and excited states as well as the involvement of 
excited triplet state of 3-HF 1 to further improve our calculation. 
4.3 Experimental Validations 
Using metadynamics calculations, we determined the hydrogen bonding complex 




ESIPT photocycloaddition. In order to test this hypothesis, we have conducted an array of 
enantioselective ESIPT photocycloadditions using methyl cinnamate 2 and stilbene 3444 as 
dipolarophiles with stoichiometric quantities of TADDOL 5. In collaboration with Dr. Neil 
Lajkiewicz, Table 4.2 was constructed to show photocycloadditions with varying 
equivalencies of the dipolarophile methyl cinnamate 2 (or stilbene 34) and stoichiometric 
amounts of 3-HF 5. Interestingly, by reducing the equivalents of 2, the enantiomeric excess 
of the observed photocycloadducts (+)-6 and (+)-35 was found to decrease. These results 
indicate that by decreasing the equivalents of methyl cinnamate, lower enantioselectivities 
were observed, which supports the idea that formation of a hydrogen bonding complex 
between TADDOL 5 and 3-HF 1 is crucial for the enantioselectivity in the ESIPT 
photocycloaddition. Presumably, this may be due to the excited tautomeric intermediate of 
3-hydroxyflavone 1 dissociating from TADDOL 5 before photocycloaddition with methyl 
cinnamate 2. Therefore, lowering the equivalents of methyl cinnamate 2 when employing 
a stoichiometric amount of host complex should have this effect according to studies and 
proposals outlined by Bach and coworkers.95 
Figure 4.4 Possible Host-Guest Complex of TADDOL 5 with 3-HF 1 in Comparison with TADDOL 5 





Additionally, the relevance of a hydrogen-bonded complex was supported by use 
of trans-stilbene 39 as dipolarophile because the hydrogen bonding acceptor, the methyl 
ester moiety on methyl cinnamate 2 (Figure 4.4), is now substituted by a phenyl group. 
Despite the lack of hydrogen bonding acceptor on trans-stilbene 39, the photocycloaddition 
still afforded high enantioselectivity in the photocycloaddition and suggested a trend that 
higher equivalents of TADDOL relative to methyl cinnamate 2 leads to greater 
enantiomeric excess. In a previous study, we have determined the absolute conformation 
of (+)-6 using X-ray crystallography.  




Entry Equiv of 1 Dipolarophile (equiv) Product (yield) ee (%) 
1 1 2 (5 equiv) 6 (34%) 78 
2 1  2 (2 equiv) 6 (15%) 66 
3 1  2 (1 equiv) 6 (6%) 48 
4 2  2 (1 equiv) 6 (3%) 60 
5 1 39 (5 equiv) 40 (27%) 82 
6 1 39 (2 equiv) 40 (15%) 67 
7 1 39 (1 equiv) 40 (9%) 48 





In order to study and compare hydrogen bonding complexation for both reactions, 
it was important to obtain the absolution configuration of the corresponding aglain 
derivative (+)-39.  We first attempted to obtain an enantioenriched crystal of (+)-39 or its 
para-bromobenzoate derivative. However, we were only able to obtain racemic material 
after recrystallization due to centrosymmetric crystallization. Previously, we have reported 
a method to employ kinetic resolution of aglain ketones using asymmetric transfer 
hydrogenation.10 We anticipated that using this methodology on the racemic stilbene 
photocycloadduct (±)-40, we could obtain an enantioenriched crystal of (+)-39 to compare 
with products obtained using enantioselective photocycloaddition (Table 4.2). 
Gratifyingly, we found that asymmetric transfer hydrogenation of aglain ketone (±)-41 via 
Rh-(III) catalysis afforded the enantioenriched aglain (±)-40 in 98% ee and 45% yield 
(Scheme 4.8). Using isopropanol with diethyl ether as a solvent mixture for 
recrystallization, compound 40 was obtained in enantioenriched form which was 
unambiguously confirmed by X-ray crystallography. The major enantiomer of 40 produced 
by photocycloaddition (Table 4.2) was found to be in agreement with the antipode shown 
in Scheme 4.8. With this data in hand, we can conclude that TADDOL-mediated 
enantioselective photocycloaddition proceeded via a hydrogen bonded complex of 








Scheme 4.8 Asymmetric Transfer Hydrogenation of Aglain Ketone ()-41 
 
4.4 Progress Towards Catalytic Asymmetric ESIPT Photocycloaddition 
Having established that hydrogen-bonding in combination with π-π stacking 
interactions could play an important role in enantioselective ESIPT photocycloadditions 
using metadynamics calculations, we next planned to take advantage of this discovery to 
design a catalytic asymmetric ESIPT photocycloaddition. Previously, Dr. Neil Lajkiewicz 
in the Porco laboratory had evaluated a substantial number of catalysts including thioureas, 
TADDOLs, and chiral trifluoroethanols in an attempt to identify ESIPT 
photocycloaddition catalysts. Namely, under UV irradiation (max = 350 nm) , 3-HF 1 was 
reacted with 1 equivalent of methyl cinnamate 2 in -78 °C using 20 mol% catalyst (Scheme 
4.9). However, 40% enantiomeric excess of the product 6 was the best result achieved in 








Scheme 4.8 Previous Attempts Towards Catalytic Asymmetric ESIPT Photocycloaddition  
 
From metadynamics-sampled geometries between TADDOL 5 and 3-HF 1, there 
is substantial population which contains a short distance between one phenanthren-9-yl 
group of TADDOL and the phloroglucinol moiety of 3-HF 1. This observation also leads 
us to consider the possibility of the formation of an exciplex between TADDOL 5 and 3-
HF 1 via π-π stacking. In order to test our hypothesis, a fluorescence quenching study was 
performed (Figure 4.5b), which clearly showed quenching of the fluorescence signal of 
TADDOL 5 upon addition of 3-HF 1 (cf. Scheme 4.4). This study indicates that formation 











Figure 4.5 UV-Vis Absorption of TADDOL 5 and Fluorescence Quenching Study. 
 
In order to achieve catalytic asymmetric ESIPT photocycloaddition, we need to 
minimize or eliminate the racemic background reaction. Accordingly, use of a red-shifted 
light source in comparison to the previously used UV-lamp (max = 350 nm) may be helpful 
for elimination of the background reaction (3-HF 1, ab,max = 365 nm). Towards this end, 
two visible light sources, namely Kessil® purple LED’s (370 nm <  < 405 nm, max = 390 
nm) and Kessil® blue LED’s (400 nm <  < 450 nm, max = 427 nm) were used.
109 In order 
to compare with our previous stoichiometric results, we chose TADDOL 5 as catalyst. 
Gratifyingly, we did observe some improvement by using visible light sources for the 
ESIPT photocycloaddition.  First, using a Kessil® purple LED (390 nm) as light source, a 
49% ee of product ()-6 was observed after 36 h of irradiation. When Kessil® blue LEDs 







Scheme 4.10 Catalytic Asymmetric ESIPT Photocycloaddition using Visible Light  
 
These preliminary results are quite encouraging; however, further photophysical 
studies will be required to decipher the mechanism of the visible light-mediated, catalytic 
asymmetric ESIPT photocycloaddition. More importantly, we will screen additional 
hydrogen bonding catalysts bearing polyaromatic substitution such as phenanthrenyl or 
anthracenyl which may potentially have π-π stacking interactions with 3-HF 1. 
Furthermore, the impact of reaction solvent and temperature should also be studied as well 
to identify optimal conditions for the catalytic asymmetric ESIPT photocycloadditions.  
4.5 Summary  
In summary, we have utilized computation to decipher the enantio-determining 
hydrogen bonding complex for the TADDOL-mediated enantioselective ESIPT 
photocycloadditions. Using metadynamic simulations under the assumption that ground 
state pre-reactant complexes (PRCs) exists prior to photoexcitation, free energy surfaces 
(FESs) were obtained based on two defined collective variables. Evaluation of these FESs 
also showed good agreement with our experimental data that re-si-endo orientation would 
lead to formation of the major enantiomer as well as diastereomer. From the sampled 




hydrogen-bonding interactions, π-π stacking interactions between TADDOL and 3-HF 
may also contribute to the stability of the PRCs. 
To further validate our computational data, we conducted a series of TADDOL-
mediated enantioselective ESIPT photocycloadditions which unambiguously confirmed 
that the hydrogen-bonding complex between 3-HF and TADDOL is the enantio-
determining assembly for the enantioselective ESIPT photocycloaddition. Furthermore, 
metadynamics calculations have also provide further insight to aid development of 
catalytic, asymmetric ESIPT photocycloadditions. 
4.6 Experimental Section  
Instrumentation and Methods: 1H NMR spectra were recorded at 400 or 500 MHz at ambient 
temperature with CDCl3(Cambridge Isotope Laboratories, Inc.) as solvent. Data for 1H NMR are 
reported as follows: chemical shift, integration, multiplicity (brs = broad singlet, s = singlet, d = 
doublet, t = triplet, q = quartet, m = multiplet) and coupling constants in Hz. 13C NMR spectra were 
recorded at 100.0 or 125 MHz at ambient temperature with the same solvents unless otherwise 
stated. Chemical shifts are reported in parts per million relative to the deuterated solvents. All 13C 
NMR spectra were recorded with complete proton decoupling. Infrared spectra were recorded on a 
Nicolet Nexus 670 FT-IR spectrophotometer. High-resolution mass spectra were obtained in the 
Boston University Chemical Instrumentation Center using a Waters Q-TOF API-US mass 
spectrometer. Melting points were recorded on a Mel-Temp apparatus (Laboratory Devices). 
Optical rotations were recorded on an AUTOPOL III digital polarimeter at 589 nm, and specific 
rotations are given [α]D20 (concentration in grams/100 mL solvent). Chiral HPLC analysis of 
enantioenriched compounds was performed using a Waters 1525 Binary HPLC Pump with a Waters 




mm silica gel 60-F plates (Silicycle, Inc.) Analytical thin layer chromatography was performed 
using 0.25mm silica gel 60-F plates. Flash chromatography was performed using 200-400 mesh 
silica gel (Scientific Absorbents, Inc.). Yields refer to chromatographically and spectroscopically 
pure materials, unless otherwise stated. HPLC grade tetrahydrofuran, methylene chloride, diethyl 
ether, toluene, acetonitrile, and benzene were purchased from Fisher and VWR and were purified 
and dried by passing through a PURE SOLV® solvent purification system (Innovative Technology, 
Inc.). Other ACS grade solvents for chromatography were purchased from Clean Harbors. 
 
General Procedure and Synthesis:  
 
General Procedure to Perform Low Temperature, Asymmetric Photocycloaddition with 
TADDOL 5: 
A flame-dried Pyrex photoreaction tube was charged with 3-hydroxyflavone 1 (20 mg, 0.061 mmol, 
1 equiv), methyl cinnamate 2 (Reaction 1 in Table 4.2, 49.4 mg, 0.305 mmol, 5 equiv), TADDOL 
5 (55.1 mg, 0.061 mmol, 1 equiv) and 2 mL dry CH2Cl2 (0.03 M). After degassing with argon for 
10 min, the mixture was irradiated at -78 °C in the Rayonet RPR-3100 reactor (300 < λ < 400 nm) 




chromatography using a gradient of hexanes/EtOAc (80:20 to 30:70) afforded 
cyclopenta[bc]benzopyran aglain ketone compound, a light yellow foam, as a mixture of isomers 
(e.g. Reaction 1 in Table 4.2 13 mg). This mixture of isomers was used without further purification 
and was transformed into the desired reduced aglain 6 using sodium triacethoxyborohydride. A dry 
test tube was charged with a stir bar, reducing agent (0.166 mmol, 6 equiv.), acetic acid (9 µL, 
0.166 mmol, 6 equiv.), and trifluorotoluene (1.5 mL) at rt under argon. The mixture was then 
sonicated briefly and stirred at rt for 10 min. The crude aglain from the previous reaction (13 mg) 
was then added at rt in one portion under argon. The resulting mixture was then stirred for 24 h and 
was quenched with saturated ammonium chloride, extracted with CH2Cl2, washed with saturated 
sodium bicarbonate, and dried over sodium sulfate. The filtrate was concentrated in vacuo. Column 
chromatography using 5:95 EtOAc/CH2Cl2 afforded compound 5 as a white solid (10.2 mg, 0.021 
mmol, 34%). Reaction 1 - 8 in Table 4.2 were all conducted using this general procedure. 
 
Kinetic Resolution of Aglain (±)-41: 
A dry flask was charged with a stir bar, (±)-41 (100 mg, 0.19 mmol, 1 equiv) and CH2Cl2 (5 mL). 
In a separate dry test tube, [RhCl2(Cp*)]2 (1.17 mg, 0.0019 mmol, 1 mol%), (S,S)-N-Tosyl 
diphenylethylenediamine (1.39 mg, 0.0038 mmol, 2 mol%), formic acid (14.33 μL, 0.38 mmol, 2.0 
equiv), triethylamine 52.7 mL, 0.38 mmol, 2.0 equiv), and CH2Cl2 (2 mL) were combined and 
stirred for 30 min. At this time, the entire contents of the separate flask were added to the reaction 
mixture and the reaction was allowed to stir at room temp. for 12 h. After this time, a saturated 




(3  10 mL), and finally dried with anhydrous sodium sulfate, filtered, and concentrated in vacuo. 
The crude product was purified via silica gel column chromatography (1:3 EtOAc/hexanes to 2:3 
EtOAc/hexanes) to afford compound 40 in 45% yield (46 mg, 0.0946 mmol) as a white solid. The 
enantiopurity of (+)-40 was determined using analytical chiral HPLC (98% ee). [α]D20 = + 53.1° (c 
= 0.1, CH2Cl2). Rf = 0.43 (EtOAc: hexanes = 1 : 1); m.p. = 108 - 110 °C (CH2Cl2). IR νmax (film): 
3482, 2941, 2839, 1618, 1518, 1252, 1148, 1090, 829, 701 cm-1; 1H NMR (500 MHz, CDCl3)  
7.48 (d, J = 9 Hz, 2H), 7.15 (m, 5H), 6.97 (m, 5H), 6.70 (d, J = 9 Hz, 2H), 6.17 (d, J = 2.25 Hz, 
1H), 5.85 (d, J = 2.25, 1H), 5.35 (s, 1H), 4.92 (s, 1H), 4.23 (d, J = 10 Hz, 1H), 4.12 (d, J = 10 Hz, 
1H), 3.76 (s, 3H), 3.72 (s, 3H), 3.48 (bs, 1H), 3.10 (s, 3H); 13C NMR (125 MHz, CDCl3)  160.9, 
158.8, 158.7, 153.4, 141.9, 137.2, 130.30, 130.25, 129.9, 128.9, 128.7, 127.5, 126.7, 125.8, 112.9, 
106.2, 94.1, 92.4, 89.4, 82.1, 79.0, 66.1, 59.3, 55.6, 55.4, 55.1; HRMS-ESI (m/z): [M+H]+ calcd 
for C32H30O6, 511.2121; found 511.2121. 
Chiral HPLC Analysis: 
Chiral HPLC analysis of aglain compound 6. 
The following chiral HPLC conditions were used for the separation of enantiomers of 6: ChiralPak 
AD 150 × 4.6 mm column, 20% isopropanol in hexane. Flow rate: 1.0 mL/min. UV detector: 214 
nm. Retention times: 13.5 min and 21.7 min. 
Reaction 1 in Table 4.2: ESIPT photocycloaddition of 3-hydroxyflavone 1 with 5.0 equiv of methyl 





Reaction 2 in Table 4.2: ESIPT photocycloaddition of 3-hydroxyflavone 1 with 2.0 equiv of methyl 
cinnamate 2 in the presence of 1.0 equiv of TADDOL 5. 
 
Reaction 3 in Table 4.2: ESIPT photocycloaddition of 3-hydroxyflavone 1 with 1.0 equiv of methyl 
cinnamate 2 in the presence of 1.0 equiv of TADDOL 5. 
 
Reaction 3 in Table 4.2: ESIPT photocycloaddition of 3-hydroxyflavone 1 with 0.5 equiv of methyl 
cinnamate 2 in the presence of 1.0 equiv of TADDOL 5. 
 
Chiral HPLC analysis of aglain 40. 
The following chiral HPLC conditions were used for the separation of enantiomers of 40: ChiralPak 
AD 150 × 4.6 mm column, 20% isopropanol in hexane. Flow rate: 1.0 mL/min. UV detector: 214 




Reaction 5 in Table 4.2: ESIPT photocycloaddition of 3-hydroxyflavone 1 with 5.0 equiv of trans-





Reaction 6 in Table 4.2: ESIPT photocycloaddition of 3-hydroxyflavone 1 with 2.0 equiv of 
trans-stilbene 39 in the presence of 1.0 equiv of TADDOL 5. 
 
Reaction 7 in Table 4.2: ESIPT photocycloaddition of 3-hydroxyflavone 1 with 1.0 equiv of 
trans-stilbene 39 in the presence of 1.0 equiv of TADDOL 5. 
  
Reaction 5 in Table 4.2: ESIPT photocycloaddition of 3-hydroxyflavone 1 with 0.5 equiv of 










Visible Light-mediated Catalytic Asymmetric ESIPT Photocycloaddition. 
 
 
To a flame-dried test tube was charged with 3-HF 1 (30 mg, 0.091 mmol, 1 equiv), 
TADDOL 5 (16.6 mg, 0.018 mmol, 0.2 equiv), methyl cinnamate 2 (18 mg, 0.111 mmol, 
1.2 equiv), and 9 mL dry CH2Cl2 (0.01 M). The resulting mixture was degassed for 15 min 
using sonication in combination with simultaneously bubbled argon into the solution. The 
test tube was then carefully sealed and put into a dewar. The low temperature was kept 




irradiation, the reaction mixture was concentrated in vacuo and redissolved in 3 mL 
trifluorotoluene. Subsequently, sodium triacetoxyborohydride (116 mg, 0.55 mmol, 6 equiv) and 
acetic acid (0.031 mL, 0.55 mmol, 6 equiv) were added. The resulting mixture was stirred at room 
temperature for 10 hours before quenched with 10 mL Sat. NH4Cl (aq.). After extraction with 
CH2Cl2, the solution was dried over anhydrous Na2SO4. The reaction mixture was 
concentrated in vacuo and purified via column chromatograph (eluent: hexanes/EtOAc = 15:1 to 
remove TADDOL and remaining methyl cinnamate, then hexanes/EtOAc = 2:1) to yield the desired 
product ()-6. 1H NMR of obtained ()-6 was found in good agreement with previous characterized 
spectrum. 
Chiral HPLC analysis of aglain compound 6. 
The following chiral HPLC conditions were used for the separation of enantiomers of 6: ChiralPak 
AD 150 × 4.6 mm column, 20% isopropanol in hexane. Flow rate: 1.0 mL/min. UV detector: 214 
nm. 
ESIPT photocycloaddition of 3-hydroxyflavone 1 with 1.2 equiv of methyl cinnamate 2 in the 
presence of 0.2 equiv of TADDOL 5 using purple LED as light source: 
 
ESIPT photocycloaddition of 3-hydroxyflavone 1 with 1.2 equiv of methyl cinnamate 2 in the 







X-Ray Crystallographic Data for Compound ()-40: 
 
Crystals of compound 40 suitable for X-ray analysis were obtained by slow evaporation 
from Et2O / isopropanol = 1 : 1.  
Crystal Data: 
  C32H30O6 Dx = 1.389 Mg m-3 
Mr = 510.56 Cu K radiation,  = 1.54178 Å 




a = 6.4886 (3) Å  = 3.8–66.6° 
b = 12.6920 (5) Å  = 0.77 mm-1 
c = 29.6551 (12) Å T = 100 K 
V = 2442.20 (18)  Å3 Block, colorless 
Z = 4 0.44 × 0.32 × 0.30 mm 
F(000) = 1080  
 
Data collection: 
  Bruker Proteum-R  
diffractometer 
4264 independent reflections 
Radiation source: rotating anode 4263 reflections with I > 2(I) 
Montel Rint = 0.039 
 and  scans max = 66.7°, min = 3.8° 
Absorption correction: multi-scan  
SADABS (Bruker, 2006) 
h = -77 
Tmin = 0.699, Tmax = 0.753 k = -1515 
75526 measured reflections l = -3535 
 
Refinement: 
  Refinement on F2 Hydrogen site location: difference Fourier map 
Least-squares matrix: full H atoms treated by a mixture of independent and 
constrained refinement 
R[F2 > 2(F2)] = 0.022  w = 1/[2(Fo2) + (0.020P)2 + 0.695P]   
where P = (Fo2 + 2Fc2)/3 
wR(F2) = 0.054 (/)max < 0.001 
S = 1.05 max = 0.21 e Å-3 
4264 reflections min = -0.15 e Å-3 
352 parameters Absolute structure:  Flack x determined using 
1791 quotients [(I+)-(I-)]/[(I+)+(I-)]  (Parsons, 
Flack and Wagner, Acta Cryst. B69 (2013) 249-
259). 






Geometry. All esds (except the esd in the dihedral angle between two l.s. planes)  are estimated 
using the full covariance matrix.  The cell esds are taken  into account individually in the estimation 
of esds in distances, angles  and torsion angles; correlations between esds in cell parameters are 
only  used when they are defined by crystal symmetry. An approximate (isotropic)  treatment of 
cell esds is used for estimating esds involving l.s. planes. 
Refinement. CheckCIF Alert and Discussion: 
 PLAT089_ALERT_3_C Poor Data / Parameter Ratio (Zmax < 18). 7.12 Note Discussion:  The 
detector on the Proteum-R has a large face which imposes geometric constraints on the collection 
of data at high angle.  Though the data set is reasonably complete to 0.84 Angstroms, there is almost 
no data to resolution < 0.84 Angstroms, and this tends to yield data sets with a low data to parameter 
ratio for noncentrosymmetric space groups. 
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2) 
 x y z Uiso*/Ueq 
O2 0.35157 (17) 0.55401 (8) 0.32504 (3) 0.0122 (2) 
O3 0.71480 (17) 0.29006 (8) 0.34882 (4) 0.0146 (2) 
H3 0.652 (3) 0.2306 (17) 0.3424 (6) 0.022* 
O4 0.85687 (17) 0.48478 (8) 0.37095 (3) 0.0141 (2) 
H4 0.921 (3) 0.4248 (16) 0.3658 (6) 0.021* 
O5 -0.13385 (17) 0.37294 (8) 0.23871 (4) 0.0165 (2) 
O1 0.69180 (17) 0.99123 (8) 0.37181 (4) 0.0181 (2) 
O6 0.40646 (18) 0.17914 (8) 0.31553 (4) 0.0171 (2) 
C10 0.4531 (2) 0.55661 (11) 0.44887 (5) 0.0118 (3) 
C2 0.6604 (3) 0.88500 (11) 0.36752 (5) 0.0144 (3) 
C9 0.4133 (2) 0.50250 (11) 0.40407 (5) 0.0112 (3) 
H9 0.2607 0.4996 0.3996 0.013* 
C29 0.1346 (2) 0.26957 (12) 0.27521 (5) 0.0141 (3) 
H29 0.0837 0.2052 0.2632 0.017* 
C26 0.2870 (2) 0.45739 (12) 0.30956 (5) 0.0117 (3) 
C15 0.2885 (3) 0.57899 (12) 0.47744 (5) 0.0146 (3) 
H15 0.1520 0.5626 0.4681 0.018* 




C6 0.4240 (2) 0.74178 (12) 0.37979 (5) 0.0133 (3) 
H6 0.2930 0.7173 0.3896 0.016* 
C5 0.5698 (2) 0.66922 (12) 0.36392 (5) 0.0119 (3) 
C13 0.5193 (3) 0.65025 (12) 0.53301 (5) 0.0168 (3) 
H13 0.5420 0.6819 0.5616 0.020* 
C17 0.3562 (3) 0.30213 (12) 0.42292 (5) 0.0132 (3) 
C7 0.4675 (2) 0.84833 (12) 0.38146 (5) 0.0144 (3) 
H7 0.3666 0.8965 0.3921 0.017* 
C16 0.4953 (2) 0.38706 (11) 0.40371 (5) 0.0117 (3) 
H16 0.6232 0.3868 0.4225 0.014* 
C11 0.6521 (3) 0.58186 (11) 0.46312 (5) 0.0139 (3) 
H11 0.7664 0.5666 0.4442 0.017* 
C23 0.5663 (2) 0.37135 (12) 0.35399 (5) 0.0118 (3) 
C30 0.3051 (2) 0.27043 (12) 0.30362 (5) 0.0133 (3) 
C27 0.1181 (2) 0.45931 (12) 0.28071 (5) 0.0130 (3) 
H27 0.0572 0.5244 0.2721 0.016* 
C25 0.3843 (2) 0.36374 (12) 0.32205 (5) 0.0123 (3) 
C18 0.1535 (3) 0.31974 (12) 0.43649 (5) 0.0153 (3) 
H18 0.0949 0.3878 0.4329 0.018* 
C8 0.5104 (2) 0.55441 (12) 0.36060 (5) 0.0112 (3) 
C22 0.4376 (3) 0.20087 (12) 0.42895 (5) 0.0163 (3) 
H22 0.5762 0.1872 0.4204 0.020* 
C14 0.3212 (3) 0.62491 (13) 0.51935 (5) 0.0173 (3) 
H14 0.2077 0.6389 0.5387 0.021* 
C24 0.6747 (2) 0.47640 (11) 0.34465 (5) 0.0124 (3) 
H24 0.7047 0.4853 0.3118 0.015* 
C19 0.0354 (3) 0.23923 (13) 0.45521 (5) 0.0184 (3) 
H19 -0.1022 0.2530 0.4644 0.022* 
C12 0.6844 (2) 0.62904 (12) 0.50465 (5) 0.0158 (3) 
H12 0.8202 0.6470 0.5138 0.019* 
C3 0.8058 (2) 0.81452 (12) 0.35122 (5) 0.0157 (3) 
H3A 0.9365 0.8390 0.3413 0.019* 
C4 0.7585 (2) 0.70718 (12) 0.34950 (5) 0.0148 (3) 
H4A 0.8582 0.6592 0.3382 0.018* 




H21 0.3774 0.0520 0.4504 0.024* 
C20 0.1176 (3) 0.13918 (13) 0.46048 (5) 0.0188 (3) 
H20 0.0368 0.0841 0.4731 0.023* 
C31 -0.2458 (2) 0.27785 (12) 0.22959 (5) 0.0177 (3) 
H31A -0.1674 0.2342 0.2084 0.027* 
H31B -0.3799 0.2954 0.2164 0.027* 
H31C -0.2667 0.2389 0.2578 0.027* 
C32 0.3694 (3) 0.08586 (12) 0.28974 (6) 0.0208 (4) 
H32A 0.3893 0.1012 0.2576 0.031* 
H32B 0.2277 0.0619 0.2948 0.031* 
H32C 0.4659 0.0306 0.2991 0.031* 
C1 0.8883 (3) 1.03058 (13) 0.35839 (6) 0.0224 (4) 
H1A 0.9090 1.0171 0.3262 0.034* 
H1B 0.9966 0.9951 0.3757 0.034* 
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